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Abstract
During the early stages of development the Xenopus endoderm 
becomes specified such that separate regions become committed to form 
different tissue types. We aimed to further understand this process, 
especially the role of signals from the mesoderm.
Using in situ hybridisation the expression patterns of 11 growth 
factors (FGF2, 4, 6, 8, 9 ,10; Wnt3A, 5A, 7A, 8; and BMP4) were determined 
at tailbud stages.
Using isolated endoderm explants from stage 20-23 embryos a 
screen was conducted with panels of growth factors and inhibitors to try 
and identify the mesodermal signals. It was found that none of the factors or 
inhibitors was able to respecify the endoderm. These negative results 
indicate either that some combination of factors is responsible or that the 
signals may be completely novel.
Recombination experiments were carried out between endoderm and 
mesoderm explants. It was found that mesoderm is needed to maintain 
endodermal specification but that there was no reproducible instructive 
induction. It was also found that early stage endoderm explants are normally 
contaminated by mesoderm.
One source of anterior-posterior information in the mesoderm is the 
pattern of Hox gene expression. It is shown that xHoxD13 is expressed 
exclusively in the mesoderm and xHoxA13 is in both mesoderm and 
endoderm. xHoxD13 overexpression does not result in any change of the 
endoderm, but xHoxA13 overexpression produces a deformed gut which is 
flat and fails to coil. These embryos have a large persistent cavity inside the 
endodermal mass. However, the normal regional specification in terms of 
expression of XIHbox8 and xcad2 is still maintained. These results indicate 
that the abnormality arises from a defect in cell movement during gut 
elongation. RNA injections at the 32 cell stage showed that overexpression 
is necesary in both mesoderm and endoderm to obtain the defect.
VII
I. Introduction
1.1. The Endoderm and its derivatives
Early in animal development gastrulation movements result in the 
formation of three principal germ layers: endoderm, mesoderm and the 
ectoderm. The inner most of these germ layers, the endoderm is responsible 
for the formation of the epithelium of two tubes within the body: the 
digestive tube and the respiratory tube. The digestive tube extends 
throughout the whole length of the body and buds from this tube form the 
liver, gallbladder and pancreas. The second tube, the respiratory tube, 
forms as an outgrowth of the digestive tube and eventually bifurcates into 
two lungs.
Both these tubes share a common chamber in the anterior region of 
the embryo, the pharynx. During development the embryo produces four 
pairs of pharyngeal pouches. The region between pairs of the pouches are 
known as pharyngeal arches. The first pair of pharyngeal pouches develops 
to form auditory cavities of the middle ear and the eustachian tubes. The 
second pair forms the walls of the tonsils in mammals. The third pair of 
pharyngeal pouches will contribute to the thymus. This will direct the 
differentiation of T lymphocytes later in development. In mouse the third pair 
of pouches are also responsible for the formation of the parathyroid glands. 
In chick however both the third and the fourth pharyngeal pouch contribute 
to a pair of parathyroid glands each. In addition to these paired pouches, a 
small, central diverticulum is formed between the second pharyngeal 
pouches on the floor of the pharynx. This pocket of endoderm and 
mesenchyme will bud off from the pharynx and migrate down the neck to 
become the thyroid gland (Gilbert, 2000; Slack, 2005).
Cells of the endoderm give rise only to the lining of the digestive tube 
whilst mesenchyme cells from the mesoderm surrounds this tube to provide 
muscles necessary for peristalsis. Evaginations from this tube grow, branch
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and will eventually form differentiated organs such as liver, pancreas and 
gallbladder (Wells and Melton, 1999). The liver and gallbladder arise from 
the hepatic diverticulum which is a tube that extends out from the foregut 
into the surrounding mesenchyme. The mesenchyme induces this 
endoderm to branch and form the glandular epithelium of the liver. A portion 
of hepatic diverticulum that is closest to the digestive tube functions as the 
drainage duct of the liver, and a branch from this duct produces the 
gallbladder. The pancreas develops from the fusion of two distinct dorsal 
and ventral diverticula. These arise from the endoderm immediately 
posterior to the stomach and as they develop, they move closer together 
and eventually fuse. The pancreas maintains its connection to the gut 
through a duct similar to that used by the liver and the gallbladder (Gilbert, 
2000; Slack, 2005).
The second tube from the endoderm, the respiratory tube is actually 
a derivative of the digestive tube. Formation of the respiratory tube begins 
with the laryngotracheal groove in the floor of the pharynx. This groove then 
goes on to develop into a separate tube to form the larynx and the trachea. 
The posterior end of the trachea eventually bifurcates into two branches that 
form the paired bronchi and lungs. In the respiratory tube, the endoderm 
forms the lining of the trachea, the two bronchi and the air sacs (alveoli) of 
the lungs (Gilbert, 2000; Slack, 2005).
1.2. Overview of Xenopus endoderm development
The development of the mature gut and its associated glands from 
the endoderm germ layer can be divided into three distinct steps: formation, 
regional specification, and differentiation (Fig 1.1). Details on each of these 
steps of development in Xenopus is outlined below.
1.2.1. Formation
In Xenopus, the definitive endoderm arises from cells localised to the 
vegetal hemisphere of the early embryo (Dale and Slack, 1987). The 
commitment to endodermal cell fate occurs early in development as a result
2
of the localisation of the maternal determinant VegT (Clements et al., 1999; 
Dale, 1999; Xanthos et al., 2001; Yasuo and Lemaire, 1999; Zhang et al.,
1998). VegT then activates expression of Mixer, Sox17a/B, Xnr-1 and Xnr-2 
which will in turn activate expression of endodermal genes (Henry and 
Melton, 1998; Hudson et al., 1997; Jones et al., 1995). This stage of 
development is thought to finish by the onset of gastrulation, after the first 
twelve hours of development (Wylie et al., 1987). Formation of the 
endodermal germ layer in Xenopus is indicated by the expression of the 
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Figure 1.1 The three stages of endoderm development
Adapted from (Horb and Slack, 2001). 1) Formation. Establishment of the 
endodermal cell fate. 2) Specification. Patterning of the endoderm along the A-P 
axis. 3) Differentiation. Expression of tissue specific gene as a consequence of the 
patterning during specification.
1.2.2. Regional Specification
The next stage of development involves the patterning of the 
endoderm. Here cells of the endoderm are given positional information 
along the anterior-posterior (A-P), dorsal-ventral and left-right axes. These 
patterning will in turn allow the endoderm to form the many different 
specialised tissue types found in the fully developed gut. In short Regional 
specification of the endoderm is the commitment of each tissue region, 
which is manifested in culture in a neutral medium but may still be reversible 
if the environment changes (Slack, 1991a). Patterning of the endoderm at
this stage of development is usually marked by the expression of Xlhbox8 in 
the anterior part (Wright et al., 1989) and Xcad2 (van den Akker et al., 2002) 
in posterior endoderm. More detailed discussion of this part of endoderm 
development can be seen in Section 1.6.1 (p20). There may also be 
advanced activation of some differentiation products such as IFABP during 
this stage of development (Shi and Hayes, 1994).
1.2.3. Differentiation
The final stage in the development of the endoderm involves the 
differentiation of the gut based on the patterning information received by the 
cells during regional specification. This usually involves the expression of 
tissue specific genes (e.g. IFABP, LFABP, and insulin) (Horb and Slack, 
2001). Expression of these terminal differentiation markers is indicative of 
the formation of the mature digestive tract and its associated organs 
(Grapin-Botton and Melton, 2000). This process is thought to occur 
sometime after day 3 of development (-stage 40) in Xenopus (Horb and 
Slack, 2001).
1.3. Regional specification in Cynops (Triturus) pyrrhogaster
One of the earliest studies regarding endoderm patterning was done 
in newt, Cynops (previously Triturus) pyrrhogaster. The study relied on 
endoderm and mesoderm explants generated from blastula and neurula 
stage embryos. These tissue explants were then recombined and left to 
develop in culture. The identity of the explant was then characterised using 
histological techniques. Here it was demonstrated that the endoderm 
explants from early gastrula which are free from mesoderm and left to grow 
on its own stay as ‘y°lk mass’ and will not differentiate. However when the 
endoderm explants were made with significant quantities of mesenchyme, 
they went on to develop differentiated endodermal organs. This then 
indicated an important role the mesoderm plays in endoderm development 
(Fig 1.2A) (Okada, 1954a; Okada, 1954b; Okada, 1955a; Okada, 1955b).
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Further recombinations have also shown that the type of 
mesenchyme has an influence on the type of tissue the endoderm would 
differentiate into (Okada, 1955a; Okada, 1955b; Okada, 1957; Okada, 1960). 
Endoderm that is normally fated to form the anterior structure such as 
pharynx was shown to only produce posterior organs such as intestine 
when combined with lateral mesoderm (Fig 1.2B). Similarly anterior and 
middle endoderm explants were found to only form pharynx when put near 
head-mesenchyme. These recombinations then showed that the mesoderm 
is capable of instructing the endodermal fate.
Figure 1.2 Newt recombinations studies.
A) Taken from (Okada, 1954a) Ventral view of the early gastrula showing the 
positions of the explanted pieces. 1. Anterior endoderm, 2. Middle endoderm 3. 
Posterior endoderm. The mesodermal tissue added to the endodermal pieces are 
taken from dorsal (DM), lateral (LM), dorso-lateral (DLM) or ventral (VM) part of the 
marginal mesoderm. B). Taken from (Okada, 1957) Scheme of recombination 
experiment. (1) shows location of pharyngial primordium source. (2) shows source 
anterior and posterior neural plate (AN and PN), anterior and posterior archenteric 
roof (AR and PR) and dorsal and ventral lateral plate (DL and VL). (3) shows 
isolation of enveloping epidermis. These were removed from the embryo and 
recombined as in (4).
Flowever these early studies carry several important limitations. At 
the time these recombinations was performed, a detailed fate map had not 
yet been established. This was mainly due to a lack of available specific 
lineage tracers at the time. A good fate map is important when studying 
specification of the endoderm and mesoderm as it allows for the
A B
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comparison of experimental results with the presumptive fate for that 
particular piece of tissue. The lack of a lineage tracer also meant that it was 
impossible to eliminate the possibility of contaminating cells in the 
recombinations as it would have been impossible to label the different 
tissues in the recombination. In other words it was impossible to 
conclusively determine whether the anterior endoderm explant does not 
contain any posterior contamination or vice versa. This also raises the 
possibility that the respecified endoderm observed in the experiment was a 
result of contaminating endoderm that was isolated along with the 
mesoderm.
At the time there was also a lack of molecular markers that label the 
different parts of the developing gut. Even though it is true that the different 
parts of the gut could be identified histologically, molecular markers would 
have allowed for a more accurate detection of the different tissue types, 
thus allowing for better detection of respecification in the endoderm. Also 
molecular markers for either endoderm and mesoderm would have allowed 
for detection of any contaminating cells in the explants, allowing for a more 
conclusive interpretation of the data.
1.4. Regional specification in mouse
1.4.1. Recombination studies
Role of epithelial-mesenchymal interactions during endoderm 
development in mouse was initially studied using recombination of the 
forestomach and glandular stomach in fetal mice. Here it was demonstrated 
that the epithelium’s survival depends on the presence of mesenchyme. 
Interestingly, heterologous recombination did not change the fate of the 
epithelium. Forestomach epithelium was not respecified when combined 
with glandular stomach mesenchyme and the opposite is also true: 
glandular stomach epithelium maintains its differential fate when 
recombined with forestomach mesenchyme. However it is worth noting that 
the type of mesenchyme present still has an effect on the rate of 
development of the endoderm. The rate of keratinization of the forestomach
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epithelium was found to be greater on recombination with homologous 
mesenchyme (i.e. with forestomach mesenchyme) than on recombination 
with heterologous mesenchyme (e.g. glandular stomach mesenchyme) 
(Fukamachi et al., 1979). A similar conclusion was achieved when the 
experiment was duplicated in rats (Fukamachi and Takayama, 1980).
There are two ways in which the mesoderm can influence the 
development of the endoderm. In a permissive model the signals sent by 
the mesoderm enable the growth and survival of the endoderm while 
maintaining an existing prepattern in the endoderm; thus, the type of 
endodermal tissue formed would be dependent on the original position of 
the endodermal tissue. For example an endoderm explant isolated from the 
anterior of the embryo would maintain its anterior fate when recombined 
with posterior mesoderm. The opposite of this model is an instructive model 
whereby the mesoderm is defining the identity of the endoderm along the A- 
P axis so that the type of endodermal tissue formed is dependent on the 
original position of the mesodermal tissue. For example an anterior 
endoderm, when recombined with posterior mesoderm would take on a 
posterior fate. These early recombination results in mouse then seem to 
support a permissive model of endoderm specification as the recombined 
mesoderm is unable to respecify the endoderm. However these 
recombinations was done with quite late embryos and as such the 
epithelium might have lost some of its plasticity and thus can not be 
respecified. It is important to note that even though these recombinations 
give insight into the timing and stability of the specification of the endoderm 
it does not indicate how the endoderm gains its original specification earlier 
in development.
Fate mapping in mouse was done using embryos at E7.5 was done 
by microinjecting horseradish peroxidase (HRP) into single axial endoderm 
cells in situ (Lawson et al., 1986; Lawson et al., 1991). The labelled 
endoderm descendants was then traced to early somite stages in vitro. Here 
they divided the endoderm at E7.5 to 4 regions (Fig 1.3). Region I, the most
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anterior endoderm, maps to the ventral foregut in somite-stage embryo 
(E8.5) which gives rise to liver, ventral pancreas, lungs, and stomach. 
Region II maps to dorsal foregut endoderm, which contributes to 
esophagus, stomach, dorsal pancreas, and duodenum. Region III maps to 
midgut/trunk endoderm, which forms the small intestine. Region IV, the 
most posterior endoderm, maps to posterior trunk endoderm and hindgut, 
which forms the large intestine.
Following from this, Wells and Melton (2000) dissected the four 
endodermal regions, as described by the fate map, from E7.5, E8.5 and 
E9.5 day mouse embryo and analysed expressions of various endodermal 
markers (Fig 1.3). Here they found that Hesxl, 3-cardiac actin and cerberus- 
like to be expressed in anterior endoderm (regions I and II) of E7.5 embryo 
whilst IFABP was found to be expressed in the posterior endoderm (regions 
III and IV). It is interesting to note that 3-cardiac actin was expressed mostly 
in endoderm and not mesoderm at this stage of development, thus making 
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Figure 1.3 Fate map of the mouse endoderm
Taken from (Wells and Melton, 2000) and reproduced with permission of the 
Company of Biologists. A). Shows the four regions of the mouse endoderm and its 
progression between E7.5 and E9.5. Spatial expression of the markers are also laid 
out for the different stages of development. B) RT-PCR showing the activation of 
the endodermal markers between E7.5 and E9.5
Expression of the genes Pdx-1, NeuroD and somatostatin (SS) was 
observed later as the gut tube is formed (E8.5). Pdx1 expression could be
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seen as early as the 3-somite stage whilst NeuroD and SS were only 
detectable at 5 somite stage (Gittes and Rutter, 1992; Jonsson et al., 1994; 
Naya et al., 1997). By E9.5 Pdx-1 expression was restricted to pancreatic 
regions I and III. NeuroD and SS were also expressed in this region however 
the SS expression extend to the posterior gut tube that will give rise to the 
intestine (Region IV) (Gittes and Rutter, 1992). The early expression of 3- 
cardiac actin and IFABP is interesting as it raises the possibility that 
endoderm from E7.5 already has positional identity indicating that the 
anterior and posterior most parts of the endoderm is specified earlier than 
the rest of the endoderm.
Indeed this hypothesis seemed to be supported with results from the 
endodermal explants. Here it was shown endodermal explants created from 
E7.5 embryo, free of the mesectoderm showed expression of the extreme 
anterior and posterior markers 3-cardiac actin and IFABP but not of the 
intermediate markers: Pdx1, SS and NeuroD (Wells and Melton, 2000). 
There are two possible explanation for this, the first is that the signals 
required for the anterior and posterior development operates prior to E7.5 
when the explants was made. The second is that there is a possibility that 
there might be mesodermal cells present in the endoderm explant. This is 
because even though the explants were negative for the mesodermal 
marker FGF4, low level of T(Bra) expression was detected, indicating that 
there might be some mesodermal cells present. However, regardless of the 
cause for the early expression of 3-cardiac actin and IFABP, the lack of 
expression of the intermediate markers (Pdx1, SS and NeuroD) indicate that 
complete patterning of the endoderm must require the presence of adjacent 
mesectodermal layer.
Next the study goes on to address whether the mesectodermal 
signals responsible for the differentiation of endoderm are instructive or 
permissive. They divided the endoderm and the mesectoderm into anterior 
and posterior pieces (Fig 1.4) and did heterologous and homologous 
recombination between them. The resulting explant was analysed using four
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endodermal markers B-cardiac actin, IFABP, SS and NeuroD. The results 
from this indicated that the mesectoderm was capable of respecifying 
heterologous endoderm explants. A posterior endoderm explant when 
recombined with anterior mesectoderm had a markedly stronger B-cardiac 
actin expression whilst showing repression of SS and NeuroD, in other 
words the endoderm had taken a more anterior fate. An anterior endoderm, 
on the other hand, when recombined with posterior mesectoderm shows a 
slight reduction in B-cardiac actin expression and an induction of IFABP and 
SS, showing posterior respecification (Wells and Melton, 2000).
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Figure 1.4 Mouse recombination experiment.
Taken from (Wells and Melton, 2000) and reproduced with permission of the 
Company of Biologists. A) E7.5 embryo and the three germ layers B) Isolated 
endoderm cultured alone or in contact with mesectoderm (top). Endoderm 
expressing 3-gal (isolated from rosa 26 mouse) spreads out along the 
mesoderm/ectoderm after 2 days of coculture (middle). Also PCR done on the 
cultured recombinants show expression of Pdx1, SS and NeuroD is maintained 
only in the presence of mesectoderm. C)Diagram showing how the endoderm and 
mesectoderm are divided to perform heterologous recombination. PCR results on 
this show that signals from mesectoderm are instructive.
It is interesting to note that from these heterologous recombination
experiment that expression of IFABP and B-cardiac actin, which have been
shown previously to not require mesectoderm in E7.5 mouse, is now
affected. This raises the question as to what is the original role of the
mesectoderm in the normal development of the anterior most and posterior
most part of the endoderm? The initial expression of these markers seems
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to be autonomous, therefore the mesectoderm’s logical role would have 
been to maintain these signals, in other words sending permissive signals 
allowing maintenance of the early patterning which is opposite to results 
from the heterologous recombination where the mesectoderm is acting in 
an instructive manner.
However we need to remember earlier that there were low levels of 
T(Bra) detected earlier in the endoderm explants. If we assume that indeed 
the presence of mesodermal cells was responsible for the initial expression 
of IFABP and B-cardiac actin then the instructive mesectoderm in the 
heterologous recombination would be the consistent result.
1.4.2. Identifying mesectoderm signals
The recombination experiments have shown that the mesectoderm is 
able to influence the development of the endoderm in mouse. However it 
was not known yet whether these influences require cell-cell contact or 
whether it was done through soluble factors. Wells and Melton (2000) 
addressed this by taking isolated endoderm and mesectoderm and placing 
a 0.4 pm pore diameter Nucleopore membrane between them. The size of 
0.4 pm is probably a compromise based on an earlier study in chick that 
found 0.2 pm is the size that allows passage of soluble factors whilst 
minimising cell-cell contact, and anything larger than 0.6 pm would allow 
whole cells to pass through (Takiguchi-Hayashi and Yasugi, 1990). This 
membrane then forms a physical barrier that prevents most cell-cell contact 
whilst still allowing soluble factors to pass through between the two germ 
layers. Hence if the signals are soluble the endoderm should still receive 
instructive signals from the mesectoderm layer and develop appropriately. 
On the other hand if the mesectoderm requires prolonged cell-cell contact 
to properly influence the development of the endoderm then the endoderm 
would have stayed as is, and not express any of the endodermal patterning 
markers.
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After a 2-day culture, the endoderm explants showed expression of 
specification markers Pdx1, SS, NeuroD and insulin (Wells and Melton, 
2000). These results then indicate that in order for the mesoderm to specify 
the endoderm prolonged cell-cell contact is not necessary and that the 
influence is most likely facilitated by soluble factors. However it is worth 
noting that the membranes used in these experiment inevitably reduce the 
signal significantly. Thus even if the signal is diffusible, the cross section 
available for diffusion is much reduced. This then would account for the 
better survival of the endodermal explants when they were in direct contact 
with mesectoderm.
Based on this, a screen study was done of several growth factors. In 
mouse they found that out of 10 growth factors tested, only FGF4 was 
found to elicit an effect on the endoderm. This effect was dose dependent 
with NeuroD induced at low doses (0.1 -1 ng/ml) and SS induced at higher 
doses (1-10 ng/ml). (Wells and Melton, 2000). This concentration 
dependence implies that FGF4 acts as a posterior morphogen. Members of 
the FGF family have been known to have strong posteriorising activity which 
is consistent with the posterior dominant patterning of the endoderm by 
FGF4. Overexpression of FGF4 homologue eFGF in Xenopus have lead to 
severe posteriorisation of the embryos, indicating that it is capable of 
patterning the embryo in a posterior manner (Christen and Slack, 1997; 
Isaacs et al., 1994; Pownall et al., 1996).
in vivo, FGF4 is normally expressed in the posterior of the embryo 
(primitive streak) (Isaacs et al., 1992a; Isaacs et al., 1992b; Niswander and 
Martin, 1992). The fate map earlier showed that in normal development SS 
is expressed in more posterior endoderm, closer to the primitive streak, and 
as such closer to FGF4. Thus it is not surprising to see that a higher dose of 
FGF4 is needed to induce SS expression in isolated endoderm. Consistent 
with this, NeuroD which is expressed more anteriorly, relative to SS, 
responds to lower doses of FGF4 in the explant. In fact a high concentration 
of FGF4 (10ng/ml) was shown to repress NeuroD expression in the
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endodermal explant (Wells and Melton, 2000). These is consistent to the 
posterior morphogen model where different thresholds of FGF4 expression 
leads to the development of distinct endodermal structure.
It is interesting to note that in this particular screen out of the FGFs 
tested (aFGF, FGF2, 4, 5, 8) only FGF4 elicited a response. A possible 
reason for this is that the FGF receptors expressed in the endoderm at this 
time, FGFR1, has several different splice variants (Wells and Melton, 2000). 
Each of these variants have different response to different FGFs. A cellular 
reporter assay found that the FGFR1 isoform b to be threefold more 
responsive to FGF4 than FGF2, and tenfold more responsive to FGF4 when 
compared with FGF5 or FGF8 (Ornitz et al., 1996). At the moment this is just 
speculation as the exact variant of FGFR1 expresed in the endodermal 
explant has yet to be characterised. Also, sometimes biochemical data on 
binding specificity obtained in vitro often does not match with in vivo 
biological activities. Thus this preferential binding to FGF4 in vitro might not 
have any consequence on its in vivo activity in endoderm specification.
We need to note however that the above interpretation is a rather 
straight forward one. There are other interpretations that need to be 
considered. FGF4 in its role in patterning the endoderm might do this by 
first inducing mesoderm formation in the endodermal explant. This 
mesoderm would then in turn pattern the endoderm, in other words the FGF 
would elicit a secondary effect on endoderm patterning. Wells and Melton 
did not address this in their study as they did not screen for mesodermal 
markers on their FGF4 treated explants. Also we need to consider the 
observation of a low level expression of T(Bra), a mesodermal marker, in 
isolated endoderm. This raises the possibility that FGF4 might instead act 
on the remaining mesodermal cells in the explant and not directly on the 
endoderm (Horb, 2000).
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1.5. Regional Specification in Avian systems
1.5.1. Epithelial-mesenchymal interactions
In chick regional differences of the digestive tract are recognizable 
soon after the establishment of a tubular tract by the form and the position 
of digestive organ rudiments. Morphological and functional differentiation of 
these different organs is dependent on cross talk between the endodermal 
epithelium and the mesenchyme. (Mizuno and Yasugi, 1990; Yasugi and 
Mizuno, 1990).
Recombination experiments have shown that the mesenchyme is 
capable of instructing the endodermal fate in chick. For example the gizzard 
(muscular stomach) in chick is usually devoid of any glands at hatching. 
However when the gizzard endoderm is recombined with proventricular or 
intestinal mesenchyme they go on to develop proventriculus-type and 
intestinal-type endocrine cells respectively (Andrew and Rawdon, 1990; 
Andrew et al., 1988; Rawdon and Andrew, 1988). Furthermore the intestinal 
mesenchyme has also been shown to be capable of respecifying the 
stomach epithelium towards the intestinal fate (Haffen et al., 1983; Ishizuya- 
Oka and Mizuno, 1984; Ishizuya-Oka and Mizuno, 1992). These results then 
show that in avian systems, unlike in mouse, late recombinations of 
endoderm and mesoderm could still lead to respecification of the 
endoderm. This difference might be caused by a later stabilisation of 
patterning in avian embryos compared to murine embryos.
Fate maps for gut endoderm and mesoderm for the 10-somite chick 
embryo, established from Dil lineage tracing studies, show that endoderm 
and mesoderm that will be in contact in the gut wall of the older embryos 
are not perfectly aligned in early embryos. In early embryos the endoderm is 
always positioned slightly more anteriorly relative to its final position. As 
development progresses, both endoderm and mesoderm move caudally 
with the endoderm moving more rapidly, resulting in alignment of the related
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endodermal and mesodermal regions at the beginning of gut closure 
(Matsushita, 1995; Matsushita, 1996). This observation has not been 
reported as yet in the mouse.
Since, it is thought that the patterning of the endoderm is not 
stabilised until the endoderm and mesoderm reach their final relative 
positions, one can hypothesise that If the mouse endoderm is aligned to its 
appropriate mesodermal regions during development, the specification of 
mouse endoderm might be stabilised sooner than the chick endoderm. The 
chick endoderm needs more time to align with its mesoderm. This then 
could account for the difference in plasticity between the two model 
organism.
1.5.2. Lateral Plate Mesoderm (LPM) and endoderm specification
Recently a more detailed analysis of the interaction of mesoderm and 
endoderm was done in chick. In this study the developing gut was divided 
into 3 distinct regions along its A-P axis (Fig1.5). Fate mapping studies 
show that these regions develop to form oesophagus and stomach (somite 
2-4 level, block a), duodenum and ventral pancreas (somite 7-9 level, block 
b), and more posterior small intestine (somite 12-14 level, block c) (Kumar et 
al., 2003; Matsushita, 1996).
Pdx1, the pancreatic transcription factor and CdxA, the intestinal 
transcription factor are used as specification markers. They are expressed in 
distinct endodermal regions and can be used to distinguish the 3 regions of 
the endoderm effectively (Fig 1.2) (Kumar et al., 2003). Note that the genes 
Hex1 and Nkx2.1 are also expressed in region I the anterior most region 
(Dessimoz et al., 2006) but these are not used as markers in the study.
Using a chick/quail chimera technique, it was shown that an anterior 
endoderm that is grafted posteriorly towards Pdx1-expressing region results 
in the upregulation of Pdx1 in the graft. Similarly grafting endoderm of 
medial domain endoderm towards the posterior domain resulted in the 
downregulation of Pdx1 and upregulation of CdxA. Interestingly, however,
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when the posterior endoderm was grafted anteriorly towards the Pdx1- 
expressing domain, expression of CdxA was not downregulated and no 
induction of Pdx1 was seen. The same was seen when medial domain 
endoderm was grafted towards the anterior, Pdx1 expression was retained. 
This then shows that only posterior shifts of the endoderm would result in 
the respecification of the endoderm whilst anterior shifts maintain the 
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Figure 1.5 Regions of the developing chick gut.
Taken from (Kumar et al., 2003)1 A) The diagram shows how the endoderm is 
divided into three different regions: foregut (a), midgut (b), hindgut (c) with the fate 
map shown on B). C) shows in situ of the three different regions for Pdx1 and 
CdxA. Pdx1 is shown to be present only in the midgut (b) whilst CdxA is only 
present in the hindgut (c). D) Shows the PCR for various markers of endoderm 
development. Expression pattern of Pdx1 and CdxA confirms the in situ result 
shown in C.
1 Reprinted from Dev Biol, 259, Kumar et al., Signals from lateral plate mesoderm 
instruct endoderm toward a pancreatic fate, 109-22, Copyright (2003), with permission from 
Elsevier
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This observation was confirmed further by heterotopic recombinations 
between endoderm and LPM. Similar to the in vivo study using chick/quail 
chimera, the endoderm was only respecified when combined with a more 
posterior mesoderm (induction of Pdx1 in foregut by midgut LPM and 
induction of CdxA and inhibition of Pdx1 in midgut by hindgut LPM). 
Recombination with anterior LPMs resulted in the maintenance of 
endodermal fate (Kumar et al., 2003).
The in vitro and in vivo study seem to suggest that the mesodermal 
signals are instructive if they come from more posterior regions to the 
endoderm and permissive otherwise. This is in contradiction to the status in 
mouse (see Section 1.4.1, p6) or even other studies in chick where the 
respecification occurs not just posteriorly but also anteriorly (Ishii et al., 
1997; Ishii et al., 1998; Wells and Melton, 2000). In the chick, using tissue 
from day 6 embryos, after organ formation and cytodifferentiation, posterior 
epithelium from the small intestine was shown to adopt an anterior 
(stomach) gene expression when cultured with the anterior mesenchyme 
(Ishii et al., 1997; Ishii et al., 1998). It is important to note however that the 
culture period done with the small intestine and stomach recombination was 
much longer (6-8 days) than the culture with endoderm and LPM (48 hours). 
Also the tissue used in the recombination was from different developmental 
stages, as such, the fact that anterior respecification can be induced from 
later stage tissue might just indicate changes in gene regulation at later 
stages in development (Ishii et al., 1997; Ishii et al., 1998; Kumar et al., 
2003).
Another explanation for the posterior-dominant patterning of the 
endoderm by the mesoderm involves the nature of the markers used. Pdx1 
and CdxA are members of the ParaHox cluster of transcription factors and 
like other members of the homeobox family they might be susceptible to a 
cluster-wide regulation. However since the LPM also regulates other 
pancreas markers outside of the ParaHox cluster such as glucagons, insulin 
Nkx6.1 and p48, this is unlikely to be the case (Kumar et al., 2003).
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The posterior dominance observed in the explants could also be a 
consequence of a posterior gradient of morphogen. In this case, transient 
exposure to a higher level of morphogen (moved posteriorly) can induce a 
higher response from the tissue if it remains competent. However the 
opposite is not true, when exposed to a lower amount of morphogen 
(moved anteriorly) the response from the tissue does not change, as the 
higher response state that have been induced are already stable.
Regardless of the mechanism, the posterior-dominant patterning of 
the endoderm shown here is strikingly similar to observations in the neural 
tube at the same stage. Neuroectodermal segments have been shown to 
only respecify when they are transplanted to a more posterior region where 
as anterior transplantation just results in maintenance of the original 
expression profile (Grapin-Botton et al., 1995).
1.5.3. Identifying signals from LPM
Attempts have been made to understand the molecular basis of the 
mesodermal signals in chick embryos. The first issue that was addressed 
was whether cell-cell contact is necessary for the mesoderm to instruct the 
endoderm. To address this a transfilter analysis was performed. Here 
endoderm and mesoderm was separated by a Nucleopore filter with a pore 
size between 0.2 pm and 0.6 pm. Here they found that mesoderm 
(proventricular mesenchyme) can induce specification in the proventricular 
and gizzard epithelia) indicated by gland formation and pepsinogen 
expression when they were separated by pores of 0.6pm and not 0.2pm 
(Takiguchi-Hayashi and Yasugi, 1990). This finding then suggests that 
soluble factors from the mesoderm might not be enough to respecify the 
endoderm and that direct contact with mesoderm cells is probably 
necessary for specification of the endoderm.
This was supported with results from a recent growth factor screen 
done on chick endodermal explants (Kumar et al., 2003). Here they found 
that the growth factors would not elicit an effect on the endoderm without
18
the presence of mesoderm. They showed that Retinoic acid (RA), BMP and 
activin family members can induce posterior transformation with endoderm+ 
mesoderm explants but not with isolated endoderm from the same region. 
The authors noted however that this does not mean that the growth factors 
do not act directly on the endoderm. Instead it was suggested that the 
mesoderm is necessary to provide the additional factors needed to elicit a 
response. In other words the specification is not done by a single growth 
factor and needs a combination of factors to act at once to elicit a response 
(Kumar et al., 2003).
FGF4 was also later discovered to be involved in patterning the 
endoderm on chick embryos. Heparin agarose beads that have been soaked 
in FGF4, and subsequently implanted into gastrulation stage chick embryo, 
was capable of inducing more posterior fate on the endoderm. In the anterior 
most endoderm FGF4 was seen to repress expression in more anterior 
markers of development (Hex1 and Nkx2.1) whilst promoting expression of 
more posterior markers (Pdx1 and CdxA). An inhibition study using heparin 
agarose beads soaked in the chemical SU5402, a FGFR1 inhibitor, 
confirmed the role of FGF4 in the patterning of the endoderm. Here inhibition 
of FGF signaling resulted in expansion of the expression of the anterior most 
marker Hex1 towards the position of the beads as well as repression of more 
posterior fate Pdx1. At early somite stages implantation of FGF4 beads 
caused expression of Pdx1 in the anterior most endoderm. Reduction of 
FGF4 signalling at these stages by SU5402 resulted in Pdx1 expression 
shifting from fore/midgut in normal embryos to the mid/hindgut and 
repression of CdxA in mid/hindgut (Dessimoz et al., 2006).
The study went on to show that when dominant negative FGFR1 
receptor, when electroporated onto an embryo, ectopic Pdx1 expression was 
induced. This demonstrates that the endoderm is directly affected by the 
FGF signaling (Dessimoz et al., 2006). However because the experiment 
was done on whole embryos with all three germ layers present and not 
isolated endoderm, one cannot exclude the possibility that the mesoderm
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was involved in the specification of the endoderm by FGF4. The mesoderm 
around the endoderm might contribute signals that cooperate with the FGF4 
signal in specifying the endoderm. Hence, in the case of chick embryos it 
seems that there is still a possibility that contact with mesoderm is necessary 
for the specification of the endoderm.
The discovery that soluble growth factors can replace or at least 
mimic the signals coming from the mesoderm and pattern the endoderm is a 
significant one (Dessimoz et al., 2006; Kumar et al., 2003; Wells and Melton, 
2000). FGF4 is particularly adept in patterning the endoderm as it has been 
shown to posteriorise the endoderm in both mouse and chick(Dessimoz et 
al., 2006; Wells and Melton, 2000). This raises the possibility that the 
regional specification of endoderm might be controlled by a posterior 
gradient of FGF4 to form a rough patterning of the endoderm which is refined 
later in development by additional permissive signals from the mesoderm.
1.6. Regional specification in Xenopus
1.6.1. Markers of specification in Xenopus
Four endodermal markers have been used extensively in the study of 
endoderm development in Xenopus: Xlhbox8, IFABP, Xcad2 and Edd. It is 
necessary to spend a bit of time to understand how these markers came to 
be used and why they are appropriate markers to study endoderm 
development.
As we have seen, in the discussion regarding regional specification in 
mouse and avian systems, that anterior specification is usually marked by 
the expression of the pancreatic development marker Pdx1. The Xenopus 
orthologue of this is Xlhbox8. First isolated in 1988, it was found to be 
expressed solely in a narrow band of the endoderm in early Xenopus 
embryos. In later stages the expression was restricted to endodermal cells 
of the duodenum and the developing pancreas, tissues originating from 
anterior endoderm (Chalmers and Slack, 2000). Expression of the RNA has 
been detected as early as stage 12.5 with more expression detected as the
20
embryo grows. The protein itself, however is not expressed until stage 33 
(Wright et al., 1988). The restricted expression of Xlhbox8 to anterior 
endoderm structures has made it an ideal marker of anterior development in 
Xenopus.
The situation with the posterior marker of development however is 
more complicated. Earlier study of specification in the endoderm had used 
IFABP (Gamer and Wright, 1995; Henry et al., 1996; Shi and Hayes, 1994; 
Zorn et al., 1999) instead of Xcad2 as a posterior marker. However a recent 
study in our lab has shown that IFABP is more appropriately used as an 
intermediate marker as it is found to be derived from both anterior and 
posterior halves of the neurula endoderm (Chalmers and Slack, 2000) which 
would account for IFABP expression in both the dorsal and ventral vegetal 
explants (Henry et al., 1996). This has been confirmed with further in situ 
and RT-PCR data (Horb and Slack, 2001). Furthermore IFABP is a product 
of differentiation that is expressed early and not a transcription factor as is 
the case for Xcad2. Since regional specification occurs prior to 
differentiation, a marker which is a product of differentiation such as IFABP 
would not be appropriate. Xcad2 which is a transcription factor would be 
the more appropriate posterior marker to use in studying the specification of 
the endoderm (Horb and Slack, 2001). This is indeed a trend we see now in 
mammalian studies as well, with the more recent studies using Cdx2 and 
not IFABP to mark posterior development (Dessimoz et al., 2006; Kumar et 
al., 2003). We believe it is better to use transcription factors to mark regional 
specification as they are more likely to be involved in the specification 
process itself and not a consequence of it. However it is worth noting that 
this does not reduce the validity of the earlier studies that used IFABP 
instead of Xcad2 as posterior markers of specification since the expression 
of the gene itself still proves that there is specification in the vegetal 
explants.
Finally there is the pan-endodermal marker gene Endodermin (Edd). 
This gene encodes a large protein with significant homology to a2-M family
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protease inhibitors. Initial expression of Edd is found in the dorsal lip during 
gastrulation, which then spreads to the entire rim of the blastopore. 
Histological sections at this stage shows Edd transcripts to be strongest in 
cells fated to form the endoderm, even though it is also found in axial 
mesoderm precursors. In late neurula it is found to be expressed in the 
notochord, prechordal plate, hatching gland and the whole endoderm. Its 
expression then becomes even stronger at tailbud stages where it is 
localised almost exclusively to the endoderm (Sasai et al., 1996). The 
abundant expression of the Edd gene in endodermal cells from early 
gastrula makes it ideal to be used as a pan-endodermal marker in Xenopus.
1.6.2. Early or Late?
Until recently much of the work done in Xenopus have suggested the 
specification of the endoderm might have taken place early in development, 
prior to gastrulation and cell-autonomously in the absence of mesoderm. 
This model for endoderm specification first came about in a study of 
Xlhbox8 regulation. It was found that vegetal explants made from stage 8-9 
blastula embryo (Fig 1.6) would go on to express Xlhbox8 in culture. The 
gene was found to be expressed in a contiguous domain of cells occupying 
about a quarter to a third of the explant with a similar time course of 
expression as in whole embryos. This expression of Xlhbox8 is attributed to 
the dorsal half of the vegetal explant (Gamer and Wright, 1995). A later 
study confirms the autonomous expression of Xlhbox8 in dorsal vegetal 
explant. The study also found both posterior markers IFABP and insulin to 
be expressed from the vegetal explants. This then further supports an early 
and autonomous model of endoderm specification in Xenopus (Henry et al., 
1996). Anterior endoderm was shown to be specified as early as blastula 
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Figure 1.6 Vegetal explants
A) Taken from (Henry et al., 1996) and reproduced with permission of the Company 
of Biologist. Generation of the vegetal explants. The diagram above showed how 
the dorsal and vegetal explants was generated from blastula stage embryo. The 
subsequent explants was then grown in culture and analysed for specification 
markers by RT-PCR. B) Taken from (Zorn et al, 1999)2. Diagram for the mechanism 
of Anterior endomesoderm development. The top diagram shows the spatial 
positioning of the signals and the bottom diagram shows the signalling cascade 
involved in the autonomous specification of the endoderm.
This early and autonomous pattern of the endoderm in Xenopus is 
thought to involve events and molecules that are also important in the 
induction and patterning of the mesoderm. The specification of anterior 
endoderm specifically has been shown to start before gastrulation as Xhex 
and Cerberus were expressed before the gastrulation stage around the
2 Reprinted from Dev. Biol, 209, Zorn et al., Anterior endodemesoderm 
specification in Xenopus by Wnt/beta catenin and TGF-beta signaling pathways, 282-97, 




same time that the Spemann organiser is induced. The specification of the 
anterior endoderm seems to involve two maternal signalling pathways: the 
dorsalising Wnt/(3-catenin pathway as well as an endodermal-specific TGF-6 
signalling pathway (Henry et al., 1996; Zorn et al., 1999). These two 
pathways then initiate a signalling cascade which are summarised in Figure
1.6B. Expression of Xlhbox8 has also been shown to rely on TGF-B as well 
as on correct cortical rotation of the embryo as inhibition of cortical rotation 
leads to loss of Xlhbox8 expression (Henry et al., 1996).
Posterior endoderm specification however is less explored. 
Expression of IFABP in vegetal explants did not seem to be affected by 
either truncated activin or dominant negative FGF receptors. Also, unlike 
Xlhbox8 it is not affected by inhibition of cortical rotation. It is however 
downregulated in UV treated embryos (Henry et al., 1996). The 
downregulation in the UV treated embryos are thought to be caused by an 
excess of ventrolateral mesoderm that acts negatively on IFABP expression 
and not as a result of disruption to cortical rotation.
These results seemed conclusive at the time, however one must 
remember that the endoderm and mesoderm are still closely related at the 
blastula stage. As such there is a risk of mesoderm contamination in the 
explant, which in turn might cause the expression of the specification 
markers. To ensure that this was not the case these studies screened the 
vegetal explants with the mesodermal marker Brachyury (Xbra), cardiac 
actin, Xtwist and a-T3 globin (Gamer and Wright, 1995; Henry et al., 1996; 
Zorn et al., 1999). However, these markers might not be appropriate to 
detect gut mesoderm that could be present in the vegetal explants. Xbra is 
only found to be expressed in the tail bud at early tadpole stages (Gont et 
al., 1993; Smith et al., 1991), muscle specific actin is localised to the 
somatic and heart mesoderm, type II collagen is localised to the notochord 
(Amaya et al., 1993), Xtwist is expressed in the neural crest (Hopwood et al., 
1989; Schuh et al., 1993) and a-T3 globin is expressed in the ventral 
mesoderm at tail bud and early tadpole stages making it unlikely to be
24
found in the mesoderm surrounding the gut at late tadpole stages (Horb and 
Slack, 2001).
Indeed using mesodermal markers that are found in the gut 
mesoderm such as FoxF1 (Koster et al., 1999) and XNkx-2.5 (Evans et al., 
1995; Patterson et al., 2000; Smith et al., 2000) as well as those found in 
lateral plate, XTbx5 (Horb and Thomsen, 1999) and xFOG (Deconinck et al., 
2000), Horb and Slack (2001) were able to show the presence of mesoderm 
in the vegetal explants. This discovery meant that the apparent cell 
autonomous specification of the endoderm might have been caused by 
patterning done by the presence of mesodermal cells. There are two 
possibilities as to where these mesodermal cells came from: the first is that 
they might have been a result of incomplete separation done during the 
generation of these vegetal explants.
The second possibility is that these mesoderm cells might have been 
formed de novo in the vegetal explants, as a response to being cultured in 
vitro. Under normal development inducing signals from the endoderm form 
a morphogen gradient that instructs cells adjacent to the endoderm to take 
on a mesodermal fate and those furthest away to take on a ectodermal fate 
(Slack, 1991a). Isolated vegetal explants when recombined with animal caps 
are able to convert the animal cells towards a mesodermal fate (Nieuwkoop, 
1969; Slack, 1991b). This then raises the possibility that when the vegetal 
explants were taken out of the embryo and grown in isolation, some of the 
cells on the outside of the explant were induced by a lower concentration of 
the inducing signal pushing it towards the mesodermal fate. In other words 
even if no fated mesoderm were present in the vegetal explants, some 
mesoderm become specified due to this embryonic regulation. It should be 
noted that this model of mesoderm induction is not consistent with the 
“ratchet” principle of posterior dominance discussed previously which also 
applies to the vegetal signals in early embryo. However the mechanisms of 
development in vivo is not always simple and may involve mechanisms that 
might initially seem incompatible.
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To avoid including mesodermal cells in the endodermal explants, 
Horb and Slack (2001) in their study used explants made from stage 20-23 
embryo. At this stage of development mesoderm and endoderm have 
formed distinct layers and can easily be separated. Indeed endoderm-only 
explants from stage 20-23 embryo do not show expression of any of the 
mesodermal markers (FoxF1, XNkx-2.5, XTbx5 and xFOG). Horb and Slack 
(2001) then demonstrated that these endoderm-only explants grow to form 
unspecified endodermal cell masses that do not express the specification 
markers Xlhbox8 or Xcad2 but do express the pan endodermal marker Edd. 
Furthermore when the endoderm was cultured with the mesoderm still 
attached, the explants went on to express both the Xlhbox8 and Xcad2 
specification markers (Horb and Slack, 2001). This then provides evidence 
that the specification of the endoderm in Xenopus takes place later than 
originally thought and that the mesoderm plays an important role in it.
1.6.3. Nature of mesodermal signals
The results outlined above showed that mesoderm plays a crucial 
role in the specification of the endoderm. However it was not yet clear 
whether the mesoderm is simply reinforcing a prepattern in the endoderm 
(permissive) or whether it is actively instructing the specification of the 
endoderm (instructive). To address this mesendodermal recombinations 
was carried out. Anterior endoderm was recombined with posterior 
mesoderm explants and vice versa, if the endoderm maintains its original 
fate then the mesoderm plays a permissive role, and if the endoderm takes 
the positional identity of its newly recombined mesoderm then the 
mesoderm would be sending out instructive signals. Horb and Slack 
showed that the recombinations resulted in the endoderm being respecified. 
In other words when recombined with an anterior mesoderm the endoderm 
would go on to express Xlhbox8 and inhibit Xcad2, on the other hand when 
recombined with posterior mesoderm the endoderm would show inhibition 
of Xlhbox8 and induction of Xcad2 expression. (Horb and Slack, 2001).
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1.6.4. Timing of regional specification
Studies in Xenopus have suggested that the regional specification of 
the endoderm becomes stable somewhere around stage 25. This can be 
seen as before stage 25 the expression of Xlhbox8 and Xcad2 is diminished 
when the mesoderm is removed. It has been suggested that this labile 
expression of the specification markers before stage 25 is due in part to the 
relative movement of the germ layers that takes place during neurulation. 
Comparison of the fate map of endoderm and mesoderm of Xenopus has 
shown that only the future epithelium and smooth muscle layer in the middle 
of the gut overlay each other in early embryo. Whilst those which are at the 
proximal end (e.g. oesophagus and stomach) and distal end (e.g. large 
instestine) do not align. (Chalmers and Slack, 2000). This is similar to the 
finding with the chick fate map where the presumptive endoderm are 
located in a more anterior position than its corresponding mesoderm and 
only becomes aligned as the gut tube closes (see section 1.5.1, p14) 
(Matsushita, 1995; Matsushita, 1996).
This hypothesis for the late stabilisation of endoderm patterning is 
supported by several other observations of late specification in Xenopus. 
For example, transgenic experiments in our lab have shown that an elastase 
promoter (marker of liver development) becomes activated about stage 31 
(Beck and Slack, 1999). Also even though Xlhbox8 mRNA is expressed as 
early as stage 10.5 in Xenopus, its protein is only visible late at stage 33 
(Horb and Slack, 2001; Wright et al., 1988; Wright et al., 1989). The Xenopus 
embryo has also been shown to develop abnormalities in the gut when 
treated with retinoic acid between stage 25-35. Indicating that the 
endoderm is still being specified at this stage (Zeynali and Dixon, 1998). 
Endoderm isolated prior to stage 28 when grafted to a new location takes a 
new identity according to their new position. While grafts made with 
endoderm older than stage 28 retain their original identity (Zeynali et al.,
2000). Finally, expression of high levels of Xlhbox8, insulin, LFABP, and 
IFABP mRNA do not begin until stages 30-35 (Horb and Slack, 2001).
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1.6.5. Studying the mesodermal signals in Xenopus
The relatively recent discovery of the role of mesoderm in endoderm 
specification in Xenopus (Horb and Slack, 2001) has brought attention back 
to the study of gut development. Thus far only the existence of the 
mesodermal signals have been established in Xenopus. This study then 
proposed to follow up on the work done by Horb and Slack (2001) to try and 
identify the instructive signals being sent by the mesoderm.
Experimental systems using embryo tissue isolation and culture have 
proven valuable in previously determining the mesodermal signals in chick 
(Kumar et al., 2003) and mouse (Wells and Melton, 2000). Such a system in 
Xenopus has already been established. In his study Horb showed that 
endoderm explants could be made from embryos between stage 20 and 23 
and be kept in culture long enough to assay for specification either by PCR 
or by in situ (Horb and Slack, 2001).
Xenopus also have several advantages compared to studies done in 
chick and mouse. From a practical point, the generation of endoderm 
explants from Xenopus should be relatively easy as the embryos are easy to 
generate, develop externally and are large enough to allow easy 
manipulation, thus making it ideal for conducting such a growth factor 
screen.
In avian systems it is not possible to prevent early contact between 
presumptive gut mesoderm and endoderm in generating the necessary 
explants (Rawdon, 2001). Similarly in mouse, the isolated endoderm 
generated from E7.5 embryo showed low level expression of Tbra, a 
mesodermal marker (Wells and Melton, 2000). However in Xenopus this 
should not be a problem. As demonstrated previously, endoderm explants 
from stage 20-23 embryo can be made to be free of any contaminating 
mesoderm (Horb and Slack, 2001). This is important as mesoderm 
contamination would lead to a complication in interpreting any results 
coming out of the screen.
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1.7. Hox genes
From the above discussions on endoderm specification in mouse, 
chick and Xenopus we see that the mesoderm is essential for the complete 
specifcation of the endoderm (Dessimoz et al., 2006; Horb and Slack, 2001; 
Kumar et al., 2003; Wells and Melton, 2000). It is thought that the mesoderm 
sends out different signals to specify different parts of the endoderm 
depending on its position along A-P axis. In order to do this the mesoderm 
must be able to tell its own positional identity along the A-P axis. It has been 
suggested that the Hox genes might be involved in providing this positional 
identity in the mesoderm.
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Figure 1.7 Hox Genes clusters and its expression pattern.
Taken from (Pearson et al., 2005) 3. A) The panel on the left shows a stage 13 
Drosophila melanogaster embryo that has been coloured in the schematic to 
indicate the approximate domains of transcription expression for all Hox genes. 
The panel on the right shows a mouse (Mus musculus) embryo, at embryonic day
12.5, with approximate Hox expression domains depicted on the head-tail axis of 
the embryo. In both diagrams the colours that denote the expression patterns of 
the Hox transcripts are colour-coded to the genes in the Hox cluster diagrams 
shown in B. B) A schematic of the Hox gene clusters (not to scale) in the genomes 
of Caenorhabditis elegans, D. melanogaster and M. musculus. Gene colours 
differentiate Hox families, orthologous gens are labeled in the same colour.
3 Reprinted by permission from Macmillan Publishers Ltd: Nat Rev Genetics, 
(Pearson et al., 2005), copyright (2005).
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The Hox genes are a subset of the homeobox genes which encode 
transciption factors that contain a 60 amino-acid domain (the 
homeodomain). Members of the Hox genes are physically linked on a 
chromosome in clusters, consisting of 8 homeotic genes in the split 
Antennapedia-Ultrabithorax complex of Drosophila melanogaster and 39 
Hox genes in 4 complexes in mammals.
An interesting property of the Hox genes is that the gene order in the 
cluster mimics the order of expression of genes and their function along the 
A-P body axis: genes found at the 5 ’ end of the cluster are expressed in, 
and pattern, the posterior part of the body, whereas genes at the 3’ end 
pattern the anterior end of the body (Fig. 1.7) (McGinnis and Krumlauf, 
1992). This unique phenomenon of the Hox genes is known as collinearity.
However recent evidence indicates that this conventional view of Hox 
gene arrangement may not be true for all animals. Studies done on the 
increasing number of animal genome sequences have shown that Hox gene 
clusters are actually either fragmented, reduced, or expanded in many 
animals instead of being arranged in a collinear fashion (Lemons and 
McGinnis, 2006).
Another interesting feature of Hox genes is that the more posterior 
Hox genes seem to be dominant over the anterior Hox genes. In the 
canonical view, Hox genes are expressed from a different anterior boundary 
towards the posterior end of the animal. Ectopic expression of Hox genes 
anterior to their normal anterior boundary results in that segment taking on 
the more posterior fate of the Hox gene. However if an anterior Hox gene is 
expressed in a position more posterior than its anterior boundary, no 
respecification takes place. This phenomenon is known as “posterior 
dominance” (Manak and Scott, 1994). This principle often times, also holds 
true with non-canonical Hox genes where the gene is not expressed until 
the posterior end. Due to this, overexpression of Hox genes usually result in 
posteriorisation of the affected tissues whilst knockdown studies result in an 
anteriorisation of the affected tissues.
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Hox genes have been known to be crucial in patterning the animal 
body along the A-P axes. Indeed mutations in the Hox genes have been 
shown to result in morphological defects that are restricted to discrete 
segmental zones along (A-P) axes in a wide variety of animals, ranging from 
nematodes to mice (Pearson et al., 2005). Several studies have shown that 
Hox genes provide positional information along the A-P axis in the 
development of mesoderm and ectoderm. In the mesoderm, the shape of a 
vertebra is controlled by Hox code, and in the hindbrain, appropriate 
neuronal differentiation is Hox-dependent (Krumlauf, 1994; McGinnis and 
Krumlauf, 1992).
1.8. Hox genes and the developing gut
1.8.1. Hox genes and the endoderm
The number of Hox genes expressed in the endoderm is not as 
numerous as those found expressed in the mesoderm. In Drosophila only 
labial is found to be expressed in the endoderm (Bienz, 1997). The case is 
similar with chick embryos where most are expressed in the mesoderm 
whilst only a subset is expressed in the endoderm at levels detectable by in 
situ hybridisation (Fig 1.8A) (Grapin-Botton, 2005). In Xenopus only one of 
the abdominal-B type Hox gene, xHoxA13, is thought to be expressed in the 
endoderm (Lombardo and Slack, 2001)
The expression boundaries of the Hox genes in the endoderm do not 
always correlate with boundaries between organs (Grapin-Botton, 2005). 
However Hox boundaries can be seen at the level of sphincters (pyloric, 
ileocaecal, anal) (Roberts, 2000). Inactivation of the endodermal Hox genes: 
Hoxa-3 (Manley and Capecchi, 1995; Manley and Capecchi, 1998), Hoxa-4 
(Tennyson et al., 1993; Tennyson et al., 1998), Hoxa-5 (Manley and 
Capecchi, 1995; Manley and Capecchi, 1998), Hoxc-4 (Boulet and 
Capecchi, 1996) and Hoxa-13 and Hox d-13 (Warot et al., 1997) have been 
shown to lead to malformations of the digestive tract. But in all these cases 
no homeotic transformations of the gut structure was reported, possibly due 
to redundancy in the Hox signalling (Grapin-Botton, 2005).
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It is worth noting that in the endoderm, another homeobox gene- 
complex, the ParaHox cluster was also expressed. In Amphioxus this 
cluster, which contain homologues of the genomic screened homeobox 
(Gsh1) gene, Pdx1 and Cdx2, have been suggested to have a possible role 
in the A-P patterning of endoderm (Brooke et al., 1998). This cluster is not 
exclusively expressed in endoderm although most of its effect seems to 
involve endoderm development. Pdx1 and Cdx2 have been shown to be 
responsible for the development of pancreas and intestine respectively 
(Grapin-Botton and Melton, 2000; Kim et al., 1997; van den Akker et al., 
2002). These three members of the Parahox cluster are expressed orderly 
along the A-P axis, Gsh1 being the most anterior and Cdx2 the most 
posterior(Grapin-Botton, 2005).
There is a suggestion that these genes might act as repressors of 
some Hox genes since the posterior expression boundaries of Hoxa-3 and 
Hoxb-4 seem to correspond quite well with the anterior limits of Pdx1 and 
Cdx2 expression (Grapin-Botton, 2005). Gene inactivation of Cdx2 results in 
homeotic transformations. Cdx2 heterozygous mutant mice exhibit 
induction of stomach tissue in the midgut and hindgut (Beck et al., 1999). 
Pdx1 inactivation results in absence of the pancreas and defects in the most 
anterior duodenum.
1.8.2. Hox genes and the mesoderm
In Drosophila most of the Hox genes are regionally expressed in the 
mesoderm, with the exception of labial which is expressed in the endoderm, 
and have been shown to control the regional secretion of Decapentaplegic 
(Dpp), a member of the TGF-B family, and wingless (Wg), a Wnt molecule. 
Both these molecules signal to the adjacent endoderm and facilitate its 
patterning (Bienz, 1997). In fact in the developing midgut of the Drosophila 
endoderm they have been shown to actually influence the expression 
domain of the only Hox gene in the endoderm, labial (Bienz, 1997).
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Figure 1.8 Regional expression of hox genes in chick and Xenopus mesoderm.
A.) Chick - taken from (Grapin-Botton, 2005)4. Shows expression boundaries of 
Hox genes in chick mesoderm compiled from results in chick embryonic day 4 
(Grapin-Botton and Melton, 2000; Sakiyama et al., 2000; Sakiyama et al., 2001; 
Yokouchi et al., 1995). B.) Xenopus - taken from (Lombardo and Slack, 2001)5. 
Shows anterior boundaries of several abdominal-B type Hox genes on stage 32 
embryo.
4 Reprinted from Dev Biol, 49, Grapin-Botton, Antero-posterior patterning of the 
vertebrate digestive tract: 40 years after Nicole Le Douarin’s PhD thesis, 335-47, Copyright 
(2005), with permission from Elsevier
5 Reprinted from Mech Dev, 106, Lombardo and Slack, Abdominal B-type Hox gene 
expression in Xenopus laevis, 191-5., Copyright (2001), with permission from Elsevier
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Several in situ studies in chick have found the Hox genes to be 
expressed in a nested, overlapping pattern in the developing gut mesoderm 
(Roberts et al., 1995; Sakiyama et al., 2000; Sakiyama et al., 2001; Yokouchi 
et al., 1995). Furthermore, unlike with Hox genes expressed in the 
endoderm, the boundaries of expression pattern of some of these 
mesodermal Hox genes match the morphological borders of the different 
gut regions (Fig. 1.7A) (Grapin-Botton, 2005). This is especially true for the 
5’ members of the Hoxa and Hoxd clusters (paralogues 9-13) (Roberts et al., 
1995). The expression pattern of these Hox genes have been shown to 
match the morphological borders of the different gut regions of the posterior 
midgut and hindgut. This then strongly supports the notion that they play a 
role in facilitating endoderm specification by the mesoderm.
Indeed the misexpression of Hoxd-13 in chick mesoderm has been 
shown to be able to induce a hindgut fate on midgut tissue (Roberts et al., 
1998). This is further supported with murine transgenic experiments where 
inactivation or misexpression of the Hox genes result in abnormal gut 
development (Pollock et al., 1992; Wolgemuth et al., 1989). In particular, 
loss of expression of Hoxa-13 and Hoxd-13 have resulted in the alteration of 
muscle layers of the sphincter, which is consistent with a partial anterior 
transformation of this region (Kondo et al., 1996; Warot et al., 1997)
In Xenopus a similar regional expression pattern is also observed with 
a number of abdominal type B Hox genes (Fig. 1.8B) (Lombardo and Slack,
2001). Eventhough these expression patterns have not been matched with 
morphological boundary of the gut in Xenopus, it certainly raises the 
possibility that they might provide the mesoderm with positional information 
along the A-P axis this allowing it to specify the mesoderm.
I.9. Aims
1.9.1. Identifying the mesodermal signals in Xenopus
The relatively recent discovery of the role of mesoderm in endoderm 
specification in Xenopus (Horb and Slack, 2001) challenges the previous
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cell-autonomous model of endoderm specification. In this new mesoderm 
dependent model of endoderm specification, only the existence of the 
mesodermal signals have been established. This study then was designed 
to follow up on the work done by Horb and Slack (2001) to try and identify 
the instructive signals being sent by the mesoderm.
This study aimed to address this by adapting the explant culture 
system from stage 20-23 embryo and developing a screen through which a 
number of commercially available growth factors would be tested. Through 
the screen growth factors which elicit an effect on endoderm specification 
would be identified for further study. Any growth factor that plays a role in 
endoderm specification would be detected by a shift or change in the 
expression of either Xlhbox8 or Xcad2, anterior and posterior markers of 
development respectively in Xenopus. We expected to be able to isolate 
several growth factors through this screen to characterise and study further.
Advantages of using a Xenopus system to study mesodermal signals 
in endoderm development have been discussed in Section 1.6.5 (p27). The 
relatively easy generation of endodermal explants and assurance that it 
would be free of mesoderm should allow us to do a more conclusive 
analysis of the mesodermal endodermal interaction in regional specification 
compared to other studies done in mouse and chick.
1.9.2. Overexpression of Hox Genes
Most of the studies done regarding endoderm development in 
vertebrate system have concentrated on the mesoderm and endoderm 
relationship without addressing the underlying factors responsible for the A- 
P patterning. Hox genes have been shown to be expressed in the 
mesoderm around the developing gut in nested overlapping regions in 
Xenopus and chick around the time of regional specification. Since they 
have been shown to provide positional information along the A-P axis in the 
development of mesoderm and ectoderm there is a possibility that they also
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are responsible for initiating the A-P patterning activities of the mesoderm 
on the endoderm.
This study aimed to explore this particular possibility by using RNA 
injection to overexpress the Hox genes to explore its possible function in 
this aspect of development. It was hoped that the misexpression of Hox 
genes would lead to a change in the positional identity of the mesoderm 
which in turn would lead to the misspecification of the endoderm. Detection 
of this change would be checked using similar PCR and in situ techniques 
as before for Xlhbox8 and Xcad2, anterior and posterior markers of 
development respectively.
The study would be focused on the more posteriorly expressed of the 
Hox genes. This is because so far the studies in both chick and mouse have 
indicated a posterior based specification of the endoderm (Dessimoz et al., 
2006; Kumar et al., 2003; Wells and Melton, 2000). Also posterior Hox genes 
are known to be more dominant than their anterior ones (Manak and Scott, 
1994). These two observations then would suggest that posteriorising the 
endoderm would be more feasible than anteriorising it through Hox 
overexpression.
Lastly, we must note that during the course of work on this study, 
there was significant progress made in the study of endoderm specification 
in chick and mouse systems, which have been referred to and discussed 
above. It should be taken into account when looking at the experimental 
chapters of this thesis that most of these results were unavailable when this 
work started in 2003.
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II. Materials and Methods
11.1. Xenopus husbandry
Adult male and female Xenopus were maintained on a diet of pellets 
(Blades Biological), braised steak and maggots. They were kept in a 
circulating water aquarium at 21 °C and exposed to a daily 12 hour light and 
12 hour dark lighting cycle. To procure eggs the female Xenopus was 
primed with an injection of 40 units of Pregnant Mare Serum Gonadotrophin 
(PMSG, Calbiochem) into the dorsal lymph sac from anything between 1 
day to a week before the eggs were needed. This helps increase the quality 
and quantity of eggs obtained for fertilisation. To induce egg laying itself the 
females were injected with 300 - 600 units of Human Chroionic 
Gonadotrophin (Chorulon, Intervet) the evening before the eggs were 
required.
11.2. Xenopus embryos artificial fertilisation
In order to obtain the sperm necessary for artificial fertilisation a 
male Xenopus was killed using a Home Office approved schedule one 
procedure. This usually involved treating the male with an overdose of 
anasthaetic (10% benzocaine in ethanol) for at least 30 minutes. After the 
male had died the abdomen was cut open and the testes were removed. 
The testis, once removed was kept moist by putting it on top of a filter 
paper soaked in NAM/2 medium (See Table 2.1 for composition of NAM 
solutions). For longer storage (up to 1 week) the testes were kept in NAM/2 
in 4°C. This kept the sperm in the testis viable for future fertilisation.
Before it could be used in artificial fertilisation the testis needed to be 
‘teased’. This was done by making several slices in the testis and 
subsequently pinching it several times using forceps (No.5 Jewellers 
forceps, Sigma) or scissors. This helped release the sperm necessary for 
artificial fertilisation. At this point Xenopus eggs were collected from the
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injected females by the application of gentle pressure on their abdomen 
towards the cloaca.
To fertilise the collected eggs, ‘teased’ testes was passed over them. 
This was done gently as the eggs can become activated by rough handling. 
The eggs were left untouched for about 5 minutes and then submerged in 
milliQ water. The embryos were then left for another 20 minutes, at this 
point the eggs should have rotated with the animal caps pointing up. Once 
rotated the eggs were dejellied using 2%  Cysteine HCI at pH 7.8-8.0, wash 
2 or 3 times with Mili-Q water and was then transfered to grow onto a Petri 
dish with NAM/10 solution.
Table 2.1 NAM solutions
NAM NAM/2 NAM/10
NaCI 110 mM 55 mM 11 mM
KCI 2 mM 1 mM 0.2 mM
Ca(N03)2.4H20 1 mM 0.5 mM 0.1 mM
MgS04.7H20 1 mM 0.5 mM 0.1 mM
Sodium EDTA 0.1 mM 0.05 mM 0.01 mM
Sodium Hepes 5 mM 5 mM 5 mM
Sodium
bicarbonate 1 mM 1 mM
Gentamicin
sulphate 2.5 pg/ml 2.5 pg/ml 2.5 pg/ml




RNA was prepared from the collected tissue samples by 
homogenising them in Trizol (Invitrogen). The quality and relative quantity of 
the isolated RNA was checked by running them on a 2%  gel. The gel should 
show the two bright ribosomal band and no smear coming from genomic 
DNA contamination. The concentration of the extracted RNA was checked 
using a spectophotometer.
Before performing reverse transcription, the RNA sample was first 
treated with RNase free DNasel (invitrogen) to help further reduce possible 
genomic DNA contamination before they were reverse transcribed using the 
Superscript III reverse transcription kit from Invitrogen. Approximately 1-2 
pg of RNA was used for each reverse transcription reaction.




EF1a Forward 5’ AGA7TGGTGCTGGATATG 3’
58°C 20
EF1a Reverse 5’ ACTGCCTTGATGACTCCTA 3 ’
Xcad2 Forward 5’ CCACCAACGGTAAGACAA 3’
58°C 25
Xcad2 Reverse 5’ GGAGATACCAAGTTGCTG 3’
Xlhbox8 Forward 5’ TGCCAACTTCATCCCAGCCC 3’
58°C 25
Xlhbox8 Reverse 5’ GGCAGATGAAGAGGGCTC 3 ’
FoxF1 Forward 5’ AACCCTCTGTCCTCCAGCCT 3’
58°C 25
FoxF1 Reverse 5’ GGTTAGTGGAATGACTAACTTC 3’
xFOG Forward 5’ TATGCCCAGAAGTTACAGGAA 3’
58°C 25
xFOG Reverse 5’ CACCTCCI I I I I GTGCCAGTG 3’
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11.3.2. Polymerase Chain Reaction (PCR)
PCR was performed using a Red PCR mastermix (ABGene) or using 
separate components of Taq, dNTPs and buffer (Invitrogen). Table 2.2 on 
the previous page lists the Primers used in this study along with annealing 
temperatures and cycle numbers for each primer pair.
Before cDNAs from the reverse transciption reaction were used, they 
were first treated with RNAseH (Invitrogen) to destroy the template mRNA. 
This reduced any possible false positives in the PCR reaction. 
Approximately 1-1.5 pi of the reverse transcription reaction was used for 
each PCR reaction. Resulting PCR products are run on 1.2-1.5% Agarose 
gel with Ethidium Bromide. At least half of the PCR reaction was loaded on 
the gel.
II.4. In situ Hybridisation
II.4.1. Generating DIG labelled probes
To generate the appropriate DIG labelled RNA probe for wholemount 
in situ hybridisation the following labelling reaction mix is prepared. At room 
temperature in a sterile RNase free eppendorf:
DEPC treated Mili-Q water to 50 /vl
5x transcription buffer (Promega) 10 y\
100mM DTT (Promega) 5 jj\
10x DIG-NTP mix (Roche) 2.5 /;l
Linear DNA template 2.5 //g
RNAout (Invitrogen) 2 /yl
RNA polymerase (SP6, T3 or T7 from Promega) 2 /yl
DEPC water is prepared by adding 0.1% (v/v) DEPC to Mili-Q water 
allowing the water to stand overnight and subsequently autoclaved. The 
RNA polymerase was chosen based on the plasmid that the probe is 
generated from (see below). Note that the DIG-NTP mix only needs to be 
added at half strength to save on resources.
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The above prepared mix was then allowed to incubate at 37°C for 
about 4 hours. Additional RNA polymerase (2pl) was added halfway through 
this incubation to help increase yield. After this incubation period the DNA 
template was removed by adding 2.5 pi RNase free DNasel (Promega) for 
20 minutes at 37°C.
The resulting RNA probe was then purified by passing them through 
a G50 sephadex column (Amersham Bioscience). This column allows the 
RNA probe to go through but not the free dNTPs. The column was prepared 
by vortexing for 30 seconds, and then with the cap half open centrifuged at 
10OOg (3000 rpm on tabletop centrifuge) for 1 minute to remove the storage 
solution. The RNA sample was then applied to this prepared column and 
then run again at 10OOg for 2 minutes. The collected solution was then run 
on a 2%  gel to check for quality. A good synthesis should yield a smeared 
band on the gel. Concentration of the RNA product was checked with 
spectophotometer. The RNA probe can be stored in either -20°C or -80°C.
In this study the following plasmid was used to generate DIG probes: 
Endodermin (Linearise with EcoRI/ transcribe with T7), Xlhbox8 (EcoRI/T7), 
Xcac/2-pCS2+ (Notl,T7). After complete linearization with the appropriate 
enzyme the DNA was isolated using Gel-clean up kit from Promega.
With constructs that are in pCS2+ it is preferable to prepare the 
template for RNA transcription via PCR. This is because pCS2+ has a 
mutated T7 promoter that prevents a good RNA transcript from being made 
from this promoter. To overcome this PCR was performed on the template 
on pCS2+ with an SP6 primer and a T7 primer with a corrected promoter 
sequence. Then 5 pi of the resulting PCR reaction were used as follows:
SP6 primer 5’ CTATAGTGTCACCTAAATAGCTTTGGCG 3 ’
Corrected T7 primer 5’ GTAATACGACTCACTATAGGTC 3 ’
The PCR reaction was performed with a melting temperature of 50°C 
for 25 cycles. The low temperature should allow for the mismatch at the T7
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promoter to hybridise with the template and ensure a good PCR 
amplification.
11.4.2. Specimen preparations
Specimens meant for in situ hybridisation were fixed for 1 hour at 
room temprature using MEMFA (0.1 M MOPS (pH 7.2), 2mM EGTA, 1mM 
MgS04 and 10% (v/v) formaldehyde pH 7.4). After fixation the specimens 
were then washed for 5 minutes in 100% EtOH and then placed in fresh 
100% EtOH and stored at -20°C. The specimens can be stored in this 
manner for up to 3 months.
11.4.3. In situ Hybridisation
The in situ hybridisation was performed as described in (Harland,
1991) over three days with minor modifications that will be described below. 
The first day involves the hybridisation of the DIG RNA probe. The first day 
protocol was carried out using 5ml glass vials placed on a nutator (Fisher) 
for agitation. The specimens that have been fixed and kept in 100% EtOH 
are first rehydrated through a series of rehydration washes: 75% EtOH in 
PBSAT (PBS + 0.1% Tween) for 5 minutes, 50% EtOH in PBSAT another 5 
minutes and three 5 minute washes in PBSAT. Once rehydrated the 
specimens were then treated with Proteinase K (10 pg/ml) for 10-20 
minutes, depending on the specimen size, to help with permeability. Care is 
taken not to agitate the specimen too harshly when treating with Proteinase 
K as it will result in excessive damage to the specimens. After Proteinase K 
treatment the samples are then washed twice with triethanolamine (0.1 M, 
pH 7.8) for 5 minutes each on the nutator. At the end of the second wash 
12.5 pi of acetic anhydride was added to each of them. For this step to 
avoid damage they were not agitated on the nutator, but were instead 
swirled gently and incubated for 5 minutes. Another 12.5 pi of acetic 
anhydride were added and samples incubated for another 5 minutes. The
acetylation with acetic anhydride reduces non-specific binding to NH2 
groups. The specimens were then washed twice for 5 minutes each in 
PBSAT and then refixed with 10% (v/v) formaldehyde in PBSAT for 20
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minutes. After fixation they are washed again with PBSAT 5 times for 5 
minutes each to remove traces of formaldehyde. At the end of the fifth wash 
the vials were filled with 1 ml of PBSAT + 250 |jl of hybridisation buffer. 
Hybridisation buffer was made by combining the following:
Final cone add
Formamide 50 % 25 ml
20x SSC 5x 12.5 ml
50 mg/ml yeast RNA 1 mg/ml 1 ml
100 mg/ml heparin 100 pg/ml 50 pi
50x Denhardt’s 1X 1 ml
20% tween 20 0.1% 250 pi
20% CHAPS 0.1% 250 pi
0 .5 M EDTA pH 8 10 mM 1 ml
Next the specimens were transferred into new vials containing 1-2 ml 
of hybridisation buffer, then incubated at 60°C for 10 minutes. After this the 
hybridisation buffer was replaced and specimens incubated for a further two 
hours at 60°C. This pre-hybridisation step is important as it blocks non­
specific sites in the specimens. The DIG-RNA probes were prepared at 1 
pg/ml concentration in hybridisation buffer and were preheated to 60°C 
before adding it to the specimens at the end of the pre-hybridisation step. 
Once the DIG-RNA probes have been added to the vials, they were 
incubated at 60°C overnight.
On day two of the in situ hybridisation, DIG-RNA probe that had been 
left to hybridise overnight was removed and was replaced with fresh 
hybridisation buffer and then left to incubate for 15 minutes at 60°C. 
Solution exchanges were performed in the 60°C water bath to prevent 
temperature loss and thus maintain the stringency of the hybridisation. The 
DIG-RNA probe that was removed can be stored at -80°C for up to 2-3 
further hybridisations. After 15 minutes the specimens were put through a 
series of washes. These comprise of three washes with 2xSSC + 0.1% 
Tween 20 for 20 minutes each at 60°C and a further two washes with
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0.2xSSC + 0.1% Tween 20 for 30 minutes each at 60°C. All of the solution 
exchanges above were performed in the 60°C water bath to prevent 
temperature loss. Next the specimens are removed from the 60°C bath and 
brought to room temperature where they underwent two washes in Maleic 
acid buffer (MAB, 100 mM Maleic acid, 150 mM NaCI, 0.1% Tween 20, pH 
7.8) for 15 minutes each. This was followed by blocking step for 30 minutes 
in MAB + 0.1% Tween 20+ 2% Boehringer Mannheim Blocking reagent 
(Roche) for 30 minutes and another 2 hours in MAB + 0.1 % Tween 20+ 2%  
Boehringer Mannheim Blocking reagent + 20% heat treated sheep serum. 
After the blocking step was finished the DIG antibody was added at 1:2000 
dilution in MAB + 0.1% Tween 20+ 2% Boehringer Mannheim Blocking 
reagent + 20% heat treated sheep serum. The antibody was incubated 
overnight at 4°C.
Day three consists mainly of washes, the antibody was removed from 
the specimens and the specimens were washed with MAB + 0.1% Tween 
20 at room temperature three times for 15 minutes each and another six 
times at 30 minutes each. At the end of the washes the solutions were 
replaced with alkaline phosphatase buffer (100 mM Tris Cl pH 9.5, 50 mM 
MgCI2, 100 mM NaCI, 0.1% Tween 20) for 3 and 10 minutes washes. The 
alkaline phosphatase buffer is replaced with BM purple solution (Roche) and 
left undisturbed until colour had developed. The length of this incubation 
varied in some cases from 1 hour to overnight depending on the abundance 
of the target mRNA. If overnight development was required the specimens 
were placed in the dark or in 4°C. 5 mM Levamisole was added to the 
alkaline phosphatase buffer and BM purple to further inhibit endogenous 
alkaline phosphatase activity and reduce background if necessary. 
Levamisole acts by inhibiting the non-intestinal isoform of alkaline 
phosphatase, which makes up most of the endogenous activity.
II.5. Microsurgery tools
Proper tools are necessary to ensure good microsurgery on Xenopus. 
These consist of 2 sharpened no.5 watchmakers’ forceps (sigma) and 2
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blunt watchmakers’ forceps. The sharpened forceps were used to remove 
vitelline membranes from early embryos. They were made by sharpening 
stock no.5 watchmakers’ forceps on a sharpening stone. It was important 
that the ends of the forceps meet exactly as otherwise it will not be able to 
grasp the vitelline membrane effectively (see Fig 2.1). Blunt forceps were 
used to move and orientate the embryos, the blunt edges help prevent 
damage to the embryo during this step
side top side top
sharpened forceps blunt forceps
Figure 2.1 Sharp and blunt forceps
Diagrammatic representation of the forceps tips for both sharpened and blunt no.5 
watchmakers’ forceps.
To make incisions in the embryo a tungsten needle was used. 
Tungsten needles were made by sharpening tungsten wire through 
electrolysing in a 1M NaOH solution. A piece of plasticine was put at the 
end of the wire and as the tungsten was electrolysed the weight of the 
plasticine pulled on the wire until it breaks. This created a very sharp end to 
the wire which was suitable for making precise incisions on embryos. To 
make a tapered end to the needle the wire was moved in and out during 
electrolysis. The sharpened wire was then mounted in glass handles for 
easy handling. The sharp end of the needle was kept from contact with 
anything solid as this will result in a blunt needle.
Microsurgical manipulations of embryos were usually performed on
1.5% agar plates with NAM/2 solution (Table 2.1). The agar helps prevent 
damage to the sharp instruments and the high salt of NAM/2 facilitates the 
healing of the embryos after surgery.
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11.6. Animal caps
Animal caps were made from stage 9-10 blastula embryos. First the 
vitelline membranes were removed from the stage 9-10 blastula embryos 
and then using either sharpened forceps or tungsten needles the animal cap 
was cut out from the embryo. Care was taken to ensure that only the thin 
animal caps are isolated, as the thick marginal tissue may contain 
mesoderm. The cut animal caps were directly transferred onto 2cm Petri 
dishes coated with 1.5% agar containing NAM/2 solution (Table 2.1) + 
1 %BSA. The animal caps were oriented with the dark outside cells touching 
the agar. The isolated animal caps are cultured in this way at 23°C for 3 
days, changing the solution with fresh NAM/2 +1 % BSA every 2 days.
11.7. Endoderm and Endoderm + Mesoderm explants
These are made from stage 20-23 embryos, the locations of the cuts 
to make the different explants are shown in figure 2.2 below. The 
microsurgery on these embryos is done using tungsten needles and 
performed in 1.5% agar plates in NAM/2 solution (Table 2.1). Cut 1 was 
made just behind the cement gland and marks the anterior end of the 
endoderm. Cut 2 was right before the proctodeum and marks the posterior 
end. Cut 3 was halfway between 1 and 2 in the middle of the embryo with 
cuts 4 and 5 made halfway between cuts 1 and 3 and 1 and 2, respectively. 
The explants were separated from the embryo by making a final cut along 
the edges of the shaded region shown in the diagram (Fig 2.2).
To make whole endoderm explants cuts 1 and 2 were made. To 
make half explants cuts 1, 2 and 3 were made. To further divide the 
endoderm into 4 regions from anterior to posterior cuts 1 -5 were made. If 
endoderm free of mesoderm explants were to be made the cuts are done in 
NAM/2 in the presence of trypsin (1 pg/pl, Sigma). This helps separate the 
two germ layers by degrading extracellular matrix material. Once separated 
the endoderm only explants were moved to NAM/2 solution containing 
trypsin inhibitor (2pg/pl, Sigma) and allowed to heal for approximately 0.5-1 
hour. After they healed the explants were moved to a fresh NAM/2 +
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1%BSA solution and cultured at 18°C. The culture solutions are changed 
with fresh NAM/2 + 1% BSA every 2 days. When making Endoderm + 
Mesoderm (endo+meso) explants, the cuts are performed in NAM/2 without 
trypsin. The explants were kept for half an hour to heal before moving them 
to NAM/2 +1% BSA solution for culture at 18°C. All the dishes used in 
explant culture are coated with 1.5% agar to prevent the endoderm sticking. 
The explants were cultured until the control embryos cultured alongside 
reached stage 41 -42 (approx 4 days).
EA
4 5
Figure 2.2 Stage 23 embryo showing locations of cuts.
Location of cuts to be made to make endodermal explants. If all cuts from 1 to 5 
are made the endoderm is divided into four regions between it’s A-P axis: Extreme 
Anterior (EA), Anterior (A), Posterior (P), Extreme Posterior (EP).
11.8. Isolating whole gut from stage 41 -43 embryos
Embryos from between stage 41-43 were first immobilised by 
incubating with 1/5000 dilution of MS222. Once immobilised the epidermis 
surrounding the gut is removed using watchmakers’ forceps to expose the 
gut. Then two cuts were made, one at the oesophagus and another at the 
cloaca to separate the gut from the embryo.
11.9. Growth Factor and Inhibitor Treatment
Treatment with growth factors and inhibitors on Endoderm or 
endo+meso explants and animal caps was done on 1.5% agar coated 2cm
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petri dishes. The dishes were pre-incubated with NAM/2 + 1%BSA for 
approximately 15-20 minutes and this was then replaced with 2ml of NAM/2 
+ 1 %BSA. The BSA acts as a carrier and prevent the plastic from absorbing 
too much of the growth factors. The growth factors or inhibitors were added 
to the solution at the appropriate concentration. The tissue to be treated 
was put on these plates and cultured at 18°C for Endoderm or endo+meso 
explants and at 23°C for animal caps.
For animal caps and Endoderm explants after 1 day of incubation the 
growth factor solution was replaced with fresh NAM/2 + 1%BSA. The 
solution was changed every 2 days until the experiment was finished, 
endo+meso explants were kept in growth factor solution in NAM/2 + 1 % 
BSA throughout the culture period. New growth factor solution in NAM/2 + 
1 % BSA was put on the explants every 2 days.
An alternative way of applying the growth factor was by using 
heparin-acrylic beads (Sigma). Heparin-acrylic beads release growth factors 
slowly creating a graded concentration from the location of the beads, 
which mimics in vivo signals. Before implantation the heparin-acrylic beads 
were soaked with 1 pg/ml of the protein for 2 hours at room temperature. 
This binds the protein onto the beads. After incubation the beads were 
washed three times with PBS. The beads were implanted through an 
incision made in the anterior of stage 20-23 embryo. Once the bead is 
inserted, the embryos were allowed to heal and cultured as for normal 
fertilised embryos.
For this study the growth factors ActivinA, BMP4, FGF4, FGF8, 
FGF10, EGF were obtained from R&D systems. Retinoic Acid (RA) and LiCI 
was obtained from Sigma. The inhibitors SU5402 and PD98059 were 
sourced from Calbiochem whilst sFRP2, Follistatin, noggin and cyclopamine 
were obtained from Sigma.
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11.10. RNA /  label injection
11.10.1.Preparing RNA for injection
Plasmids containing the constructs to be injected should be in the 
plasmid pCS2+ as RNA made from pCS2+ constructs have a polyA added 
that contributes to the stability of the mRNA after injection. RNAs for 
injections were made from plasmid constructs using the appropriate 
polymerase (Sp6 for constructs in pCS2+) mMessage machine RNA 
synthesis kit (Amersham). After synthesis the RNA was cleaned using G-50 
sephadex column (Amersham) and diluted as necessary. Unused RNA can 
be stored at -20°C for approximately 1 -2 months.
11.10.2. Injection procedure
RNAs or labels (BrdU/FDA) were injected using the Nanoject Injector 
(Drummond). Needles were prepared using a horizontal needlepuller. The tip 
of the pulled needle was clipped using forceps so that an opening is made 
no more than 10-20 pm diameter. The needle was then filled with mineral oil 
and loaded onto the injector. Once on the injector the needle was backfilled 
with solution containing the substance of interest. Injections were done in 
NAM/2 + 1 % Ficoll (Sigma) solution in a 1.5% agar coated dish. Ficoll was 
added to the injection medium to help suppress the ‘leakage’ that would 
otherwise come out of the hole made by the needle. To target the injections 
the embryos were held with forceps and injected from the other side. The 
injected embryos were then allowed to heal in NAM/2 + 1% Ficoll for a 
minimum of 2-3 hours. Once healed the embryos were put in fresh NAM/10 
solution and kept overnight at 18°C. Ficoll can cause failure of gastrulation 
and was removed to ensure normal development. The next day protruding 
tissues coming out of injection site were removed and the embryos were 
placed into fresh NAM/10 solution. The embryos were then treated as with 
normal artificially fertilised embryos.
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11.11. Histology
II. 11.1. Paraffin sections
Specimens were fixed in MEMFA (0.1 M MOPS (pH 7.2), 2mM EGTA,
1mM MgS04 and 10% (v/v) formaldehyde pH 7.4) for an hour at room
temperature and then placed in 70% ethanol before being processed for 
Wax embedding. They were processed by putting them through dehydration 
steps of 70% EtOH than 90% EtOH and twice in 100% EtOH. Then 
specimens were put into 2 incubations with histoclear and 3 incubations 
with molten Paraffin wax. For small specimens such as embryos from stage 
35 or earlier each step was performed for 30 mins. For larger embryos 
(stage 38 or above) each step was performed for 1 hour each.
Once processed the specimens were embedded in wax and 
sectioned between 10-20 pm depending on the need. Thicker sections were 
sometimes needed to help visualise weak in situ signals. They were then put 
on polylysine superfrost slides (Fisher), dewaxed with histoclear. The 
specimens could now be counterstained with Ehrlich’s haematoxylin 
solution (Sigma), dehydrated and mounted. For in situ specimens 
counterstaining was not necessary and the specimens are directly dewaxed 
with histoclear and mounted with Depex (National Diagnostics).
II.11.2. Cryosections
Specimens for cryosectioning were fixed in 4% PFA at room 
temperature for 1 hour (up to stage 35 embryo) or 2 hours (stage 40 or older 
embryo). They were then transferred to 15% sucrose in PBS for 
approximately 5 hours at 4°C until they sank and then 30% sucrose in PBS 
overnight at 4°C. The specimens were now embedded in with OCT (Sigma). 
They were flash frozen with dry ice and either sectioned directly or stored at 
-80°C for up to 1 month.
Cryosections were cut between 15-20 pm depending on need. 
Sectioned samples were dried at room temperature for approximately 2 
hours. They were then washed in PBS before being mounted with Gelmount
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(Biomeda). Gelmount is a water-miscible mountant that maintains signals in 
fluorescent samples and is necessary for GFP visualisation.
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III. Growth Factor Expression
pattern
111.1. Introduction
Growth factors are proteins which are present in animal tissues at 
very low concentrations and have high biological activity. They are typically 
found in specific places, usually close to the cells that produce them as a 
result of them being bound to cell surfaces or to extracellular materials 
(extracellular matrix). The growth, differentiation and survival of a cell 
depends largely on the composition of growth factor molecules in the 
microenvironment around it (Slack, 1991a). Due to the localised nature of 
growth factors, finding out where they are expressed can give valuable 
insight to their possible biological functions.
Spatial expression pattern have been previously used to help 
understand the roles of growth factors in endoderm specification. 
Experiments in chick and mouse embryos have shown that growth factors 
are able to mimic or replace mesodermal signals in endoderm specification 
(Dessimoz et al., 2006; Kumar et al., 2003; Wells and Melton, 2000). One of 
the growth factors tested, FGF4, was shown to pattern the endoderm in a 
posterior dominant fashion (Dessimoz et al., 2006; Wells and Melton, 2000). 
In the mouse FGF4 has been previously shown to be expressed in the 
posterior of the embryo near the primitive streak (Niswander and Martin,
1992). In chick FGF4 was also found to be expressed at high concentration 
near the posterior of the embryo after gastrulation, near the hindgut and 
midgut (Shamim and Mason, 1999). In Xenopus the closest homologue to 
FGF4, eFGF has a similar expression pattern during gastrulation (Isaacs et 
al., 1992b). In mouse and chick this posterior expression of FGF4 was used 
in conjunction with the results from growth factor screens to draw up a
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posterior morphogen model for the specification of the endoderm 
(Dessimoz et al., 2006; Wells and Melton, 2000).
The study done by Horb and Slack (2001) indicated that regional 
specification was not completed until after stage 25. Information regarding 
the expression pattern of the growth factors around stage 25 was 
incomplete. We aimed to address this by performing in situs on various 
different growth factors on stage 23 and 27 embryos. We had initially 
considered performing immunostaining alongside the in situs since it would 
give additional information as to where the growth factors maybe active. 
However this was difficult as antibodies for growth factor proteins in 
Xenopus that would work for whole mount immunostaining are not readily 
available.
111.2. Materials and Methods
In situ hybridisation probes for the growth factors were made by 
linearising the plasmid containing the gene with a restriction enzyme and 
synthesising the DIG probe with the appropriate RNA polymerase. Table 3.1 
lists the restriction enzymes and polymerases used to generate the growth 
factor probes. In situs were then performed on stage 23 and 27 embryo.
Table 3.1 Enzymes and RNA polymerase for probe synthesis













Once the in situ were fully developed the embryos were bleached 
with 2%  H20 2 (Sigma) to allow better visualisation of the expression pattern.
111.3. Results
The in situ revealed that eFGF/FGF4 and FGF8 were expressed in 
posterior of the embryo. eFGF/FGF4 and FGF8 have been shown previously 
to be posteriorising factors which was consistent with the posterior 
expression pattern observed here (Christen and Slack, 1997; Isaacs et al., 
1994; Pownall et al., 1996). FGF8 also exhibited staining in the anterior of 
the endoderm around the branchial arches at stage 20 and 27 and the mid 
brain - hind brain boundary at stage 27. We do not think that this expression 
was relevant to the development of the endoderm. FGF10 was seen to be 
expressed in the otic vesicle which was clear at stage 27 but not in the 
stage 23 embryo. No other domains were seen with the FGF10 in situ. 
bFGF/FGF2, FGF6 and FGF9 as well as the Wnts (Wnt3A, Wnt5A, Wnt7A 
and Wnt8) in situ did not show any relevant endodermal/mesodermal 
staining.
Figure 3.1 (next 2 pages) In situ on stage 23 and 27 embryo for probes 
bFGF/FGF2, eFGFIFGF4, FGF6, FGF8, FGF9, FGF10, Wnt3, Wnt5A, Wnt7A, 
Wnt8.
bFGF/FGF2 column shows the orientation of the embryos at stage 23 and 27: 
A=Anterior, P=Posterior, D=Dorsal, V=Ventral. The staining with bFGF/FGF2 and 
FGF6 did not show any relevant endodermal or mesodermal staining. FGF9 shows 
a slightly blue overall staining with no apparent endodermal or mesodermal 
staining. eFGFIFGF4 and FGF8 were shown to be expressed in the posterior of the 
embryo at these stages. Inset in both FGF4 and FGF8 stage 23 panel shows a 
close up look at the posterior staining for these genes. FGF8 also has a staining at 
the anterior of the embryo at the branchial arches at stage 20 and 27 and mid 
brain-hind brain boundary at stage 27. Whilst FGF10 was expressed in the otic 
vesicle which can clearly be seen at stage 27 (see inset for a higher magnicifaction 
picture). BMP4 is the most interesting with a possible endodermal expression 
pattern. The Wnts examined here do not seem to be expressed in either the 













In situ for BMP4 showed that it was expressed near or around the 
endoderm in the anterior and posterior of the embryo. This may indicate a 
possible involvement in endoderm specification. From the whole mount in 
situ it was not possible to tell whether the BMP4 expression was in the 
mesoderm or whether it was also expressed in the endoderm. To solve this 
we processed the whole mount in situ embryos, wax embedded and 
sectioned transversely.
Figure 3.2 Sections of BMP4 whole mount in situ for stage 20 and 27 embryo.
Transverse sections are made of BMP4 whole mount in situ at 10pm thickness. The 
blue line indicates position of the anterior sections whilst the red line shows the 
posistion of the posterior sections. Photographs of the sections are shown to the 
right. The arrows point the position of the in situ signal in the sections. Here we can 
see that the signal seems to be expressed in the mesoderm in both anterior and 
posterior sections.
Sections of the whole mount in situ for BMP4 revealed that the 
staining was contained in a tight band near the outside of the embryo in 
both the anterior and posterior domains (Figure 3.2). This then showed that 






eFGF/FGF4 and FGF8 were seen expressed towards the posterior of 
the embryos. This is consistent with the posteriorising roles of eFGF/FGF4 
and FGF8 previously seen in Xenopus (Christen and Slack, 1997; Isaacs et 
al., 1994). A posterior expression domain of FGF4 have been seen in chick 
and mouse before (Niswander and Martin, 1992; Shamim and Mason, 1999). 
In both these organisms FGF4 has been shown to be capable of 
posteriorising the endoderm (Dessimoz et al., 2006; Wells and Melton,
2000). This then raises the possibility that FGF4 might posteriorise the 
endoderm as well in our growth factor screen (see Chapter IV)
At the moment there are no known functions of FGF8 in endoderm 
specification. However FGF8 has been implicated in the formation of 
somites in chick embryo. Regular spacing of somites is thought to involve a 
dynamic gradient of FGF signalling that controls the timing of maturation of 
cells in the presomitic mesoderm (PSM) (Delfini et al., 2005). FGF8 has been 
shown to form a posterior morphogen gradient of mRNA along the A-P axis 
in the PSM of chick and mouse embryos through a mechanism of mRNA 
degradation (Dubrulle and Pourquie, 2004). In this mechanism FGF8 
transcription is restricted to the tail bud only. As the embryos elongate, 
descendants of the tail bud then inherits the FGF8 mRNA. As the axis 
continues to elongate these cells are then pushed towards an increasingly 
anterior position. Taking into account RNA decay it can be seen how more 
anterior cells (older descendants) would have a lower level of FGF8 mRNA 
compared to more posterior cells (recent descendants), creating a posterior 
gradient of FGF8 mRNA (Dubrulle and Pourquie, 2004).
The high levels of FGF8 in the posterior of the embryo is thought to 
inhibit the differentiation of the PSM through the Erk/MAPK pathway. 
Because of the mechanism by which the gradient is formed, the highest 
level of FGF8 is always in the tail bud. As the axis elongates the point at 
which the FGF8 concentration stops inhibiting somitogenesis, the threshold, 
moves in a posterior direction. Thus as a result of this posterior movement
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more and more posterior somites are formed, resulting in the regular 
spacing seen in the mature structure (Dubrulle and Pourquie, 2004). 
However we need to note that we did not find a gradient of FGF8 mRNA 
from our in situ on stage 23 and 27 embryo. Thus if in the growth factor 
screen FGF8 was indeed found to be involved in endoderm specification it 
is unlikely that it acts through this mechanism.
BMP4 also showed an interesting expression pattern in both the 
anterior and posterior of stage 23 and 27 embryo. Although from the whole 
mount in situ it appears to be expressed in both endoderm and mesoderm, 
transverse histological section have shown that it is only expressed in the 
mesoderm. In chick BMP4 was also found to be expressed in mesoderm 
around the gut but only near the posterior of the embryo (Roberts et al., 
1995; Roberts et al., 1998), consistent with its ability ito inducen inducing a 
posterior respecification in chick endoderm and mesoderm culture (Kumar 
et al., 2003). The expression of BMP4 in both anterior and posterior 
extremes of stage 23 and 27 Xenopus embryos might suggest that BMP4 
could be acting through a different mechanism in Xenopus and not just 
posteriorising the endoderm as previously seen in chick.
However there is also the possibility that the expression domain of 
BMP4 might not have any relevance at all to the specification of the 
endoderm. The development of other organs has been shown to be 
dependent of the BMP4 signal. The ventral foregut endoderm has the 
potential to develop into either liver or pancreas (Deutsch et al., 2001). 
Studies in mouse and chick have shown that the liver fate is dependent on 
signals from adjacent mesoderm: FGF signalling from adjacent cardiogenic 
mesoderm (Fukuda-Taira, 1981; Jung et al., 1999; Le Douarin, 1975); BMP 
from nearby septum transversum mesenchyme (Rossi et al., 2001); as well 
as an unidentified third signal coming from endothelial cells (Matsumoto et 
al., 2001). In Xenopus only FGF signalling have been implicated in liver 
development as a dominant negative inhibitor of FGF has been shown to 
inhibit induction of liver specific genes (Chen et al., 2003). Even though no
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link has been made in Xenopus between BMP4 and liver development, the 
anterior domain observed in our in situ is well placed to signal to the ventral 
foregut endoderm and induce liver fate.
The development of tail in Xenopus have also been shown to involve 
BMP4. Previous experiments in our lab have shown that ectopic BM.P4 
expression in the posterior neural plate of early neurula embryo results in 
the formation of tail-like structure (Beck et al., 2001). It is also known that 
BMP4 is expressed in the cells immediately ventral to the site of the future 
tail bud (Fainsod et al., 1994), and that it is active in the ventral part of the 
future tail bud itself which is fated to form tail somites (Beck et al., 2001). It 
is thought that BMP4 is involved from an early stage in tail bud formation, as 
it is being determined (Beck et al., 2001). However the expression we see in 
our in situs does not show expression in the tail-bud and is slightly too 
anterior. Perhaps if we had used later stages embryos or developed for 
longer we might be able to see this tail bud expression.
Despite all these possible roles in liver and tail formation, we need to 
remember that BMP4 was found to be expressed at the stages when 
endoderm specification occurs. Thus it is still possible that it is involved in 
the specification of the endoderm as well as the development of liver and 
tail. The functional role of BMP4 as well as other growth factors in 
endoderm specification is something that we aimed to investigate in the 
growth factor screen in the next chapter
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IV. Identifying mesodermal signals
IV.1. Introduction
Early studies on Xenopus endoderm development have suggested 
that it undergoes regional specification early in development and it does so 
autonomously. Expression of endodermal markers of development such as 
Xlhbox8 and IFABP were found in vegetal explants isolated from blastula 
stage embryos (Gamer and Wright, 1995; Henry et al., 1996; Zorn et al., 
1999). However a recent study in our lab has shown that this apparently 
autonomous specification of the endoderm in Xenopus is most likely due to 
the presence of mesoderm in these vegetal explants, which was previously 
missed due to the use of inappropriate mesodermal markers (Horb and 
Slack, 2001). The early studies in endoderm development had screened for 
Xbra, cardiac actin, Xtwist and a-T3 globin to show that there was no 
mesoderm in the vegetal explants (Gamer and Wright, 1995; Henry et al., 
1996; Zorn et al., 1999). However these genes were not expressed in the 
mesoderm surrounding the gut at tadpole stages. For the purpose of 
detecting mesoderm in the vegetal explants it is more appropriate to use 
mesodermal markers that are found in the gut mesoderm including those 
such as FoxF1 (Koster et al., 1999),XA//cx-2.5 (Evans et al., 1995; Patterson 
et al., 2000; Smith et al., 2000), XTbx5 (Horb and Thomsen, 1999) and xFOG 
(Deconinck et al., 2000). Expression of these was, in fact, evident in the 
vegetal explants (Horb and Slack, 2001), although whether this is due to 
dissection error, or to some regulative response of isolated endoderm is still 
not clear.
(Horb and Slack, 2001) in their study showed that mesoderm-free 
endoderm explants can only be made from later stage (stage 20-23) 
embryos, when the endoderm and mesoderm have formed distinct layers. 
These endodermal explants remain unspecified when cultured on their own. 
Expression of Xlhbox8 and Xcac/2 were only seen if the endoderm explants 
were cultured in the presence of mesoderm. We need to note, however, that
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in normal intact embryos Xlhbox8 expression begins in late gastrula or early 
neurula. However Horb and Slack showed that this expression was lost in 
the absence of mesoderm, indicating that there must be a continuous 
requirement for mesoderm to maintain Xlhbox8 expression in its normal 
territory. Only endoderms made from after stage 25 were able to maintain 
Xlhbox8 expression in the absence of mesoderm. These observations 
suggested that the regional specification of the endoderm requires 
signalling from the mesoderm and is likely to occur later in development, 
becoming stable around stage 25 (Horb and Slack, 2001). This model for the 
regional specification of the Xenopus endoderm, where the mesoderm is 
essential, is similar to those in other organism such as mouse (Wells and 
Melton, 2000) and chick (Kumar et al., 2003).
In Xenopus only the instructive nature of the mesodermal signals 
have so far been characterised. Through heterologous recombinations, It 
was shown that posterior endoderm takes on an anterior identity when 
recombined with anterior mesoderm. Similarly anterior endoderm takes on 
posterior identity when recombined with posterior mesoderm thus indicating 
that the mesoderm is instructing the endodermal fate (Horb and Slack, 
2001). The present study was intended to follow up from this and perform a 
screen to try and find the identity of the mesodermal signals being sent to 
the endoderm.
Simultaneous with this work, similar screens have been carried out in 
mouse (Wells and Melton, 2000) and chick (Kumar et al., 2003). In mouse it 
was found that FGF4 induces endodermal explants made from E7.5 embryo 
in a dose dependent manner. High doses of FGF4 were found to induce 
expression of somatostatin a posterior marker of development. Lower doses 
of FGF4 induced NeuroD, a more anterior marker of development whilst 
also downregulating somatostatin (Wells and Melton, 2000). Considering 
that In vivo FGF4 is normally expressed in the posterior of the embryo 
(primitive streak) (Niswander and Martin, 1992), these results indicate that
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FGF4 might be acting as a posterior morphogen in patterning the 
endoderm.
In chick, FGF4 was also seen to pattern the endoderm in a posterior 
manner. FGF4 heparin-agarose beads implanted in the anterior most 
endoderm were seen to repress expression of the anterior markers Hex1 
and Nkx2.1 whilst expression of the more posterior markers Pdx1 and CdxA 
was upregulated. A complementary inhibitor study using SU5402 (FGFR1 
inhibitor) heparin-agarose beads showed the opposite effect. Here Hex1 
expression was expanded whilst Pdx1 was inhibited (Dessimoz et al., 2006). 
Another study in chick found that other growth factors such as RA, BMP and 
activin can induce respecification of the endoderm in the presence of 
mesoderm (Kumar et al., 2003). Here endoderm-mesoderm explants were 
induced to express more posterior specification markers when treated with 
these growth factors. It is worth noting that the patterning by growth factors in 
chick have not been demonstrated to be dose dependant.
In our study the growth factor screen would be based on the stage 20- 
23 endoderm explant culture that has been established in (Horb and Slack,
2001). In the screen, these explants would be treated with various growth 
factors and tested for expression of the specification markers Xlhbox8 
(anterior) and Xcad2 (posterior) with either in situ or PCR.
Since the signals from the mesoderm have been shown to be 
instructive we expected to find expression of the Xlhbox8 throughout the 
whole endoderm explant when treated with an anteriorising growth factor. 
Similarly we expected expression of Xcad2 throughout the whole endoderm 
explant when treated with a posteriorising growth factor. Since in chick some 
growth factors only elicit a response in the presence of mesoderm we 
decided to perform a screen on explants where the mesoderm was cultured 
alongside the endoderm (endo+meso). A complementary inhibitor screen 
was also performed alongside the growth factor screen to provide a more
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complete picture. A summary of the expected result from this screen can be 














Loss of Xcad2 or Xlhbox8 
expression
Endoderm + Mesoderm 
Figure 4.1 Summary of Hypothesis.
A) Endoderm-only screen. Untreated endoderm explant does not express either 
Xlhbox8 or Xcad2. B) & C) Endoderm+Mesoderm screen. Untreated endo+meso 
explants show expression of Xlhbox8 in the anterior and Xcad2 in the posterior. 
Overall Xlhbox8 expression was expected in both types of explant when treated 
with anteriorising growth factor whilst overall Xcad2 was expected for 
posteriorising growth factors. Inhibitors that inhibit mesodermal signals should 






Before going on with the growth factor screen we needed to optimise 
the detection methods to make sure that they could cope with the relatively 
small explants. PCR and in situ were the two methods used for the 
detection of specification markers. We explored the advantages and 
disadvantages of each of these techniques to determine a suitable detection 
method for the growth factor screen.
IV.2.1 .PCR
RT-PCR was performed on RNA isolated from whole embryos of 
stage 10,18 and 27 for Xlhbox8 and Xcad2 (Fig 4.2). Here we saw a weak 
expression of Xlhbox8 at stage 10 which increased through to stage 27 as 
was previously seen in (Horb and Slack, 2001). Xcad2 expression was high 
throughout these stages, because it is expressed in mesoderm as well as 





10 18 27 1x 10x 20x 100x 200x 400x -RT
Figure 4.2 RT-PCR with whole embryos.
RT-PCR result for Xcad2 and Xlhbox8 for stage 10.18 and 27 are shown on the left. 
RNA samples from stage 27 was then diluted for 1x,10x, 20x, 100x, 200x and 400x 
to test the limits of RT-PCR detection. Results of this dilutions are shown to the 
right. EF-1a was used as a positive control.
aSince the screening was to be done on smaller pieces of tissue we 
wanted to see how far we could extend the sensitivity of the RT-PCR 
detection. To do this RNA was isolated from a single stage 27 embryo and
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was put through a dilution series up to 1 in 400 before being reverse 
transcribed (Fig 4.2). The result showed that for Xcac/2 detection was still 
possible up to a dilution of 1 in 200 with Xlhbox8 being slightly less sensitive 
and detectable up to 1 in 100 dilution. The very high sensitivity of this 
method means that it should be possible to detect expression of both these 
genes from small tissue explants..
Previously in (Horb and Slack, 2001) RT-PCR detection was done on 
half endoderm samples, dividing the whole endoderm into anterior and 
posterior pieces. The establishment of this high threshold of RT-PCR 
detection meant that we could further divide the endoderm and thereby 
increase the spatial resolution of this method of detection. Thus, we 
decided on dividing the endoderm into 4 regions along its A-P axis into 






Gut EA A P EP -RT
Figure 4.3 Explant diagram and RT-PCR.
The diagram on the left shows how the regions of the endoderm were divided 
along the A-P axis. This was explanted from stage 23 endoderm cultured and then 
processed for RT-PCR. Result for this are shown on the right with Gut from stage 
42 was used as positive control.
Endo+meso explants of these regions were then made and cultured 
until the control reached stage 42. Note that in making the endo+meso 
explants the ectoderm was not removed. Even though the PCR can detect 
up to 1 in 100 dilution of RNA we found that the RNA extraction step was 
less efficient for small explants and so at least 20 pieces of each region is 
necessary for good RNA extraction. For a positive control the complete gut
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from the stage 42 embryo was used. This gut represents a normally 
developed endoderm tissue and gives a representation for the normal 
expression levels of Xlhbox8 and Xcad2 in the endoderm. 5 whole guts were 
collected and then processed as a positive control. Results of the PCR on 
cultured explants and dissected gut are shown in Fig 4.4.
From this RT-PCR we found that Xcad2 was expressed throughout 
all four regions, with a slightly higher level seen at the EP region. Xlhbox8 on 
the other hand was expressed only in the anterior pieces with EA expression 
being slightly higher. These results showed that the spatial resolution of the 
PCR was not increased dramatically by increasing the number of explants 
made from the endoderm from 2 to 4.
Xcad2
Xlhbox8
Figure 4.4 Liver diverticulum explants.
A) Diagram from a parasagital section of stage 20 endoderm showing the liver 
diverticulum. B) White arrow on the top photo shows the position of the liver 
diverticulum on whole endoderm. The resulting explants generated from this cut is 
shown on the bottom photos. C) RT-PCR result for these explants with stage 42 
gut used as control. Expression of Xcad2 or Xlhbox8 is contained in the posterior 
piece (Post). No expression was seen in the anterior piece (Liv Div).
RT-PCR on the explants also showed the lack of an Xlhbox8-or\\y 
expressing region which would be advantageous for detecting posterior 
shifts in identity. To address this we tried a more refined cut of the 
endoderm. Between stage 20-23 of the endoderm development the liver 
diverticulum is a visible small indentation in the endoderm. By cutting the 




EA region described in Fig 4.4, which should hopefully remove the part that 
expresses Xcac/2. The diagram on Fig 4.4 shows the liver diverticulum (Fig 
4.4A) and the explants created as a result of a cut at this part of the 
endoderm (Fig4.4B). 20 of the small anterior (Liv Div) and larger posterior 
(Post) explant pieces were collected and processed by RT-PCR for Xlhbox8 
and Xcad2 (Fig 4.4 C).
The result shows that the Liv Div explants contain no expression of 
either Xlhbox8 or Xcac/2. It would seem that the expression of Xlhbox8 and 
Xcac/2 was from tissue posterior to the liver diverticulum. The EF-1a 
expression in Liv Div shows that the lack of Xlhbox8 and Xcad2 expression 
was probably a real result and not an artifact.
N .2 .2 .ln  situ
Three probes were made for the in situ hybridisation: Xlhbox8t Xcad2 
and Edd. There were no problems in generating DIG-RNA probes for Edd. 
This probe when tested with gut isolated from stage 41 -43 embryo gives an 
expression pattern that covers the entire gut with the exception of liver (Fig 
4.5A). Although there is a period when Edd is ubiquitous in the endoderm, 
by this stage of development expression of Edd has been turned off in the 
liver.
On the other hand, initial attempts to generate a DIG-RNA probes for 
Xcad2 and Xlhbox8 from linearised plasmid template transcribed it with 17 
polymerase was unsuccessful. The transcription reaction yielded no 
detectable RNA. This was probably because the constructs for Xihbox8 and 
Xcac/2 were in pCS2+ which has a mutated 17 promoter. Our first attempt 
to solve this problem was by using PCR. PCR primers that flanked the gene 
construct were made, one just before the polylinker and another at the 17 
promoter. The primer at the 17 promoter was modified so that it contained 
the normal 17 sequence to subtitute for the mutated 17 promoter in the 
plasmid (see Section 2.4.1, p41). Thus using this primer pair, we can obtain 
PCR products that have a normal 17 promoter and the appropriate gene
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construct suitable to be used in a transcription reaction to produce RNA. 
We were able to obtain DIG-RNA probes for both Xlhbox8 and Xcac/2 using 
this method. However only the Xlhbox8 probes generated with this method 
consistently gave an anterior expression pattern on stage 41-43 gut (Fig 
4.5A). Xcac/2 was more inconsistent, on average only 1 in 4 transcription 
reactions would give rise to the posterior expression pattern on stage 41-43 
gut (Fig 4.5B).
Figure 4.5 Control in situs.
All in situs were performed on whole gut isolated from stage 41-43 embryo. To help 
orientate the samples the positions of Liver bud (L) and proctodeum (P) are 
highlighted in the panels. A) shows the expression pattern for Edd and Xlhbox8 on 
gut. Edd was expressed throughout most of the gut with exception of liver, whilst 
Xlhbox8 was only expressed in the anterior B) shows the expression pattern of 
Xcac/2 DIG-RNA made from pCS2 construct on gut. Only 1 in 4 gave a correct 
pattern where the anterior of the gut was not stained. C) the expression pattern of 
Xcad2 DIG-RNA made from pBS construct. Results from this construct were 
consistent, showing posterior expression domain for Xcac/2.
We tested our stock Xcac/2 plasmid for possible contamination and 
found that it had been contaminated with empty pCS2+ plasmid. This 
empty pCS2+ plasmid would have resulted in the production of non-specific 





inconsistencies observed in the in situs. We later obtained an Xcac/2 
construct from Harv Isaacs that was in pBS which has a normal T7 
promoter. DIG-RNA probes made from this construct were able to give 








Figure 4.6 In situ on explants.
A). Ahows in situ done for Xlhbox8, Xcad2 and Edd on endoderm-only explanta. No 
expression of Xlhbox8 or Xcac/2 was seen B). Shows in situ done for Xlhbox8, 
Xcad2 and Edd on endo+meso explants. In the top row the ‘bubble’ possible from 
the ectoderm surrounding the explant was not removed. Xcac/2 photo shows 
retention of BM purple and dark colours. Bottow row shows in situ where explants 
have had the ‘bubble’ removed showing clearer staining. An unstained anterior part 
was visible in the Xcad2 in situ.
Having established consistent and reliable probes for the genes Edd, 
Xlhbox8 and Xcac/2, we moved on to test expression patterns on explants. 
Whole endoderm and endo+meso explants were made from stage 20-23 
embryo and cultured in vitro until control embryos reached stage 41. Figure 
4.6 shows the expression pattern of Xlhbox8, Xcad2 and Edd on these 
explants. These results were the same as previously reported in (Horb and 
Slack, 2001) where endoderm cultured in the absence of mesoderm showed 
no expression of the specification markers Xlhbox8 or Xcac/2 (Fig 4.6A). This 
was not due to the explant dying as Edd was still expressed. With
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endo+meso we saw expression of Xlhbox8 in the anterior and Xcad2 in the 
posterior indicating normal specification of the endoderm (Fig 4.6B)
The surrounding ectoderm that were present in endo+meso explants 
is thought to form a bubble of epidermis surrounding the explant during the 
culture period. This bubble may cause problems during the in situ 
development as it seemed to retain the BM-purple substrate used in colour 
development. This was most evident in the Xcad2 in situ in Fig 4.6B top 
row. Although not evident in the in situs we have performed so far, retention 
of the substrate also brings up the possibility of false positives and 
misrepresentation of expression domains. To avoid this we removed the 
bubbles surrounding the explants prior to fixation using forceps. This 
resulted in better and clearer staining of the explants as can be seen when 
we compare in situs done on endo+meso explants with and without the 
“bubble” (Fig4.6B). Xcad2 staining in particularly better as it now revealed 
an unstained anterior domain in the endo+meso explant where before it may 
have appeared to be expressed on the whole explant.
IV .2.3 .Screen strategy
We have seen that both PCR and in situ can be used to detect the 
specification markers Xlhbox8 and Xcac/2 in explants. However for the 
purpose of our screen we decided that in situ was more appropriate. 
Detection of specification and shifts in expression domain requires spatial 
resolution which is more evident in the in situs compared to PCRs. Also 
since the in situs do not require the endoderm to be divided into separate 
regions to obtain the spatial resolution, it would make for a simpler and 
quicker screening method.
The screen was performed on whole endoderm and endo+meso 
explants from stage 20-23 embryo. These explants were then cultured with 
or without growth factor and inhibitor until the control embryos reached 
stage 41. At this point the explants were fixed and processed with in situ 
hybridisation for Xihbox8, Xcad2 and Edd. Table 4.1 lists the growth factors
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and inhibitors to be tested along with the concentration they were tested at. 
Growth factors were selected to encompass the major pathways in 
embryonic development: FGFs (FGF4, 8 and 10), BMP (BMP4), TGF-B 
(ActivinA), Wnt (LiCI), EGF and RA. LiCI was used to mimic the Wnt pathway 
as the Wnt protein was not commercially available. LiCI mimics activation by 
Wnt by inhibiting the action of Gsk38 leading to accumulation of B-catenin 
(Klein and Melton, 1996; Schneider et al., 1996). In our LiCI treatments we 
used a modified NAM solution where the the NaCI salt were replaced with 
LiCI. Embryos were treated for 30 mins, an hour or overnight with this 
solution to mimic Wnt activation.
Table 4.1 Growth Factor and Inhibitor list
Endoderm Endoderm +Mesoderm
Growth Factor Growth Factor Inhibitor
Activin A (2 & 20ng/ml)
BMP4 (50 & 500ng/ml)
FGF4 (10 & 100ng/ml)
FGF8 (10 & 10Ong/ml)
FGF10 (10 & 10Ong/ml)
Egf (10 & 100ng/ml)
*LiCI (in NAM 30 min,
1 hr and overnight)
RA (1 O'4 to 10'7 M)
Activin A (2 & 20ng/ml)
BMP4 (50 & 500ng/ml)
FGF4 (10 & 100ng/ml)
FGF8 (1 OOng/ml)
FGF10 (10 & 100ng/ml)
Egf (10 & 10Ong/ml)
*LiCI (in NAM 30 min,
1 hr and overnight)
RA (1 O’4 to 10'7 M)
Cyclopamine (10 & 100 
ng/ml)




sFRP-2 (10 & 10Ong/ml) 
Noggin (10 & 10Ong/ml) 
PD 98059 (1 OOng/ml) 
SU5402 (5 & 10 pM)
* Note that LiCI is not a growth factor and is listed here as a subtitute for 
WNT.
For the complementary study, we chose inhibitors that would block 
the pathways that were tested in the growth factor screen. Follistatin is an 
Activin antagonist, sFRP-2 inhibits Wnt; noggin inhibits the BMP pathway 
(Dale and Jones, 1999; Delaune et al., 2005; Slack and Tannahill, 1993); 
PD98059 is a MAPK kinase inhibitor; SU5402 inhibits FGFR1 binding
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(Chung et al., 2004; Delaune et al., 2005); EGF/EFRB-2 inhibits activity of 
Egf; and cyciopamine inhibits Sonic hedgehog (Shh).
The concentrations at which these growth factors and inhibitors were 
tested was set arbitrarily. This was because that even though some of the 
growth factors and inhibitors have been tested in Xenopus previously they 
have not been tested on the endoderm and endo+meso explants 
exclusively. Thus we decided to have two concentrations tested, a low and 
a high concentration for each growth factor.
IV.2.4 .Growth Factor Screen -  Positive control
The activity of the growth factors were tested alongside the explant 
experiment to ensure that they were active under the conditions used, and 
not, for example inactive because of absorption onto the vessels. The 
methods for the positive controls differed depending on the growth factor 
(Figure 4.7). The FGFs and ActivinA were tested using the animal cap assay. 
Addition of ActivinA (Asashima et al., 1990; Smith et al., 1990; Thomsen et 
al., 1990) has been shown to induce mesoderm formation and elongation of 
animal caps. FGF4 (XeFGF in Xenopus) (Isaacs et al., 1992b), FGF8 
(Christen and Slack, 1997) and FGF10 have been shown to induce formation 
of mesoderm in animal caps indicated by the formation of vesicles 
(Godsave et al., 1988; Slack et al., 1987). For our animal cap assay we used 
a concentration of 1 ng/ml for ActivinA and 10Ong/ml for FGF4, 8 and 10.
FGF8 mRNA is also a very potent posteriorising factor when injected 
into embryos (Christen and Slack, 1997). Therefore FGF8 function was also 
tested by injecting 500pg of FGF protein into blastula stage embryo and 
observing posteriorisation of the embryo. BMP4 was also tested in this way. 
Injection of BMP4 mRNA into blastula stage embryo has been shown to 
produce ventralised embryos (Dale et al., 1992; Fainsod et al., 1994; Jones 
et al., 1992). EGF protein was tested by treating fertilised embryos with 200 
ng/ml of the protein. Approximately 30% of the embryo shows 
posteriorisation of the embryo similar to that of FGF8 protein injection.
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RA and LiCI were tested by treating whole embryos. These three 
substances have been shown to disrupt normal development of the embryo 
when applied to pre-gastrulation embryos. RA is known to inhibit head 
formation when put in the culture medium (Eagleson et al., 2001) whilst LiCI 
provokes dorsalisation (Klein and Melton, 1996; Schneider et al., 1996). RA 
was put on in the medium at 10'4M overnight and LiCI (0.1 M substituting for 
Na in NAM) for 30 mins and an hour (overnight treatment killed the 
embryos). Figure 4.7 shows the results of these positive control tests on the 
different growth factors. These showed that the growth factor proteins and 
other substances were biologically active under the conditions used.
Figure 4.7 Positive controls for growth factors.
The photographs above show result of activity assays done for the various growth 
factors. Control animal cap and stage 32 embryo were untreated. ActivinA treated 
animal cap showed clear elongation. An expansion of the animal cap was seen 
when FGF4, 8 and 10 were put on the animal caps indicating mesoderm induction. 
FGF8 also induces posteriorisation when injected onto embryos. EGF also has a 
similar posteriorising effect. RA produces a shortened trunk and head suppression. 






The positive controls described above did not address whether the 
growth factors have the expected biochemical effect on the explants. We 
have attempted to create an assay based on western blots to detect directly 
whether the growth factors did activate their respective signalling pathways 
on the explant. However there was a difficulty in obtaining good blots 
especially with phosphorylated proteins such as p-Erk. At early stages most 
of the embryo consists of yolk proteins and these usually cause problems in 
loading and running the gel and must be removed. Also, most of the 
commercially available antibodies were not designed for the Xenopus 
protein, making detection of phosphorylated protein that has a very small 
antigenic determinant even more difficult. Without the ability to detect the 
phosphorylated proteins reliably, we would not be able to tell whether the 
pathways were activated or not in the explants. Thus the western blot 
method was not pursued further.
IV .2 .5. Endoderm growth factor screen -  in situ hybridisation
Here we present the result from our first screen, the treatment of 
growth factors on mesoderm free endoderm explants with growth factors. 
Each treatment was performed in triplicate on 60 endoderm explants for 
each replication. This was to ensure that results were reproducible and that 
a significant number of explants would be available for the in situ 
hybridisation (20 per probe). On average approximately 90-100% of the 
growth factor treated explants survived the length of the culture period with 
one exception. LiCI treatments overnight resulted in the death of the 
explants. Figure 4.8 on the next page shows the in situ results done on the 
treated explants. The explants shown in this figure were those treated with 
the highest concentration of growth factor listed in Table 4.1 as results were 
similar with treatment at the lower concentrations (data not shown).
We observed no expression of Xlhbox8 or Xcad2 in any of the 
treatments. The in situ pattern of these treated explants were similar to 
untreated explants (Fig 4.8). Because Edd was still expressed, the missing 
Xlhbox8 and Xcad2 expression were probably indicative that the endoderm
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was still unspecified. In other words none of the growth factors tested were 
able to mimic or replace signals being sent by the mesoderm during 
regional specification of the endoderm.
IV .2.6. Endoderm + Mesoderm growth factor screen -  in situ hybridisation
Similar to the endoderm explant growth factor screen, the screen on 
endo+meso explants was performed in triplicates for each treatment with 60 
explants per treatment. With endo+meso explants the survival rate was very 
close to 100% with one exception, the overnight treatment with LiCI. The 
presence of mesoderm on these explants increased their viability compared 
to the endoderm-only explants an observation that was noted as well in 
mouse (Wells and Melton, 2000) and chick (Kumar et al., 2003).
Figure 4.9 shows the in situ results for the treated endo+meso 
explants with Xihbox8, Xcad2 and Edd. Here we observed that neither 
Xlhbox8 or Xcad2 expression had strayed from its normal expression 
domain. Xlhbox8 was still found to be expressed in the anterior part of the 
explants whilst Xcad2 covered the posterior part with a distinct, unstained 
anterior part. This pattern was very similar to that observed in untreated 
endo+meso explants (Fig 4.9) and shows that the growth factors had no 
effect on the specification of the endoderm in endo+meso explants.
Figure 4.8 In situ results on growth factor treated endoderm-only explants.
Results for Xlhbox8, Xcad2 and Edd in situ on the different growth factors tested 
are shown on the next page. No expression of Xihbox8 or Xcac/2 was seen from 
any of the growth factor treatments. The expression of Edd seen in all the 
treatments indicates that the explants were still alive and that the lack of Xlhbox8 





















































Figure 4.9 In situ results on growth factor treated endo+meso explants.
Results for Xlhbox8, Xcad2 and Edd in situ on the different growth factors tested 
are shown above. Expression domains remained unchanged, Xlhbox8 was still 
found in the anterior part of the explant whilst Xcac/2 still had a distinct unstained 
anterior section. Edd expression indicated that the explants were alive
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IV.2.7. Inhibitor screen -  positive control
Amongst the inhibitors tested in our experiments only noggin and 
SU5402 had a previously documented phenotype on Xenopus embryos, 
and in both cases we were able to reproduce this. SU5402 causes loss of 
axial structures on embryos treated from before gastrulation in a dose 
dependent manner (Delaune et al., 2005). When the embryos were treated 
with 10pM SU5402 we saw a bent tail phenotype in the embryos. Noggin 
has also been shown previously to act as a dorsalising factor in Xenopus 
(Dale and Jones, 1999; Delaune et al., 2005; Slack and Tannahill, 1993). 
500pg of noggin protein was injected to blastula stage embryos and lead to 
dorsalisation of the embryo. In addition to these, the following new results 
were obtained for the other inhibitors. Embryos treated with cyclopamine (1 
pg/ml) shows a curved axis, something that has not been previously 
described. The other 4 inhibitors tested EGF/EFRB-2, Follistatin, sFRP-2 
and PD98059 did not show any visible phenotype when added at 
concentrations up to 1pg/ml.
For the inhibitors that have not been characterised previously in 
Xenopus we decided to treat whole embryos with the inhibitors at 
concentrations of 1 pg/ml. The lack of a visible phenotype with some of the 
inhibitors does not rule out a possible effect on the embryos as it might not 
be immediately obvious. We decided not to characterise the phenotype of 
each of the inhibitors as we were more interested in their possible effects on 
the endoderm. To mitigate the lack of a positive control phenotype with 





Fig 4.10 Inhibitors positive control.
The figures above shows the resulting phenotypes obtained from treating whole 
embryos prior to gastrulation with the inhibitors listed in Table 4.1. Cylopamine 
embryos has a curved axis. SU5402 showed a bent tail phenotype. Whilst Noggin 
injection resulted in dorsalisation of the embryo. EGF/EFRB-2, Follistatin, sFRP2 
and PD98059 showed no phenotype at the concentrations tested.
Deciding what concentrations would be ideal for treating explants 
was difficult as we did not have a viable method for detecting 
downregulation of the target pathways in the explants. Thus we decided to 
base the concentrations we used on the positive control for those that had a 
clear or previously characterised phenotype. For those molecules that did 
not have a clear or previously characterised phenotype we decided on the 
arbitrary concentration of 100 and 10ng/ml to match the concentrations at 

















Figure 4.11 In situ results for inhibitor treated endo+meso explants.
Results for Xlhbox8, Xcad2 and Edd in situ on the different inhibitors tested are 
shown above. Expression domains remain unchanged, Xlhbox8 was still found in 
the anterior part of the explant whilst Xcad2 still had a distinct unstained anterior 
section. Edd staining confirmed that the embryos were alive.
IV.2.8. Endoderm + Mesoderm Inhibitor screen -  in situ  hybridisation
Again treatment of the endo+meso explants with inhibitors were done 
in triplicates with 60 explants per repetition. Survival of the explants was
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close to 100%. Figure 4.11 shows in situ results done on these explants for 
Xlhbox8, Xcad2 and Edd. All treatments was done in NAM/2 with 1 % BSA 
as carrier.
We observed no changes in the expression domains of either 
Xlhbox8 and Xcad2. Xlhbox8 was still expressed in a tight anterior domain 
and Xcad2 was expressed in the posterior domain with a distinct unstained 
anterior region. This result then complemented the results observed with the 
endoderm and endo+meso growth factor treatments where no change was 
seen when compared to untreated explants.
IV .2 .9. Bead experiment
There was a possibility that the negative results observed with the 
growth factor and inhibitor screen was because the growth factor delivery 
method was not appropriate. The explant method delivered the growth 
factors in vitro at a specific concentration for a limited amount of time. 
However in vivo growth factor signals are usually continuously released and 
may form a gradient. We can mimic this by using heparin-acrylic beads, an 
in vivo method of delivering growth factors. FGFs are known to bind to 
heparin-acrylic beads (Slack et al., 1987). The heparin bound FGFs can then 
be implanted to the embryo to treat the endoderm in vivo, this implanted 
bead will then continuously release the growth factor throughout the culture 
period, mimicking more accurately in vivo signals. We decided to start the 
treatment with FGF4 as this had been shown to have a posteriorising effect 
in chick (Dessimoz et al., 2006) and mouse (Wells and Melton, 2000). To 
confirm that FGF4 can be bound to heparin-acrylic beads and was active, 
we performed an animal cap assay. Animal caps that were put in contact 
with the FGF4 beads showed elongation, while those put in contact with 
control PBS beads did not (Fig 4.12B). This was consistent with mesoderm 
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Figure 4.12 FGF4 bound heparin-acrylic beads treatment.
A) shows the typical appearance of bead treated embryos at stage 42. The 
presence of beads inside the embryos were confirmed by dissecting the gut and 
through histology. Position of the beads were highlighted by the yellow circle. B) 
Animal cap assay showing that the FGF4 incubated beads were capable of 
inducing mesoderm in animal caps whilst PBS beads were not. C) in situ results for 
Xlhbox8, Xcad2 and Edd performed on guts isolated from bead treated embryos. 
To help orientate the positions of liver bud (L) and proctodeum (P) are highlighted 
in the panels.
After confirming the activity of the FGF4 beads, we went on to 
implant the beads into the anterior of stage 20-23 embryo. The embryos 
were allowed to heal and were cultured until stage 42. Once the embryos 
reached stage 42 their guts were dissected out and processed for in situ 
hybridisation for Xlhbox8, Xcad2 and Edd. Since normally FGFs are
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posteriorising agents (Christen and Slack, 1997; Isaacs et al., 1994) we 
expected this anterior placement would posteriorise the anterior of the 
Xenopus endoderm, inhibiting expression of Xlhbox8 whilst promoting 
Xcac/2.
The FGF4 bead-treated embryos at stage 42 looked similar to PBS 
bead-treated embryos, no abnormalities of the gut was observed (Fig 
4.12A). In situ results further confirmed that there were no difference 
between gut of FGF4 bead treated embryos (Fig 4.12C). This was indicative 
that the lack of response seen in the in vitro screen for FGF4 was not due to 
the growth factor delivery method used as both beads and growth factor in 
media did not change the specification of the endoderm.
At this time we discovered that James Wells and his lab have 
attempted a similar FGF4 bead implantation in Xenopus embryos 
(unpublished results). They claimed that FGF4 bead implanted on the 
anterior of stage 15 embryos would lead to a bulging of the anterior of the 
embryo. This was an indication that endoderm development had been 
affected by the FGF4 beads although no attempt had been made to 
determine if specification was also altered.
Based on this we decided to expand our FGF4 bead experiment to 
include implantation done on stage 9,10.5, 13 and 15 embryos. The beads 
were implanted in the embryos by making an incision in the anterior in stage 
13 and 15 embryos or in the dorsal of stage 9 and 10.5 embryos and 
inserting the bead from the gap created. Once implanted the embryos were 
allowed to heal and were cultured until they reached stage 42. We found 
however that our results was not similar to James Wells’ claim. From our 
experiments we saw that the FGF4 implanted embryos did not show any 
visible bulging or defect in the endoderm when implanted at stage 9, 10.5, 
13 and 15. This was similar to when the beads were implanted in stage 20- 
23 embryos (data not shown).
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IV.3. Discussion
All of the experiments described above showed that none of the 
growth factors tested can affect the specification of the endoderm, as 
expression patterns of either Xlhbox8 or Xcad2, anterior and posterior 
markers of endoderm development remained similar to untreated controls in 
either endoderm or endo+meso explants. The growth factors were shown to 
be biologically active through the positive control experiments performed 
alongside the screen. Thus, based on this we have shown that there were 
no evidence tha the growth factors tested can influence the specification of 
the endoderm at the concentrations tested..
From all the growth factors tested a lack of respecification of the 
Xenopus endoderm by FGF4 is particularly interesting considering that in 
chick and in mouse it has been shown to affect specification of the 
endoderm (Dessimoz et al., 2006; Wells and Melton, 2000). From our 
previous in situ results (chapter III) we observed that FGF4 is expressed at 
the posterior of the endoderm, so at least it is expressed in a relevant region 
to act as a posteriorising agent. We have attempted both in vitro (explants) 
and in vivo (beads) approaches with this growth factor and still found no 
respecification, leading us to believe that FGF4 was not involved in 
endoderm specification.
We need to note, however, that our in vivo (beads) result was in 
contradiction with another study from James Wells (unpublished data). In 
their study it was claimed that FGF4 did alter the morphology of endoderm 
when implanted around stage 15. We, however, found that embryos 
implanted with FGF4 bead at stages 9, 10.5, 13 or 15 bead showed no 
visible abnormality. We have demonstrated that the FGF4-bead used was 
active as it induced vesicle formation in animal caps, indicating that the lack 
of result is not due to lack of activity.
However at this time we are not able to completely discount James 
Wells’ result as there might be technical differences that could account for
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the different observations. First of all, the beads are not all the same size 
and there is a possibility that James Wells might have used a larger or 
smaller sized bead in his implant, resulting in a difference in the amount of 
FGF4 delivered to the embryo. Also the exact position of implantation of the 
FGF4-bead might be different. Flowever, at this time, based on our own 
results we are inclined to say that FGF4 are not involved in the specification 
or development of the endoderm.
The complementary inhibitor study was found to be in agreement 
with the growth factor study as inhibitor treatment on endo+meso explants 
also resulted in normal expression of Xlhbox8 and Xcad2. Flowever we can 
only say for certain that noggin, SU5402 and cyclopamine are not able to 
repress specification of the endoderm at tne concentrations tested as we do 
not have a satisfactory positive control result for follistatin, sFRP-2, 
EGF/EFRB-2 and PD98059. Ideally one would spend the time to investigate 
and characterise the phenotypes of each of these inhibitors, however this is 
a very time consuming task as we have to try various different 
concentrations and ideally to confirm repression of the target biochemical 
pathway probably with western blots. Considering the difficulties in setting 
up western blots for phosphorylated proteins with Xenopus embryos, we 
decided that this was not a worthwhile effort given the limited time available.
There are several possible explanation for the lack of respecification 
seen in the explants. One possibility is that the specification of the 
endoderm might involve other growth factors not on the list. Our assay 
depended on using commercially available protein growth factors and our 
selection was limited by this. One protein that was not available 
commercially at the time of the experiment was Sonic Hedgehog (Shh). Shh 
is a homolog of the Drosophila segment polarity gene hedgehog. It has 
been shown, in chick, to be involved in mediating pattern in several regions 
of the embryo including the limb bud (Riddle et al., 1993), somite (Fan and 
Tessier-Lavigne, 1994; Johnson et al., 1994) and neural tube (Echelard et 
al., 1993; Krauss et al., 1993; Roelink et al., 1994). With regards to
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endoderm development Shh is an interesting molecule as its earliest 
expression is restricted to the endoderm of anterior and caudal intestinal 
portals prior to invagination (Roberts et al., 1995). It has been suggested 
that Shh might be the initiating signal in the epithelio-mesenchymal 
interaction that takes place during endoderm specification, as in chick its 
receptors are found in the mesoderm and overexpression of Shh in the early 
primitive gut leads to a mesodermal and not endodermal phenotype 
(Roberts et al., 1998). However we must note that the mouse knockout for 
Shh has been shown to develop gut with severe foregut abnormalities 
(Litingtung et al., 1998; Pepicelli et al., 1998). These null mutants have 
malformed esophagi with enlarged lumens and disorganised or absent 
subjacent mesoderm.
There is also the possibility that the relevant factor(s) could be novel 
molecule(s). Recently Aaron Zorn has completed a microarray focussing on 
anterior endoderm development (unpublished data). This microarray has 
uncovered several novel genes that might be responsible for the patterning 
of the endoderm. The main technical challenge in investigating the 
commercially unavailable growth factors or novel genes is in producing the 
proteins. RNA injections would not be appropriate for investigating regional 
specification as it would be hard to control when the RNA is translated. RNA 
overexpression of growth factors might lead to disruption of the earlier 
stages of development. Also the injected RNA itself might decay before 
reaching the stage of interest.
One method that would be appropriate to produce the necessary 
protein is by using oocytes. Manually defolliculated oocytes when injected 
with mRNA coding for the protein of interest continually produce and secrete 
that protein when cultured in oocyte culture medium (OCM). This method has 
been used previously with animal caps to successfully constitute inductive 
signaling (Lustig and Kirschner, 1995). This test then could be adapted to 
study endoderm respecification by putting on the endoderm or endo+meso 
explants on the injected oocytes. However this method would be very
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labour intensive and as a consequence might be difficult to generate a 
statistically significant number of results.
Multiple collaborative signals instead of a specific signal transduction 
pathway may also be involved in specification of the endoderm. The 
collaborative effect of two or more pathways has been seen in the 
developmental mechanism of other organs. In eye development interplay 
between hedgehog (HH), RA and FGFR signalling specifies the ventral 
regionalisation of the eye (Lupo et al., 2005). Overexpression analysis of the 
three signals shows that the Xenopus eye gets more ventralised when more 
than one pathway is overexpressed. Similar interactions were also seen in 
neural induction where three different pathways IGF, FGF and anti-BMP 
(chordin) induced neural fate by inhibiting Smad-1 activity (Pera et al., 2003). 
Smad-1 activity was shown to be inhibited at two locations. BMP 
antagonists such as noggin and chordin inhibits the phosphorylation of the 
carboxy terminal serines (De Robertis et al., 2000; Weinstein and Hemmati- 
Brivanlou, 1999), whilst FGF8 and IGF2 activates MAPK which in turn 
phosphorylate the Smad-1 linker region further inhibiting its activity 
(Kretzschmar et al., 1997; Pera et al., 2003). These two actions act together 
to downregulate Smad-1 activity and thus promote neurogenesis. Looking 
at these examples of synergy between different pathways raises the 
possibility that specification of the endoderm might involve more than one 
pathway and simultaneous activation might be necessary to induce 
specification. To address the possible necessity for multiple pathways to be 
activated in endoderm specification, the growth factor screen would have to 
be performed using pools of growth factors instead of just one growth 
factor per treatment.
In conclusion, the growth factor and inhibitor screen performed here 
have shown that none of the molecules listed in Table 4.1 is sufficient on its 
own to induce regional specification of the endoderm. In future the screen 
could be expanded either to test for multiple signals for specification or 
using oocytes to test novel or commercially unavailable gene products.
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V. Heterologous Recombinations 
of Mesoderm and Endoderm
V.1. Introduction
Heterologous recombination experiments have provided great 
insights into the interactions between mesoderm and endoderm in the 
regional specification of the endoderm. By recombining endoderm with 
mesoderm from different regions one can start to understand how the 
endoderm is specified along its A-P axis. The earliest homologous 
recombination experiment with the endoderm was done in the newt, Cynops 
(formerly Triturus) pyrrhogaster. Here it was demonstrated that a significant 
amount of mesoderm is required for the proper specification of the 
endoderm (Okada, 1954a; Okada, 1954b; Okada, 1955a; Okada, 1955b). 
Further recombinations with the newt showed that the mesoderm has an 
instructive influence on the endoderm. Endoderm that would normally 
develop to form pharynx can be respecified to produce more posterior 
organs when recombined with lateral mesoderm. Similarly anterior and 
middle endoderm explants can also be respecified to form pharynx when 
put near head-mesenchyme (Okada, 1955a; Okada, 1955b; Okada, 1957; 
Okada, 1960). However these recombinations were done with relatively later 
stages, indicating that this is testing more for the plasticity of the late 
tissues rather than the initial specification event.
Also these studies have several important technical limitations. At the 
time, due to a lack of a specific lineage tracers, no detailed fate map was 
available. This meant that comparisons could not be made between 
experimental results and the presumptive fate for that particular piece of 
tissue. There was also a lack of molecular markers that would label the 
different parts of the developing gut. As a consequence the different parts 
of the gut were identified histologically, a much less reliable method 
compared to using molecular markers.
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In mouse, heterologous recombination using tissues from 
forestomach and glandular stomach at later stages showed no 
respecification. Here it was shown that forestomach epithelium could not be 
respecified when recombined with glandular stomach mesenchyme. The 
opposite recombination also showed that the glandular stomach epithelium 
maintains its differential fate when recombined with forestomach 
mesenchyme (Fukamachi et al., 1979). Similar observations were seen when 
the experiment was performed in rats (Fukamachi and Takayama, 1980). 
However these recombinations were done with tissues from late embryos 
(14.5 -  18.5 day embryos) and as such the endoderm may have already 
become determined and or the mesoderm lost its signalling specificity, 
accounting for the lack of respecification seen.
In chick, heterologous recombinations were also used to help 
understand how endoderm and mesoderm interact in development. Gizzard 
(muscular stomach) in chick would normally be devoid of any glands at 
hatching. However when gizzard endoderm is recombined with 
proventricular or intestinal mesenchyme it goes on to develop 
proventriculus-type and intestinal-type endocrine cells respectively (Andrew 
and Rawdon, 1990; Andrew et al., 1988; Rawdon and Andrew, 1988). 
Recently a more detailed analysis of chick endoderm respecification on 10- 
somite stage embryos showed a posterior-dominant relationship between 
mesoderm and endoderm in chick (Kumar et al., 2003). Here the endoderm 
was shown to only be respecified when recombined with a more posterior 
mesoderm. For example Pdx1, normally expressed in midgut could be 
induced when recombined with midgut lateral plate mesoderm (LPM). Also 
induction of CdxA and inhibition of Pdx1 was seen in midgut endoderm 
when recombined with hindgut LPM. Recombinations with more anterior 
LPMs only resulted in the maintenance of the current endodermal 
anteroposterior fate (Kumar et al., 2003).
In Xenopus, heterologous recombinations between anterior and 
posterior endoderm and mesoderm from stage 20 explants showed that the
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mesoderm patterns the endoderm in an instructive manner (Horb and Slack, 
2001). In this study it was shown that Xlhbox8 expression was suppressed 
when anterior endoderm was recombined with posterior mesoderm. On the 
other hand Xlhbox8 expression was induced when posterior endoderm was 
recombined with anterior mesoderm. However in this study the change in 
expression of markers was only demonstrated using PCR. Since our growth 
factor screen used in situ instead of PCR, we thought it would be essential 
to complete the heterologous recombination data with in situ. This would 
help demonstrate that the detection method we chose for the screen was 
sufficiently sensitive to detect any induction or respecification that might be 
caused by growth factor treatment. It would also help to confirm that the 
lack of respecification observed in the growth factor screen was because 
the factors tested are not involved in endoderm specification.
V.2. Materials and Methods
To generate the heterologous recombinants, endoderm and 
mesoderm were cut and divided into anterior and posterior halves (see Fig 
5.2 A for diagram). These cuts were done in NAM/2 in the presence of 
trypsin to allow complete separation of endoderm and mesoderm. Anterior 
endoderm and posterior mesoderm was transferred to NAM/2 solution with 
anti-trypsin, and recombined. The recombination was done in a small well in 
the agar made with forceps. A piece of glass was put on top of the 
recombinant to keep the tissues in place. They were then allowed to heal for 
approximately 1 hour before being transferred to fresh NAM/2 + 1 %BSA for 
culture. Posterior endoderm and anterior mesoderm recombinants were 
also made similarly.
For the control halves, the endoderms were cut out from the embryo 
with the mesoderm and cut in half in NAM/2 solution without trypsin 
according to the diagram in Fig 5.2 A. They were then allowed to heal and 
transferred to fresh NAM/2 + 1%BSA for culture. All the explants were 
cultured until the control embryos reached stage 42 before being fixed for in 
situ with Xlhbox8, Xcad2 and Edd
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V.3. Results






Figure 5.1 In situ on stage 20 heterologous recombinations.
The pictures above show in situ hybridisation done on anterior (AEM) and posterior 
(PEM) half explants as well as the heterologous recombinations between anterior 
endoderm and posterior mesoderm (AEPM) and posterior endoderm and anterior 
mesoderm (PEAM). Isolated stage 42 gut here acts as a positive control for the 
makers. The expression of the markers Xlhbox8 in anterior endoderm explants and 
Xcad2 in all explants indicate that mesoderm is not respecifying endoderm in these 
recombinations.
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The results from the in situ were not what we expected (Fig 5.1). Here 
our heterologous recombinations seemed to show that the mesoderm was 
only playing a permissive role and not an instructive one as previously found 
(Horb and Slack, 2001). Anterior endoderm still shows expression of 
Xlhbox8 when recombined with posterior mesoderm. Similarly posterior 
endoderm shows no expression of Xlhbox8 or downregulation of Xcad2 
when recombined with anterior mesoderm. This pattern is similar to that of 
the control AEM and PEM explants. To confirm that this lack of 
respecification of the endoderm was not because of the detection method 
used {in situ and not PCR), we decided to repeat the experiment using PCR 
to detect expression of Xlhbox8, Xcad2 and EF1-a (Fig 5.2 A).
Xlhbox8
Gut AEM PEM -RT AEPM PEAM -RT
Xlhbox8
AEM EPEM EAE EPE
EAEM PEM -RT EpM -RT
Figure 5.2 PCR of stage 20 heterologous recombinations.
A). Diagram on the left shows how the stage 20 endoderm was halved. The PCR 
was done for the markers Xlhbox8, Xcad2 and EF1-a in the half explants. Results 
here confirmed that seen with the in situ as Xlhbox8 was expressed with anterior 
endoderm regardless of whether it remains with anterior or with posterior 
mesoderm. Whilst posterior endoderm only expresses Xcad2. B) The diagram on 
the left shows how the endoderm was divided into 4 regions: extreme anterior (EA), 
anterior (A), posterior (P) and extreme posterior (EP). Explants done with quarters 
showed recombination of the extreme anterior and extreme posterior pieces. 
Extreme anterior endoderm (EAE) surprisingly lost expression of Xcad2 when 
recombined with extreme posterior mesoderm (EPM). Extreme posterior 
endoderm (EPE) did not show expression of Xlhbox8 when recombined with 
extreme anterior mesoderm (EAE). All recombinations was performed at least in 
triplicate.
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The PCR results confirmed the in situ observations. Anterior 
endoderm maintains expression of Xlhbox8 when recombined with posterior 
mesoderm and posterior endoderm shows no expression of Xlhbox8 when 
recombined with anterior mesoderm. At this point it looked very likely that 
Horb and Slack’s result was not repeatable. However there is still the 
possibility that the anterior and posterior halves of the embryo was not 
separated enough. Because the halves were made arbitrarily there is a 
possibility that there might be some overlap of tissue between the two 
halves. This overlap of tissue might result in a posterior signal being present 
in anterior mesoderm inhibiting expression of Xlhbox8 in posterior 
endoderm. Similarly, anterior signal might be present in the posterior 
mesoderm maintaining Xlhbox8 in anterior endoderm.
To address this we decided to do a recombination based on quarter 
embryos. The extreme anterior and extreme posterior regions are on 
opposite ends of the endoderm, which means that there should be no 
overlap in explants made from these regions (Fig 5.2 B). Results show that 
control extreme anterior endo+meso explant (EAEM) expressed both 
Xihbox8 and Xcad2 whilst extreme posterior endo+meso explant (EPEM) 
only expressed Xcad2.
Extreme posterior endoderm maintained its expression of Xcad2 
when recombined with extreme anterior mesoderm indicating no 
respecification occurred. However when extreme anterior endoderm was 
recombined with extreme posterior mesoderm Xcad2 expression was lost 
whilst Xlhbox8 was maintained. This was unexpected as posteriorisation of 
the anterior endoderm should lead to the suppression of Xlhbox8 and not 
Xcad2.
Initially we suspected that this might be an artefact as a result of the 
recombination procedure (e.g. the mechanical compression or tissue mass 
augmentation). To test for this we performed homologous recombinations 
with the extreme anterior and extreme posterior quarters. Extreme anterior 
endoderm and mesoderm were separated in NAM/2 solution with trypsin,
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moved to NAM/2 + trypsin inhibitor, recombined and helped into place with 
a piece of glass. The recombinants were then allowed to heal for an hour 
before being transferred to fresh NAM/2 + 1%BSA for culture. Homologous 
extreme posterior recombinants was also made in this way. RT-PCR for 
Xlhbox8, Xcad2 and EF1-a on these explants is shown in Figure 5.3.
Here we see that the extreme anterior quarter homologous 
recombinant still maintains expression of both Xlhbox8 and Xcac/2 unlike the 
heterologous recombinant between extreme anterior endoderm and 
extreme posterior mesoderm. This then confirms that the downregulation of 
Xcac/2 in these explants was real and not an artifact. We can then conclude 
from this that the extreme posterior mesoderm does respecifiy the extreme 




Figure 5.3 Homologous recombination.
The panels on the right show PCR results for Xlhbox8, Xcad2 and EF1-a for the 
homologous recombinations with the extreme anterior and extreme posterior 
quarters. Here we see that Xcad2 expression is maintained in extreme anterior 
homologous recombination. Results from the control quarter explants are shown 
on the left.
V.3.2. Stage 20 Mesoderm and early Endoderm recombinations
We had established that the result on heterologous recombination 
obtained by Horb and Slack was not reproducible. The possible reasons for 
these differences are discussed at the end of this chapter. However 
considering that we performed at least three in situs and four repeats of the 
RT-PCR in the heterologous recombination, we are inclined to believe that 
our observation is the correct one: mesoderm from stage 20 mesoderm was 
not able to direct the specification of stage 20 endoderm.
EAEM AEM PEM EPEM EAE EPE -RT
+EAM +EPM
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One interpretation of this lack of respecification is that the mesoderm 
explants from stage 20 were only playing a maintenance role and not an 
instructive role. If the mesoderm was only maintaining a previously existing 
pattern, there is a possibility that the endoderm acquired its patterning at an 
earlier stage of development, prior to stage 20, but that it does not become 
stable until a later stage. Based on this we decided to do more heterologous 
recombinations using endoderm from earlier stage embryos (stage 10.5 and 
13). We decided not to use stage 9 because of the previously reported 
phenomenon of appearance of mesoderm in endoderm explants (whether 
by contamination or regulation) making the pregastrulation vegetal explant 
unreliable for this type of study. Whole endoderm from these early embryos 
was isolated and then recombined with stage 20 mesoderm (anterior or 
posterior). We chose not to use earlier mesoderm in the recombinations as it 
was not possible to generate separate anterior and posterior mesoderm 
explants from early stage embryos making it unsuitable for studying 
respecification.
Whole endoderms from stage 10.5 and 13 embryos were isolated as 
shown in the top of Figure 5.4. The cut from stage 10.5 avoids the 
invaginating edge of the endoderm as there have been evidence that this 
leading edge of the endoderm already expressed XHex and Cerberus, 
markers of anterior endoderm development (Zorn et al., 1999). This 
indicates that this leading edge might already received patterning at stage 
10.5. Thus, inclusion of this leading edge in the explant might lead to 
possible complications in interpreting the results.
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EAEM AEM PEM EPEM-RT 10E 10E 10E 13E 13E 13E
20M 20M 20M 20M
Ant Post Ant Post
Figure 5.4 Stage 10.5&13 recombinations.
The diagram on the top shows how the endoderm from stage 10.5 and 13 embryos
was isolated. They were then recombined with either anterior or posterior stage 20
mesoderm. 15-20 of each explants were then collected and tested for the markers 
Xlhbox8, Xcad2 and EF1-a. From the three PCR reactions shown above we saw 
that eventhough the expression pattern of the controls based on the quartered 
explants were constant the recombination and endoderm from stage 10.5 and 13 
embryos vary from reaction to reaction.
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With stage 13 embryos, the cut was made so that the thin flap of the 
endoderm that was attached to the roof of the archenteron was preserved in 
the explant. This was done by making the initial dissection from opposite 
the yolk plug and teasing gently the thin endoderm until it was detached 
from the roof of the archenteron. Once the endoderm was isolated it was 
recombined with either anterior or posterior mesoderm halves from stage 20 
embryos. The recombinant was allowed to heal in NAM/2 solution under a 
piece of glass for 1 hour. Once healed the recombinant was then transferred 
to fresh NAM/2 + 1 %BSA for culture. Once the control embryos reached 
stage 42 the explants were collected for RT-PCR with Xlhbox8, Xcad2 and 
EF1 -a  (Figure 5.4).
The PCR for these early recombinants were found to be 
unreproducible. Figure 5.4 shows PCR results for 3 different recombinations 
with stage 10.5 and 13 endoderm as well as the control explants. Analysis 
on the first recombination (the upper right panel) showed a result similar to 
the Horb and Slack result with Xlhbox8 induced by anterior mesoderm and 
not posterior mesoderm, suggesting regionally specific programming by the 
mesoderm. However, different repeats of the experiments with 
recombinants of stage 10.5 and 13 endoderm showed different expression 
of the markers. Sometimes we found Xlhbox8 expressed in the anterior, 
sometimes in the posterior, sometimes in both anterior and posterior and 
othertimes in none. We also found similar unreproducible expression of 
Xcac/2 with stage 10.5 and 13 explants. Because the expression of the 
markers Xlhbox8 and Xcac/2 were consistently repeatable with the control 
stage 20 quarter explants we concluded that this unreproducible 
observation with the stage 10.5 and 13 endoderm was due to the way the 
recombinant/explant was generated.
Initially we thought that there was not enough contact between stage 
20 anterior or posterior mesoderm halves and the whole endoderm of stage 
10.5 and 13 embryos. The whole endoderm is approximately 3-5 times 
larger than the mesoderm halves, thus in the recombinants only part of the
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stage 10.5 and 13 endoderm were in contact and received signals from 
stage 20 mesoderm. To test for this we decided to recombine 3 stage 20 
anterior or posterior mesoderm halves with one endoderm from stage 10.5 
or 13. This would help ensure that most of the endoderm was in contact 
with the mesoderm. However when we analysed these explants we saw the 
same unreproducible expression of Xlhbox8 and Xcad2. This then meant 
that the unreproducible pattern of expression was not due to a lack of 
contact between the endoderm and mesoderm in the recombinant.
Another possible source for the unreproducible expression pattern 
might be contamination. We identified two possible sources of 
contamination in making the recombinant. First, there could be endoderm 
attached to the isolated mesoderm from stage 20 which could contribute to 
the expression of Xlhbox8 and Xcad2 in the recombinant. Second, there 
could be contaminating mesoderm in the endoderm explants.
To address the first possibility we decided to isolate stage 20 anterior 
and posterior mesoderm halves and analyse them for expression of 
Xlhbox8, Xcad2 and EF1-a. This will allow us to see if they contributed to 
the expression of Xlhbox8 and Xcac/2 seen in the recombinations. Results of 
the RT-PCR halves showed that the isolated stage 20 anterior and posterior 
mesoderm had no expression of Xlhbox8 or Xcac/2 (Figure 5.5A). Thus 
indicating that the stage 20 mesoderm used in the recombinations did not 
contribute to the unrepeatable results observed earlier.
To address the second possibility of whether or not there were 
mesodermal contaminations in the endoderm explant from stage 10.5 and 
13 embryos, we decided to test for the expression of the mesodermal 
markers xFOG and FoxF1. The mesodermal markers xFOG and FoxF1 are 
normally expressed in the mesoderm around the endoderm and have been 
previously used in detecting mesodermal contaminations in endoderm 
explants (Deconinck et al., 2000; Horb and Slack, 2001; Koster et al., 1999). 
We isolated stage 20 endoderm and endo+meso explants as well as whole 
endoderm from stage 9, 10.5 and 13 to test with these markers. Stage 20
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anterior and posterior mesoderm were also collected as positive controls. 
The recombinants were not tested as they contained stage 20 mesoderm. 
We also decided not to test more than these two markers as expression of 
these two markers would be enough to determine whether or not there was 
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Figure 5.5 Testing for contaminations.
A). Shows PCR for Xlhbox8, Xcad2 and EF1-a done on 20 mesoderm only explants 
taken from stage 20 embryos. B). PCR for the mesodermal markers xFOG and 
FoxF1 done using various different explants to see if mesoderm might be present 
in the endoderm only explants.
The RT-PCR with the mesodermal markers xFOG and FoxF1 revealed 
that the whole endoderm from stage 10.5 and 13 embryo did contain a 
significant amount of mesodermal contamination (Figure 5.5B). This then 
suggests that the unreproducible expression pattern of Xlhbox8 and Xcac/2 
observed earlier may be due to mesodermal contaminations in the whole 
endoderm explants. We were also able to confirm previous observations 
that vegetal explant from stage 9 embryo contained mesodermal tissue and 
that stage 20 endoderm explants can be made to be free of mesoderm 
(Horb and Slack, 2001).
V.4. Discussion
One of the essential results of the paper of Horb and Slack (2001), 
was that the endoderm only becomes specified after stage 25. This result 
has been amply confirmed in our present study as Xlhbox8 and Xcad2 
expression is only maintained when the endoderm from stage 20 embryo is
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cultured with mesoderm. However, our in situ and PCR results with the half 
explants here demonstrated that the mesoderm does not pattern the 
endoderm in an instructive manner as was previously reported in (Horb and 
Slack, 2001). We did not observe any induction of Xlhbox8 expression in 
posterior endoderm when recombined with anterior mesoderm and similarly 
Xlhbox8 expression was not downregulated in anterior endoderm when 
recombined with posterior mesoderm. Instead it seems from the current 
results that any mesoderm (anterior or posterior) will provoke a re-activation 
or a maintenance of Xihbox8 in the anterior and Xcac/2 in the middle and 
posterior of the endoderm. This then indicates that the mesoderm might 
only be acting in a permissive role at these stages and not instructing 
endoderm development as previously thought.
There was one notable exception to the lack of respecification in the 
heterologous recombinations. This was seen with the quarter explants in 
which Xcac/2 expression is lost when the anterior most (EA) endoderm is 
recombined with the posterior most (EP) mesoderm (See Figure 5.2B for 
details of segment in quarter explants). This was extremely surprising 
considering Xcad2 is a posterior marker and one would expect it to be 
induced instead of downregulated by EP mesoderm. We have confirmed 
that this loss of Xcac/2 expression is reproducible and was not an artifact of 
the recombination itself as Xcad2 expression is maintained when EA 
endoderm is separated and then recombined with another EA mesoderm.
At the moment we do not have a clear idea as to the possible 
mechanism that would account for this particular patterning event. Our 
closest model involves a signalling centre that is positioned in the middle of 
the embryo. Whilst this would account for the loss of Xcac/2 when EA 
endoderm is recombined with EP mesoderm, it does not account for the 
maintenance of Xcac/2 in EP endoderm and EP mesoderm homologous 
recombination. To be more certain of what exactly is going on more 
heterologous recombinations need to be made between the EA endoderm 
and mesoderm from the other types of quarter explant (A and P see Fig 5.2
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B). If the downregulation of the Xcad2 expression is isolated to the EA 
endoderm and EP mesoderm recombination then there might be a 
positional mechanism involved. On the other hand if the downregulation is 
observed in all the recombinations then it might indicate that the expression 
of Xcac/2 in the EA endoderm is very labile and can only be maintained by 
the presence of EA mesoderm.
Even though there was an anomaly with the quarter explant 
heterologous recombinations, our results with the half explant heterologous 
recombinations are clearly different from that presented in Horb and Slack 
(2001). There are several possible explanations for the different results 
which we will consider. First there is the possibility that the explants cut by 
Marko Horb from stage 20 endoderm differ slightly from the ones generated 
in this study. The anatomical markers for where the cuts were made in 
generating the explants are somewhat arbitrary. For example, Marko might 
have cut slightly more dorsal to separate the explant from the embryo or 
that he might have cut more anterior or posterior than we have resulting in a 
longer explant along the A-P axis. It is then conceivable that the extra tissue 
could be expressing the instructive signals which would in turn respecify the 
endoderm. We also need to consider the opposite situation, Marko Horb 
might have cut slightly less ventral or anterior and posterior resulting in a 
smaller shorter explant. The smaller piece of tissue then might have lost a 
source of inhibitory signal that would result in the signals sent by the 
mesoderm becoming instructive instead of permissive.
In this interpretation, two separate signalling centres must exist in the 
mesoderm that patterns the endoderm. When only one is present the 
mesoderm would behave in a permissive manner and maintain expression 
of the specification markers in the endoderm. On the other hand when both 
signalling centres are present and active the mesoderm would behave in an 
instructive manner and be able to induce respecification in the endoderm. 
We have considered previously, in Chapter 4, cooperation between different 
signalling pathways and how they have been shown to exist in the
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development of the eye and the neural plate (Lupo et al., 2005; Pera et al., 
2003). If this hypothesis were true then screening the endoderm explants 
using a multiple signal approach, as was discussed in Chapter 4 might 
reveal the existence of cooperative signals that are instructive when 
together and permissive on their own.
Another possible explanation for the difference between our results 
and Marko’s is the wide genetic variability in Xenopus. Most of the Xenopus 
used in science is still supplied from the wild. Frogs with different genetic 
backgrounds might behave slightly differently to treatment. We recently 
discovered this with the refractory period of regenerating tail. Normally a cut 
tail in Xenopus would be regenerated. However there is a period of 
development where the cut tail does not regenerate, this is called the 
refractory period and lies between stage 45-47 (Beck et al., 2003). This was 
characterised using ten spawnings from the wild caught South African frogs 
(from Xenopus Express) in use in the lab at the time. Since then, problems 
with disease prompted a switch to lab-reared frogs from NASCO. With 
tadpole batches from the NASCO frogs there is often no refractory period. 
We need to note however that the refractory period, when it occurs, does so 
late in development and involves tissue that would be lost during 
metamorphosis.
We do not expect the same level of variation to exist for the 
development of the endoderm as it occurs much earlier and involves tissues 
that are essential for the entire lifespan of the animal. Indeed throughout this 
entire study we have gone through 4 different batches of Xenopus laevis 
from three different suppliers (Blades, Xenopus Express and NASCO) 
making it unlikely that the source of the difference in results is from the 
source of the Xenopus used.
Lastly we need to consider the possibility that Marko Horb might 
have made not made enough repetitions in his observation (Horb and Slack, 
2001). As we discussed previously, the position of the cuts in the 
experiment was arbitrary. This then increases the possible variability of the
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results. It is possible that in his studies Horb did not repeat it often enough 
and as a result he only observed the apparent instructive role of the 
endoderm. Also his experiments showed RT-PCR results from the 
heterologous recombinations and not in situ hybridisations data. Perhaps if 
he had performed the in situ, it would bring attention to the possible 
variability of this method. In our own repetitions we found that all of them 
showed a permissive mesoderm.
Thus, assuming that our result is the correct result, it is then possible 
that the endoderm might be patterned at an earlier stage and that the 
subsequent role of the mesoderm is entirely permissive. We have repeatedly 
observed through both PCR and in situ hybridisation that at stage 20 the 
mesoderm was not able to respecify the endoderm. Instead, it was only 
capable of re-activating or maintaining normal expression patterns of 
Xlhbox8 and Xcac/2 in the endoderm. Thus, it follows that if the specification 
markers can only be re-activated or maintained by the mesoderm at stage 
20 then there must be another patterning event that occurred earlier to give 
the endoderm its identity along the A-P axis. We attempted to identify 
possible stages when this event might have occurred by making endoderm- 
only explants from earlier stages (stage 10.5 & 13). However we later found 
that explants made from these stages to be contaminated with a significant 
amount of mesoderm resulting in variable expression patterns of Xlhbox8 
and Xcac/2 with heterologous recombinations involving endoderm from 
stage 10.5 and 13 embryos.
The existence of a significant amount of mesoderm in the explants 
meant that this method is unsuitable for studying endoderm respecification 
in early embryos. We need to consider other methods that would affect the 
endoderm development in vivo, avoiding the mesodermal contamination 
altogether. The transgenic method is a very powerful and flexible tool for 
overexpression of genes in Xenopus. In order to adapt it to study endoderm 
we need to have spatial and temporal control, so that the transgenes are 
only overexpressed in the mesoderm at the stage of interest.
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Our lab has previously created a transgenic construct containing the 
heat shock promoter Hsp70 (Beck et al., 2003). Under the control of this 
promoter, genes are only expressed when the embryos are subjected to a 
temperature of 34°C, thus allowing for temporal control of the expression of 
the gene of interest. To gain spatial control for the expression we need to 
use another well known method in Xenopus, grafting. Microsurgery is 
relatively easy in Xenopus embryos since the embryos are relatively large 
and heal well after surgery. Previous work in our lab has shown that it is 
possible to make specific grafts of presomitic mesoderm from stage 14/15 
embryo (Gargioli and Slack, 2004). Thus to restrict the expression of the 
growth factors specifically to the mesoderm one can graft the mesoderm 
from that particular stage of development from a heat shocked transgenic 
embryo to a wildtype recipient.
The discovery that the result from heterologous recombinations on 
stage 20 embryos (Horb and Slack, 2001) were not repeatable has certainly 
raised a lot of new questions regarding the timing and mechanism of 
regional specification of the Xenopus endoderm. From the various 
hypotheses discussed here we feel that the most probable one is that at 
stage 20 the mesoderm is only acting in a permissive role, maintaining an 
earlier, labile, patterning event. The next step is then to investigate the 
precise timing when this patterning event takes place. We have shown that 
this investigation could not be carried out using the explant system as it is 
difficult to remove completely the mesoderm contamination. This also 
means that we cannot use heterologous recombination to try and identify at 
which stage the patterning of the endoderm actually occurs. This then 
makes identifying the early patterning event much more difficult as we must 
rely on misexpression or overexpression of various growth factors at various 
stages to hopefully identify exactly when the earliest endoderm patterning 
event occurred. Both the transgenic and the implanted bead approach may 
be applicable to solving this problem.
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VI. Hox genes and the endoderm
VI.1. Introduction
Data from heterologous recombinations of endoderm and mesoderm 
in chick, mouse and Xenopus have shown that the mesoderm plays a 
pivotal role in specifying the endoderm along the A-P axis (Dessimoz et al., 
2006; Horb and Slack, 2001; Kumar et al., 2003; Wells and Melton, 2000). 
The mesoderm is thought to send out different signals to pattern different 
parts of the endoderm depending on its position along A-P axis. In order to 
do this the mesoderm must be able to tell its own positional identity along 
the A-P axis. It has been suggested that the Hox genes might be involved in 
providing this positional identity in the mesoderm.
Hox genes are a subset of the homeobox genes which encode 
transcription factors containing the 60-amino acid homeodomain (McGinnis 
and Krumlauf, 1992). They are excellent candidates for providing positional 
information along the A-P axis of the endoderm as they have been shown to 
play an important role in the A-P patterning of the mesoderm. Mutations to 
the Hox genes have been shown to result in morphological defects that are 
restricted to discrete segmental zones along the A-P axis in a wide variety 
of animals, ranging from nematodes to mice (Pearson et al., 2005). Hox 
genes have also been shown to provide positional information along the A-P 
axis in the development of both mesoderm and ectoderm. In the mesoderm, 
the shape of a vertebra is controlled by Hox code, and in the hindbrain 
(ectoderm), appropriate neuronal differentiation has been shown to be Hox- 
dependent (Krumlauf, 1994; McGinnis and Krumlauf, 1992).
Hox genes are expressed in the correct germ layer to provide 
positional information in the mesoderm, as most of the Hox genes are found 
to be expressed in the mesoderm and not the endoderm. In Drosophila only 
labial is found in the endoderm (Bienz, 1997). In chick as well, most of the 
Hox genes are found to be expressed in the mesoderm whilst only a subset
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are expressed in the endoderm at levels detectable by in situ hybridisation 
(Grapin-Botton, 2005).
In chick the Hox genes have been found to be expressed in a nested, 
overlapping pattern in the developing gut mesoderm (Roberts et al., 1995; 
Sakiyama et al., 2000; Sakiyama et al., 2001; Yokouchi et al., 1995). 
Furthermore, the boundaries of expression for some of these mesodermal 
Hox genes align with the morphological borders of the different gut regions 
further supporting their possible role in providing positional information in 
the mesoderm (Grapin-Botton, 2005). This is especially true for the 5 ’ 
members of the Hoxa and Hoxd clusters (paralogues 9-13) (Roberts et al., 
1995). The expression pattern of these Hox genes have been shown to 
match the morphological borders of the different gut regions of the posterior 
midgut and hindgut.
This alignment of the borders of mesodermal Hox gene expression 
and morphological borders is more significant when we consider that the 
Hox genes are master transcriptional regulators, capable of regulating the 
expression of many downstream genes. Through this mechanism it is then 
conceivable that the Hox genes are activating the expression of various 
signal molecules in the mesoderm depending on their position along the A- 
P axis. These different signals might then induce different fates in the 
endoderm along the A-P axis, resulting in the patterning of the endoderm.
In Xenopus similar regional expression pattern is also observed for a 
number of Abdominal B-type Hox genes (Lombardo and Slack, 2001). Even 
though the boundaries of these Hox genes have not been matched with 
morphological boundaries in the gut in Xenopus, it certainly raises the 
possibility that they might provide the mesoderm with positional information 
along the A-P axis. So far the in situs have only been performed on whole 
embryos or on isolated gut, so we do not know whether the genes are 
expressed in endoderm or mesoderm or both layers. Thus to further build 
up evidence for the role of Hox genes in endoderm specification we aimed 
to investigate the expression patterns of these Hox genes in more detail.
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As was shown previously the endo+meso explants contains the 
minimum amount of tissue necessary for the specification of the endoderm 
as they maintain expression of Xlhbox8 and Xcac/2 (Horb and Slack, 2001). 
Expression of the Hox genes in these explants would give further support to 
the argument that Hox genes are playing a role in the specification of the 
endoderm. We aimed to investigate this by performing in situs on 
endo+meso explants for the genes xHoxA9, xHoxD9f xHoxDIO, xHoxC12 
and xHoxA13 which have previously been studied in whole embryo and 
isolated gut in Xenopus (Lombardo and Slack, 2001). We also included 
another posterior Abdominai S-type Hox, xHoxD13 (Christen et al., 2003).
We also aimed, through this study to determine conclusively whether 
the Abdominal B-type Hox genes are expressed in the endoderm or the 
mesoderm. Previously Aurora Lombardo in her experiments showed that the 
xHoxA13 is expressed in both endoderm and mesoderm. However this was 
done by manually hemisecting a stage 42 gut after wholemount in situ. We 
feel that this method does not have enough resolution to say conclusively 
whether it is in both layers or just in the mesoderm. Also the location of the 
other Hox gene transcripts have not been established. We then aimed to 
address this by performing sections on the gut following wholemount in situ 
hybridisation. This should provide us with the resolution needed to draw firm 
conclusions on whether the Hox genes are expressed in the endoderm or 
mesoderm or in both layers.
VI.2. Materials and Methods
The probes for the in situ were made by linearising plasmids with the 
appropriate enzyme and transcribing the DIG-RNA probe using the 
appropriate polymerase. The list of enzymes and polymerase used to make 
the Hox probes are listed in Table 6.1. It is worth noting that the 
development time for histochemical reaction were especially long for these 
Hox probes, up to 48 hours. This was due to the relatively low level of 
expression of the Hox genes in normal embryo. The embryos were bleached 
after colour development to better visualise the expression pattern.
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Table 6.1 Restriction enzyme and polymerase for Hox probes








VI.3.1.Testing in situ  probes
Before we proceeded with in situ on the explants, it was necessary to 





Figure 6.1 Hox in situ with stage 35 whole embryo.
Probes for xHoxA9, xHoxD9, xHoxDIO, xHoxC12, xHoxA13 and xHoxDI3 all show 
the correct staining with the control stage 35 whole embryo (see Lombardo and 
Slack, 2001 for reference). Yellow arrow head indicate anterior boundary of 
expression for each of the Hox genes.
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The results of the in situ hybridisations (Fig 6.1) showed that all of the 
probes tested were functional. xHoxA9, xHoxD9, xHoxDIO, xHoxC12 and 
xHoxA13 gave patterns that have been previously described (Lombardo and 
Slack, 2001). xHoxD13 also showed a previously described posterior 
expression pattern (Christen et al., 2003). xHoxA9 was found to have the 
most anterior boundary of expression followed by xHoxD9, xHoxDIO, 
xHoxC12 with xHoxA13 and xHoxD13 having the most posterior expression.
VI.3.2./A7 s/fivwith endoderm, endo+meso explants and stage 42 gut
Once we confirmed that the DIG-RNA probes were functional, we 
went on to test them with the endoderm and endo+meso explants. These 
explants were made as described in the Materials and Methods (Section 
2.7, p45). The explants were cultured until the controls reached stage 42 
before being fixed in MEMFA and processed for in situ. Gut isolated from 
stage 42 embryos were also collected to act as control and also to repeat 
previous experiments by Lombardo and Slack (2001).
We found that the development time was again long, approximately 
36-48 hours, similar to in situ with stage 35 whole embryos. Results for the 
in situ are shown in Figure 6.2. Here we can see that xHoxD9, xHoxDIO and 
xHoxC12 were expressed in both endo+meso explant as well as stage 42 
gut but not in the endoderm-only explants. Both xHoxDIO and xHoxC12 
showed expression in the posterior of the gut only. xHoxD9 on the other 
hand showed expression in the posterior of the gut as well as a fainter stain 
in the anterior of the gut. These expression patterns were similar to those 
previously reported in Xenopus (Lombardo and Slack, 2001).
The staining with xHoxA9 in the isolated gut were very faint and may 
simply be non-specific staining. The endo+meso staining was slightly 
clearer but still faint. We made three further attempts, once more with the 
same probe and another two times with new DIG-RNA probes, to get a 
clearer, cleaner staining pattern with xHoxA9. However we were unable to 
obtain a different staining for this gene in either the explants or the isolated
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stage 42 gut. The stage 35 whole embryo positive control, however 
repeatedly showed the pattern seen in Figure 6.1. Based on these 
observations we were inclined to conclude that the pattern seen here is 
non-specific and not a real staining of xHoxA9.







Figure 6.2 Hox in situ.
in situ hybridisation results with probes for the Hox genes xHoxA9, xHoxD9, 
xHoxDIO, xHoxC12, xHoxA13 and xHoxD13 done on endoderm, endo+meso 
explants as well as stage 42 gut. xHoxA9 showed expression in the anterior and 
posterior of the gut and endo+meso explant. xHoxD9 showed expression in 
anterior and posterior in the gut and endo+meso explant as well although stronger. 
xHoxD 10 showed a sharp band in the posterior of the endo+meso explant and a 
wider posterior expression domain in the gut. xHoxC12 showed a small posterior 
expression domain (highlighted with yellow circle) in the endo+meso explant and a 
wider posterior expression in the gut. xHoxA13 and xHoxD13 only showed a 
posterior expression domain in the gut. None of the Hox genes tested showed 
expression in the endoderm only explants.
With xHoxA13 and xHoxD 13 we were only able to get a clear signal 
with the isolated stage 42 gut but not with any of the explants. The 
expression pattern otxHoxA13 seen in the gut was similar to that previously 
described in Xenopus (Lombardo and Slack, 2001). The lack of expression 
of these genes in endo+meso explants were unexpected, especially 
considering the strong staining observed in the isolated stage 42 gut. 
However we need to take into account that the xHoxA13 and xHoxD13 were 
expressed at the most posterior of the embryo. Thus it is possible that the 
lack of staining observed with xHoxA13 and xHoxD13 was because the 
posterior part expressing xHoxA13 and xHoxD13 was not included in the 
endo+meso explant.
VI.3.3. More posterior explant expresses xHoxA13 and xHoxD13
To help address the question as to whether or not the xHoxA13 and 
D13 is expressed in more posterior tissue we devised a modified cut that 
would generate endo+meso explants with more posterior tissue (Figure 
6.3A). As can be seen from the diagram the new explant cut now contained 
the entire posterior of the embryo which should include the piece of tissue 
expressing xHoxA13 and xHoxD13.
Results from this in situ, with the more posterior explant, show clearly 
that xHoxA13 and xHoxD13 were expressed in this new more posterior 
explant (Figure 6.3). This confirmed our previous hypothesis that these two 
Hox genes were expressed in the most posterior tissue not included in our 
original endo+meso explant.
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VI.B.4. Endoderm or Mesoderm expression?
Previous Hox in situ in Xenopus have shown that at least one of the 
Hox genes, xHoxA13 was expressed in the endoderm (Lombardo and Slack, 
2001). However this conclusion was made by observing the expression 
pattern on gut that was hemisected after in situ. We felt that this was not 
conclusive as the resolution from this method would not be sufficient to 
confirm the location of the signal inside the gut. Thus to address the issue 
as to which germ layer each of the Hox genes are expressed, endoderm or 
mesoderm, we decided to section the wholemount in situ gut. The samples 
were fixed, processed and subsequently embedded in paraffin wax. 
Transverse sections were then made from these paraffin fixed samples at 





Endoderm + Mesoderm Gut
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Figure 6.3 More posterior explants.
A) Diagram on the left shows how whole endoderm explant were normally made. 
This method was modified to include more posterior tissue to see if xHoxA13 & 
xHoxD13 might be expressed in more posterior tissue. The new cutting positions 
are shown on the right diagram. B) Shows the in situ hybridisation fox xHoxAl3 & 
xHoxD13 with the new more posterior explant and stage 42 gut. The more 
posterior explant shows clear expression of the Hox genes xHoxA13 and xHoxD13.
The sections from the whole mount in situ gut provided us with 
several new pieces of information regarding the expression pattern of the 
Hox genes (Figure 6.4). xHoxA9 and xHoxD9 due to weak staining, did not 
give a clear indication as to where they were expressed, endoderm or 
mesoderm. XhoxD 10 and xHoxC12 were clearly expressed in the mesoderm 
as the staining was very strong in the mesoderm (a thin layer around the 
outside of the gut) with no staining at all in the endoderm (inside cells of the 
gut).
Analysis of the expression pattern oixHoxA13 and D13 however was 
not as straightforward. At a glance it would seem that the expression was 
only in the mesoderm. However a closer look at the sections show that the 
inside endodermal cells may also show weak staining. It is interesting to 
note that in these sections we saw the strength of the staining being 
strongest at the outside of the gut where it is most exposed, gradually 
getting weaker towards the centre of the endoderm.
We believe that such outside to inside graduated staining patterns 
can be indicative of penetration problems with regard to the probe or the 
antibody. The strength of an in situ staining is directly correlated to the 
amount of probe hybridised at that particular area. If the probe is having 
difficulty penetrating the tissue then it follows that the highest amount of 
probe available for hybridisation would be on the outside most exposed 
side of the tissue sample gradually getting less toward the center of the 
sample. Because of this unequal distribution of probe, we would get a 
graduated stain, even if the gene of interest was expressed to an equal 
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Figure 6.4 Wholemount in situ sections.
10 |jm transverse wax sections cut following whole mount in situ hybridisation with 
stage 42 gut for xHoxA9, xHoxD9, xHoxD 10, xHoxC12, xhoxA13 and xHoxD13. 
xHoxA9 and xHoxD9 did not show any staining probably due to the weak whole 
mount in situ observed earlier. xHoxDIO and XhoxC12 showed a distinct 
mesodermal staining. xHoxA13 and xHoxD13 have the strongest expression in the 
mesoderm but also showed a graduated staining that gets weaker as towards the 
center of the sample.
Thus in order to get around this penetration problem, we need to 
increase the amount of tissue exposed. An obvious way to achieve this 
would be by sectioning the gut sample prior to in situ. We attempted this 
with wax, cryosection and vibratome but were not successful in obtaining a 
good in situ stain. Each of the methods had its own drawbacks and 
problems. We found the wax sectioned samples to have a greater tendency 
to develop non-specific staining, even when levamisole was included in the 
reaction mixture. Cryosectioned samples had a tendency to fall off the slide 
during the in situ process. We tried using various different slides: superfrost, 
superfrost gold and polylysine coated slides but none of them were able to 
keep the cryosectioned samples from falling off. The vibratome sections 
also had a tendency to be lost in the process of in situ. However this was 
because vibratome samples can not be mounted on a slide prior to in situ 
and must instead be collected in a 5ml tube and treated as a whole mount 
sample during in situ. Since the sections were small they tended to get 
sucked up by the glass pipettes during solution changes.
Due to all these difficulties performing in situ hybridisationon 
sectioned samples we decided to take an alternative route to increasing the 
amount of exposed surface area in the sample. The main problem with 
wholemount in situ of xHoxA13 and D13 was that we were not sure that the 
probe was capable of penetrating all the way to the endodermal cells inside 
the gut. Thus, to address this we decided to hemisect the gut prior to in situ 
in order to expose the inside cells of the gut. This would allow penetration of 
the tissue from both the outside and the middle of the gut, aiding the probe 
in reaching the endodermal cells located inside the gut. The cut was made 
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Figure 6.5 In situ on hemisected gut.
A). Results for in situ hybridisation where the posterior of the gut was hemisected 
after fixation but prior to in situ. B) The gut and hemisected gut was wax 
embedded and cut transversally at 10 pm. Black arrows on the hemisected gut 
figures indicates the inside exposed edge.
We tried hemisecting the gut before and after fixation and found that 
gut hemisected prior to fixation in MEMFA tend to curl. This was unsuitable 
for our purposes as it would make it difficult to perform traverse sections on 
the curled tissue, making it impossible to conclusively determine if the 
signal was in the endoderm or mesoderm. The gut remained relatively 
straight if cut after fixation in MEMFA. Flowever care must be taken when
xHoxD13
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hemisecting the gut after fixation as the tissue is more brittle and more 
prone to breaking. Our previous in situ hybridisation with the whole gut had 
shown that xHoxA13 and xHoxD13 were only expressed in the posterior of 
the gut. Thus there is little benefit in hemisecting the gut all the way from the 
anterior to the posterior compared to just hemisecting the posterior. 
Hemisecting the posterior is much easier as we only need to split a much 
smaller part of the gut, minimising the chance of the gut breaking and 
becoming unusable.
Once hemisected the gut was then collected in a 5 ml tube and 
processed for in situ as a whole mount sample. Result of the in situ with 
xHoxA13 and D13 with whole gut and hemisected gut are shown in figure 
6.5A. Looking at the hemisected gut it seems that these two genes might be 
expressed in both layers. However as was previously discussed, this 
method does not have enough resolution to conclusively say one way or the 
other. Thus we decided to process the hemisected gut, embed them in wax 
and perform transverse 10pm sections to see where the signal was.
Results from sectioning the hemisected gut was unexpected. As we 
can see from the photographs in figure 6.5B, hemisecting the gut and 
increasing the amount of exposed surface did not seem to change the 
expression pattern previously observed with xHoxA13. the strong dark 
staining was still only on the mesoderm layer around the outside of the gut 
and gradually getting weaker towards the endoderm. We see no increased 
staining in the endoderm where the cut was made. This means that we now 
know conclusively that the staining was real and not a result of the probe 
accumulating on the exposed side as there was no staining in the 
endodermal cells.
With xHoxD13, expression in the hemisected gut was only seen in the 
outside cells of the mesoderm. No expression was seen in the endodermal 
cells. This then indicates that the earlier staining in the endodermal cells 
might be non-specific staining and we can conclusively say that xHoxD13 is 
expressed in the mesoderm only.
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V IA  Discussion
We found that the Hox genes xHoxD9, xHoxDIO, xHoxC12, xHoxA13 
and xHoxD13 that were shown previously to be expressed regionally in the 
whole embryo to be expressed in the endo+meso explants but not on the 
endoderm-only explant. We must note however that a more posteriorly cut 
endo+meso explant was needed to see expression of xHoxA13 and 
xHoxD13. This raises a few questions as to whether or not they are involved 
in endoderm specification. This posterior expression indicates that they 
might be expressed at the proctodeal level, where other genes are 
expressed in the endoderm. This region of the endoderm is a different 
territory from the future intestine (Chalmers and Slack, 2000).
However, it is possible thatxHox/473 and D13 might still be involved 
in endoderm development. It is conceivable that xHoxA13 and D13 can 
induce the formation of a posterior gradient in the embryo which in turn 
might pattern the endoderm. We will discuss further the possible role for 
XhoxA13 and D13 in endoderm development in the next chapter.
We were unable to obtain a clear expression pattern for the Hox gene 
xHoxA9 in either the explant or gut samples. The staining we found on 
isolated gut and explants for this gene might be attributed to non-specific 
hybridisation, which was consistent with observations made on the 
sectioned gut samples. This was unexpected as previously xHoxA9 has 
been shown to be expressed in the posterior isolated gut of stage 42 and 
later embryos (Lombardo and Slack, 2001). We are confident that the non­
specific staining was not due to the probe as we tested with probes made 
from 3 separate transcription reaction and found all of them gave the 
expected pattern in control stage 35 embryos whilst showing non-specific 
background staining in the gut and endo+meso explant samples. There is 
the possibility that we might be able to obtain a staining in the gut and 
endo+meso explants if we developed the in situs for longer. Hox genes are 
expressed in very low levels and as such in situ for Hox genes usually 
requires a relatively longer development time. At the moment we have tried
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development of up to 48 hours. We had considered and attempted longer 
development times but the non-specific staining became much too strong 
for this to be useful.
There is also the possibility that the expression levels of xHoxA9 
might have simply dropped off by stage 42, accounting for the faint, almost 
background like expression seen in our experiments. To test for this we 
would need to do RT-PCR with xHoxA9 on different stages of embryos. RT- 
PCR would be more appropriate than in situ for this purpose as it is a more 
quantitative method. This method would also help to find the highest level of 
xHoxA9 expression, indicating the likely stage at which it is involved in the 
development of the embryo.
We also attempted to confirm the location of the expression of the 
Hox genes by sectioning the gut post in situ. We can conclusively say that 
three of the Hox genes, xHoxDIO, xHoxC12 and xHoxD13, are expressed 
exclusively in the mesoderm. We were not able to confirm the location of 
xHoxD9 expression, as the weak wholemount staining was not visible in the 
10 pm wax sections. xHoxA13 was definitely expressed in the mesoderm 
and it is possible that there is also some graduated staining in the 
endoderm. Initially we thought that the graduated staining pattern found 
with these probes might be due to limited penetration. However looking at 
in situ results with hemisected guts, where the inside endodermal cells were 
similarly exposed as the mesoderm cells on the outside we can be sure that 
this was not the case and that the observed pattern was genuine
Graduated staining is usually indicative of a gradient, normally 
observed with morphogen gradients involving proteins. Our current result 
however was showing graduated levels of xHoxA13 RNA. A gradient 
involving RNA instead of protein has been known to exist. In chick and 
mouse FGF8 mRNA is seen to form a posterior gradient from the tail bud 
and is involved in the formation of somites (Delfini et al., 2005; Dubrulle and 
Pourquie, 2004). This FGF8 gradient is formed as a result of axis elongation 
and RNA decay. FGF8 mRNA expression is restricted to the tail bud only.
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During axis elongation, the tail bud cells divide resulting in a posterior 
extension of the embryo. The descendants of the tail bud inherits the FGF8 
mRNA and due to polarised axis elongation take up an increasingly more 
anterior position in the embryo. Thus taking into account mRNA decay it can 
be seen how more anterior cells (older descendants) would have a lower 
level of FGF8 mRNA compared to more posterior cells (newer descendants), 
creating a posterior gradient of FGF8 mRNA (Dubrulle and Pourquie, 2004). 
However a similar mechanism is unlikely to be the cause of the xHoxA13 
gradient as it involves two germ layers. The graduated expression in 
xHoxA13 seems to be strongest from the mesoderm getting weaker 
towards the inner endodermal cells. Thus since the endodermal cells are 
unlikely to be derived from the mesodermal cells, the gradient could not be 
formed using the same mechanism as the FGF8 gradient.
There is no clear explanation as to why the level of expression was so 
much lower in the endoderm compared to the mesoderm. It could be the 
endoderm has a lower threshold of xHoxA13 response that it only needs to 
express it at low amounts. It is also possible that xHoxA13 is acting 
differently in these two layers, hence the different level of expression. To 
address this a study into the activity of downstream targets of xHoxA13 
would be needed through either differential RNA analysis or microarrays.
In conclusion, the discovery that the regionally expressed Hox genes 
xHoxD9, xHoxDIO, xHoxC12, xHoxA13 and xHoxD13 are expressed in the 
endo+meso explant is lends support to their proposed role in endoderm 
specification. The observation of the strong expression of xHoxDIO, 
xHoxC12, xHoxA13 and xHoxD13 in the mesoderm means that these genes 
are expressed in the right germ layer to provide positional information to the 
mesoderm along the A-P axis, which in turn could allow the mesoderm to 




Hox genes, a subset of the homeobox genes, have been shown to be 
involved in the A-P patterning of the mesoderm and ectoderm (Krumlauf, 
1994; McGinnis and Krumlauf, 1992; Pearson et al., 2005). There is some 
evidence suggesting that they might be involved in the A-P patterning of the 
endoderm as well. The Hox genes have been found to be expressed in a 
nested, overlapping patterns in the mesoderm of developing gut in chick 
(Roberts et al., 1995; Sakiyama et al., 2000; Sakiyama et al., 2001; Yokouchi 
et al., 1995). The nested expression pattern is particularly relevant to 
endoderm development as the boundaries of the expression pattern of 
some of these mesodermaly expressed Hox genes have been shown to 
align with the morphological borders of different gut regions (Grapin-Botton, 
2005). This is especially true for the 5’ members of the Hoxa and Hoxd 
clusters (paralogues 9-13) in chick (Roberts et al., 1995).
Previous heterologous recombination experiments in chick, mouse 
and Xenopus have shown that the mesoderm is important in patterning the 
endoderm along the A-P axis (Horb and Slack, 2001; Kumar et al., 2003; 
Wells and Melton, 2000). To pattern the endoderm along the A-P axis the 
mesoderm needs to be told of its position along the A-P axis. Thus this 
nested expression of Hox genes in the mesoderm puts them in the ideal 
position for providing positional information to the mesoderm along the A-P 
axis.
Indeed the misexpression of Hoxd-13 in chick has been shown to be 
able to induce a hindgut fate on midgut tissue (Roberts et al., 1998). This is 
further supported with murine transgenic experiments where inactivation or 
misexpression of the Hox genes result in abnormal gut development 
(Pollock et al., 1992; Wolgemuth et al., 1989). In particular, loss of 
expression of Hoxa-13 and Hoxd-13 have resulted in the alteration of
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muscle layers of the sphincter, which is consistent with a partial anterior 
transformation of this region (Kondo et al., 1996; Warot et al., 1997).
In Xenopus members of the Abdominal B-type Hox genes have been 
shown to be regionally expressed in the mesoderm (Lombardo and Slack, 
2001). Even though in Xenopus the boundaries have not yet been aligned 
with morphological boundaries, it still raises the possibility that, similar to 
that observed in chick and mouse, Abdominal B-type Hox genes might be 
involved in the development of the endoderm. We aimed to overexpress 
some of these Hox genes and study their possible roles and function in 
endoderm development.
An interesting feature of the Hox genes is that more posterior Hox 
tend to be dominant over the anterior Hox. Typically, if a posterior Hox gene 
is expressed ectopically at a more anterior position it results in that segment 
of the animal taking on a more posterior fate. However if an anterior Hox 
gene is expressed at a more posterior position, the tissue is not respecified 
towards a more anterior fate. This feature is known as “posterior 
dominance” (Manak and Scott, 1994).
Due to this we decided that it would be most informative to start by 
overexpressing the two most posterior Xenopus Hox genes, xHoxA13 and 
xHoxD13. These genes were likely to be dominant and as such more likely 
to respecify anterior tissue yielding a visible abnormal phenotype. We 
expected that an overexpression of xHoxA13 or D13 in the whole embryo 
would lead to the posteriorisation of the gut, indicated by the expansion of 
Xcad2 expression and down regulation o1Xlhbox8.
VII.2. Materials and Methods
VII.2.1. Generating mRNA for injection
The mRNAs of xHoxA13 and xHoxD13 were generated by linearising 
the plasmids using Notl followed by a transcription reaction using SP6 
mMessage machine kit (Amersham). The GFP mRNA was generated from 
Apal linearised plasmid which was then put in a transcription reaction using
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T7 mMessage machine (Amersham). Once obtained, the mRNA of interest 
was injected at the appropriate concentration in 4.6nl of solution using a 
Drummond injector. A total of 500pg of GFP mRNA was also injected along 
with the Hox mRNA. This coinjection allows us to trace the location of cells 
that have taken up the mRNA. For 4-cell dorsal injection the GFP marker 
should be clearly visible along the notochord and in the head structure.
VII.2.2. Cryosection
To observe the GFP signal in sections the embryos need to be fixed 
in 4%PFA for 2-3 hours at 4°C. Once fixed they are then washed twice in 
PBSA before being processed for cryosection. Cryosection is the preferred 
sectioning method here as it best preserves the fluorescence signal. The 
preparation for cryosection involve incubation in 15% sucrose and 30%  
sucrose both overnight at 4°C before embedding in OCT (Sigma).
The embedded samples were cryosectioned at -20°C with 15 pm per 
section. The sections were put on polylysine slides (Fisher) and allowed to 
dry at room temperature for approximately 3-4 hours. The slides were then 
washed with PBSA again twice for 5 minutes each to wash off the excess 
OCT before finally being mounted using Gelmount (Biomeda). Once 
mounted in Gelmount the GFP signal should be stable for a few months at 
room temperature.
VII.3. Results
VII.3.1. xHoxA13 and xHoxD13  overexpression
Overexpression in Xenopus can be done through two methods: RNA 
injections or transgenics. Each of these methods has their own advantages 
and disadvantages. RNA injection is clearly quicker to perform and all of the 
injected embryos would express the mRNA. However there is no temporal 
regulation of expression: translation commences shortly after injection and 
continues thereafter. The mRNA will eventually decay and its activity will 
terminate. Transgenics may enable permanent or regulated trasngene
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expression but only a fraction of the injected eggs would express the 
integrate the injected plasmid and express the genes.
One of the advantages of working with Xenopus is that we have 
access to a complete fate map of the embryo (Dale and Slack, 1987; Lane 
and Sheets, 2002). Using this information we can inject specific blastomeres 
in the early embryos to target a particular set of tissues. This also gives us 
flexibility, for example if we need to target a different set of tissues we 
would only have to inject a different blastomere. In transgenics to target a 
different tissue we would have had to make a new construct driven by a 
different promoter. Based on these considerations we decided that it would 
be more effective to use RNA injections in establishing a possible role for 
xHoxA13 and D13 in the specification of the endoderm.
Both the recently completed (Lane and Sheets, 2002) and the original 
(Dale and Slack, 1987) fate maps of Xenopus indicate the same blastomeres 
that contributes to the endoderm and mesoderm. However for the sake of 
clarity we would like to note that in this thesis we are still using the 
traditional dorsal/ventral nomenclature (Dale and Slack, 1987) and not the 
recently proposed rostral/caudal nomenclature (Lane and Sheets, 2002).
VII.3 .2.Dorsal Injection
Before testing if the Hox has any effect on endoderm specification, 
we decided to confirm that the mRNAs for xHoxA13 and xHoxD13 were 
functional by injecting them to the dorsal side of a 4-cell stage embryo. 
Overexpression of posterior Hox genes on the dorsal side of an embryo is 
known to suppress development of the anterior/head structure (Pownall et 




Figure 7.1 Top view of 4-cell stage embryo.
Figure above shows the difference between dorsal and ventral blastomeres at 4- 
cell stage. The injection for positive control is done on the dorsal blastomeres, 
highlighted in green above.
Dorsal injections with 2ng total xHoxD13 resulted in one of two 
different phenotypes: a complete loss or reduction in the size of the eyes 
(Figure 7.2A), both of these representing a reduction in anterior/head 
structures. Approximately 76.2% of the embryos injected with 2ng of 
xHoxD13 showed either one of these phenotype, confirming the biological 
activity of the xHoxD13 mRNA.
Our initial injections of 1ng total xHoxA13 mRNA resulted in most 
(>90%) of the embryos showing a severely deformed phenotype extremely 
shortened with no visible anterior structures (Figure 7.2B). Initially we 
suspected that this might be due to toxic chemicals (e.g. phenols) present in 
the RNA preparation. However considering that we still observed a low 
number of embryos with the less severe head/eye suppression we 
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Figure 7.2 Dorsal injections of xHoxA13 & D13.
A) xHoxD13 injections in the dorsal blastomeres leads to suppression of the eye. 
Three different phenotypes were observed: normal, reduced eyes and complete 
eye loss. The numbers obtained with each phenotype is shown on the table to the 
right with the percentages in brackets. B) xHoxA13 injections in the dorsal 
blastomeres leads to suppression of the eye and head. There were four 
phenotypes observed: normal, eye suppression, head suppression, extreme head 
suppression. The numbers obtained with each phenotype is shown on the table to 
the right with the percentages in brackets.
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To confirm this we did injections with a lower amount of mRNA 
(500pg). If indeed this was a more severe phenotype of xHoxAl3 
overexpression then we expected to get more of the less severe phenotype 
(e.g eye or head suppression) with lower amounts of xHoxAl3.
Indeed when 500pg of xHoXAl3 was injected only 30.3% of the 
embryos were severely deformed. A majority of the injected embryos 53.6% 
showed either eye or head suppression. This then confirmed that the 
phenotypes observed were due to the biological activity of xHoxAl3 and not 
due to toxicity.
VII.3.B. xHoxD13 ventral injections
After confirming that both the xHoxAl3 and D13 RNAs had biological 
activity, we decided to target mesoderm and endoderm. Both layers were 
targeted as there was an indication that xHoxAl3 might normally be 
expressed in both endoderm and mesoderm and not mesoderm only. Also 
by targeting both these layers we could do the injection at an earlier stage, 
making it easier and faster. Injections were made on the ventral vegetal side 
of an 8-cell stage embryos (Figure 7.3). We injected both the left and the 




Figure 7.3 Diagram for 8-cell stage injection.
Side view of an 8-cell stage embryo. Location for the injection of the xHoxD13 and 
A13 is highlighted in green.
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Figure 7.4 xHoxD13 8 cell ventral injections.
A) Shows the whole embryo for control injections with 2ng GFP as well as the 
experimental injections with 2 & 1 ng xHoxD13. The xHoxD13 injected embryo 
looked similar to control GFP injected embryos. B) In situ for Xlhbox8, Xcad2 and 
Edd with guts from the injected embryos. Highlighted in the panels are positions of 
liver bud (L) and proctodeum (P). Here we can see that the patterning of the gut is 
not affected by xHoxD13 overexpression as the pattern with Xlhbox8 and Xcad2 
remains similar to control GFP injected embryos.
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We decided to do the injections at various concentrations to see 
which would have an effect on the development of the endoderm. Again as 
before xHoxAl3 mRNA were coinjected with 500pg of GFP mRNA to allow 
visualisation of affected embryos, thus confirming that the correct 
blastomere had been affected. Results for the injection of xHoxD13 at 1 and 
2 ng as well as the 2ng GFP control injection can be seen in Figure 7.4.
There was no visible difference between the xhloxD13 injected 
embryos compared to the GFP injected embryos. xHoxD13 did not seem to 
affect the normal development of the gut. This observation was confirmed 
when we did in situs for Xlhbox8, Xcad2 and Edd with guts isolated from the 
injected embryos. In the xHoxD13 injected embryos Xihbox8 was still 
expressed in the anterior of the gut whilst Xcad2 was expressed throughout 
the posterior of the gut with a distinct lack of staining in the anterior. This 
expression pattern was similar to that of GFP injected embryos which 
confirmed the normal expression pattern of both these markers. Thus, 
based on this it appears that ventral vegetal injections of xHoxD13 at 8-cell 
stage does not affect endoderm specification.
VII.3.4. x H o x A l3  ventral injections
We also injected a series of concentrations of the xHoxAl3 mRNA 
towards the ventral vegetal side of 8-cell stage embryos. Again 500pg of 
GFP mRNA was coinjected with the xHoxAl3 mRNA to help visualise the 
location of the injections and thus confirm that the correct cells had been 
affected. Results for the injections oixHoxA13 at 1ng and 500pg as well as 
the control 2ng GFP injection can be seen in Figure 7.5.
A clear phenotype with the xHoxAl3 injections were seen when at 
least 500pg of mRNA was injected (Figure 7.5A). In approximately 30-40%  
of the embryos we observe a bubble forming around the gut of these 
embryos. The gut itself seems thinner and lacks coiling. These observations 
indicated that the normal morphological movements that takes place in the 
development of the gut were affected by the overexpression of xHoxAl3.
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Figure 7.5 xHoxAl3  8 cell ventral injections.
A) Shows the whole embryo for control injections with 2ng GFP as well as the 
experimental injections with 1ng & 500 pg xHoxA13. The xHoxA13 injected embryo 
shows an expanded gut that seems to have failed to coil properly. B) In situ for 
Xlhbox8, Xcad2 and Edd with guts from the injected embryos. Highlighted in the 
panels are positions of liver bud (L) and proctodeum (P). Here we can see that the 
patterning of the gut is not affected by xHoxAl3 as the pattern with Xlhbox8 and 





To see if the xHoxAl3 overexpression affected the specification of 
the endoderm as well as the morphology we followed up by performing in 
situs for Xlhbox8, Xcad2 and Edd on the isolated guts of the injected 
embryos. Unexpectedly results from these in situs showed that the normal 
specification of the endoderm was maintained in these deformed guts. We 
can see that Xlhbox8 is still expressed in a narrow band in the anterior of 
the gut and that Xcad2 is still expressed in the posterior of the gut with a 
distinct lack of expression in the anterior of the gut (Figure 7.5B).
Thus the results from the ventral vegetal injection at 8-cell stage 
indicates that xHoxAl3 does not have any effect on the regional 
specification of the endoderm. Its visible effects in inhibiting coiling of the 
gut may indicate that it is involved with morphological movements that 
takes place later than endoderm specification in the development of the 
Xenopus endoderm (Chalmers and Slack, 1998). Also we had only observed 
the gut deformation when an oedema was present. This then raises the 
possibility that the influx of water into the embryo might also have gone into 
the gut, which in turn would cause morphological defects.
In both xHoxAl3 and D13 ventral vegetal injection at 8-cell stage did 
not yield any respecification of the endoderm. However, according to the 
fate map the dorsal vegetal blastomere also contributes to some of the 
endoderm. We did not inject this in our experiment because injection to the 
dorsal side might bring up the head/anterior suppression phenotype which 
in turn would complicate the observation. But in doing this we might not 
have filled the anterior dorsal and ventral regions that form the Xlhbox8 
domain with the Hox RNA. Since a posterior respecification, would manifest 
in downregulation of Xihbox8, this incomplete delivery of RNA might result 
in a false negative result of no respecification.
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VII.3.5. xHoxA13 phenotype characterisation
To better understand the phenotype observed earlier with the ventral 
vegetal injections of xHoxA13 to 8-cell embryos we needed to characterise 
it further. When we looked closer at the xHoxAl3 embryos, we observed 4 
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Figure 7.6 Classification of xHoxAl3 phenotypes.
We observed four different types of phenotypes observed when xHoxAl3 was 
injected at ventral vegetal blastomeres of 8-cell stage embryo. The photograph 
above shows examples of all four of the different phenotypes observed: normal, 
type I, II & III. Relative frequencies of each of the phenotypes observed for 2ng GFP 




The normal phenotype is self explanatory, a control phenotype 
indicating that the embryo has developed normally. In the type I phenotype 
a bubble has formed around the gut. The bubble tend to be cylindrical, with 
the gut apparently attached to the bubble and thinner towards the posterior 
end. The bubble around the gut was less distended than type II phenotype, 
possibly indicating an incomplete malformation. Therefore we believe that 
this phenotype is the least severe abnormal xHoxAl3 phenotype.
Type II phenotype embryos had also developed a bubble surrounding 
the gut, however the bubble in these embryos was larger and was not 
cylindrical. The gut was not attached to the bubble as it was with the type I 
phenotype, but was instead flattened and attached to the dorsal side of the 
embryo. This was more severe than the type I phenotype as the oedema 
was larger and the gut was visibly more deformed.
The type III phenotype was the most severe of all the phenotypes. 
The embryos have been severely shortened with most of the structure not 
developing normally. This phenotype was more typical following injection of 
1ng or higher amounts of xHoxA13. At this high concentration there is a 
possibility that the xHoxA13 had reached toxic levels. Thus, this phenotype 
might be a result of having a significant number of cells dying due to toxicity 
caused by an excess amount of xHoxAl3 protein.
We did a series of injections with 250pg, 500pg and 1ng of xHoxAl 3 
as well as 2ng GFP control. Again the xHoxAl3 was coinjected along with 
500pg GFP as a label. The relative frequencies of the different phenotypes 
can be seen in the graph at Figure 7.6. The frequencies of the phenotypes 
seem to be dependent on the amount of xHoxAl 3 injected.
From all the three phenotypes present, we decided to concentrate on
the type II phenotype as this could be considered the most representative of
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the xHoxA13 phenotype. Thus we decided to concentrate on the type II 
phenotype, which will be referred to simply as xHoxAl3 phenotype from this 
point. Looking at the relative frequencies of the phenotypes we decided that
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the optimal amount of xHoxAl3 that needs to be injected was 500pg per 
embryo as it generates the highest number of the type II phenotype.
VII.B.6 .Timing of phenotype
Previously, from looking at the gut in the whole embryo as well as in 
situ results we concluded that xHoxAl3 is most likely affecting gut 
morphogenesis and not specification. Since gut morphogenesis is a late 
event, that starts sometime between stage 40-41 (Chalmers and Slack, 
1998), we thought it might be interesting to identify the time at which the 
xHoxAl3 injected embryos starts developing abnormally. As before, 
embryos were injected at the ventral vegetal side (Figure 7.3) of 8-cell stage 
embryo. The injected embryos were then cultured in Nam/10 and were 
checked daily. A sample of injected embryos (about 10) was taken each day 
and fixed in 4%FA. These samples would later be sectioned to help 
characterise the phenotype.
Observing the xHoxAl3 injected embryos we noted that the embryos 
develop normally up to stage 39. The bubble only developed on the 
xHoxAl3 injected embryos starting from around stage 41 (Figure 7.7). From 
this we were able to conclude that the xHoxAl3 is only visibly affecting the 
development of the endoderm between stage 39 and 41. This was 
consistent with our earlier analysis that xHoxA 13 affects gut morphogenesis, 
which is a late event, and not endoderm specification. However because of 
a lack of temporal control with RNA overexpression, we cannot rule out a 
possibility that the visible abnormal phenotype we see between stage 39 
and 41 might be a manifestation of an earlier xHoxA 13 effect. The injected 
xHoxAl3 mRNA might have elicited its effects anytime between when it is 
injected and stage 39.
Once we established the timing, we then sectioned the fixed samples 
to see exactly how the gut development had been disrupted. Transverse 
sections of stage 41 GFP injected and xHoxAl3 injected embryos were 
made at 10pm per section. Photographs of these sections is shown below
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in figure 7.8. We observed the epidermal bubble clearly in the xHoxAl3 
injected embryos. Also we can clearly see a lack of coiling in the gut of 
xHoxAl 3 injected embryos confirming our observations on the 
wholemounts.
Figure 7.7 GFP and xHoxAl3 injected embryos at stage 39 & 41.
The xHoxAl3 injected embryos look normal at stage 39. At stage 41 however they 
have developed a bubble around the gut.
Observations of the sections also reveal that the inside of the 
endodermal mass contains a cavity. In the last three posterior sections of 
the xHoxA13 embryos shown in Fig 7.8 we can clearly see the gap starting 
to develop and gradually getting larger. It would seem that the layer of 
endodermal cells in the xHoxAl3 embryos is quite thin, unlike in the GFP






injected controls where it forms a solid mass of cells. This is most evident 
with the posterior most section of the xHoxAl3 embryos.
There are several possibilities for the cause of this cavity in the 
middle of the endoderm. One is that somehow the cells in the middle of the 
gut have died off leaving the gap in the middle. However this is unlikely 
because we did not observe any necrotic cells in the sections. Thus 
considering that the gut cells seem to be thinning especially towards the 
posterior we believe it was more likely that the cavity was a result of 
abnormal morphogenetic movements instead of cell death.
Figure 7.8 Transverse sections of GFP and xHoxA13 injected embryos.
Figure above shows transverse sections of stage 41 embryos that have been 
injected with GFP and xHoxAl3.
During normal development, two different cavities form and close in 
the embryo: the blastocoel, which is formed early and the archenteron, 
which is formed late. Considering that thexHox/473 phenotype occurs late, 
around stage 39-41, it is more likely that the cavity observed here is derived 
from the archenteron and not blastocoel. Previous study have shown that 
morphogenetic movements of the endodermal cells causes the archenteron 
to close around stage 38 before re-opening to form part of the gut cavity at 







movements by xHoxAl3 might prevent the archenteron from closing, 
leading to the large cavity seen in \hexHoxA13 phenotype.
V II.3.7. Affected Cells, endoderm or mesoderm?
During our injections we injected on the ventral vegetal side of 8-cell 
stage embryo. According to the fate map, these blastomeres contribute to 
both the mesoderm and endoderm layer derivatives (Dale and Slack, 1987). 
The distribution of the injected cells is somewhat random and as such there 
is no way to control which layer would have taken the most of xHoxAl3 
RNA.
This might explain the incomplete penetrance of the phenotype. The 
uneven uptake of the RNA by either layer could conceivably lead to different 
phenotypes being observed. For example the bubble that develops around 
the gut could be due to most of the xHoxAl3 mRNA being taken up by the 
endoderm or it could be by the mesoderm or it could be by both. The 
location of the effect is especially relevant for xHoxAl3 as it is normally 
expressed in both endoderm and mesoderm and as such may have an 
equal chance of affecting either layer when overexpressed. Thus to go 
further and understand the mechanism and causes of the phenotype it is 
important to see which germ layer is primarily affected.
In all of our injections we always coinjected with GFP mRNA. GFP 
here acts as a label, thus to see exactly where the xHoxAl3 has 
accumulated we would need to see the GFP on transverse sections of the 
affected embryos as whole mounts would not have enough resolution.
Photographs of the transverse cryossections of GFP and xHoxAl3 
injected embryos can be seen in Figure 7.9. Looking at the GFP we can infer 
that the xHoxAl3 mRNA has been taken up by the endodermal cells of the 
gut as well as the somites which would indicate that both the mesoderm 






Figure 7.9 Transverse sections embryos injected with GFP and xHoxA13.
GFP shows the location of cells that have taken up the injected RNA. As can be 
seen most of the GFP seen in the xHoxAl3 injected embryos are localised to the 
endoderm.
However with the xHoxAl3 injected embryos, the GFP signal seems 
to be found only in the endoderm. There was no signal coming from the 
somites. Thus it would seem that from this initial evidence that the xHoxAl3 
was eliciting its effect in the endoderm and not mesoderm. We need to note 
however that It was difficult to determine whether or not GFP was 
expressed in the sphlanchnic mesoderm. This particular layer of cells is hard 
to detect in normal embryos and even harder to see in a deformed one.
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VII.B.8. 32 cell injections
To test if it was the case that xHoxAl3 only needs to affect the 
endoderm to induce the phenotype, we went on to do injections on 32-cell 
stage embryos. This later stage injection should allow us to be more specific 




Figure 7.10 Diagram of 32-cell stage embryo.
Diagram showing the location of injections done on 32-cell stage embryos. The 
orange blastomeres indicates C3 and C4 blastomere and the green blastomere 
indicates D3 and D4 blastomeres.
According to the fate map the C3 and C4 blastomeres (orange 
blastomeres on Figure 7.10) mostly contribute to mostly mesodermal cells 
and the D3 and D4 blastomeres (green blastomeres on Figure 7.10) 
contribute to mostly endodermal cells (Dale and Slack, 1987). Thus by doing 
injections to either ventral C-tier (C3 and C4) or ventral D-tier (D3 and D4) 
blastomeres we can target the mesoderm or endoderm respectively. The 
total amount of mRNA injected was maintained at a total of 500pg per 
embryo for all of these injections. The volume of injections per blastomere 
was also kept at 4.6nl.
Injections to the C3 and C4 blastomeres with xHoxAl3 resulted in a 
normally developing embryo, and surprisingly, so did the injections to the 
D3 and D4 blastomeres (Figure 7.11). This then raised the possibility that 
both the mesoderm and endoderm is required to generate the phenotype.
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To confirm this we decided to do injections to all four blastomeres on 
the ventral vegetal side of the 32-cell stage embryo (C3, C4, D3 and D4). 
The total amount of xHoxA13 mRNA was again kept at 500pg per embryo 
and was injected at 4.6nl per blastomere. Results from this injection showed 
that when all four of the blastomere were injected we were able to generate 
the phenotype again. This then indicated that both the mesoderm and 
endoderm needs to take up the xHoxA13 mRNA to be able to generate the 
phenotype.
This was very interesting considering that our earlier observation 
showed the GFP in the 8 cell stage xHoxA13 injections were mostly 
localised to the endoderm. There are several possible explanations as to the 
lack of apparent GFP staining in the mesoderm of xHoxA13 embryos. It is 
possible that the mesodermal cells that have taken up xHoxA13 mRNA 
might have mixed in with the endoderm thus disrupting the gut development
Similarly possible is that the mesodermal cells might have been more 
sensitive towards xHoxA13. Thus the cells that have taken up xHoxA13 
might have been killed off leading to the disruption of interaction between 
endoderm and mesoderm. This would then result in the disruption of gut 
morphogenesis leading to the deformed gut in the xHoxA13 phenotype. In 
this case the GFP signal would also be missing from the mesoderm.
To be able to test for these two possible mechanism we would need 
to be able to label the mesodermal and endodermal cells differently. This 
would require using two different labels to label each type of cells. Thus far 
in our experiments we have used GFP to label which cells have taken up the 
mRNA. There is another marker that will work in a similar fashion, 
rhodamine-dextran. Rhodamine-dextran is a fluorescent chemical molecule 
giving out a red fluorescence which is very different from the green emitted 
by GFP thus allowing for distinction. Like GFP; however, it can also label 
cells that have taken up mRNA in an injection.
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Figure 7.11 Injections of GFP and xHoxA13 done on 32-cell stage embryos.
Injections were done on the C3 and C4 or D3 and D4 or all four blastomeres with 
GFP and xHoxA13. Here we can see that xHoxA13 seem to only induce 
malformations of the gut when injected on all of C3&4 and D3&4 blastomeres.
Earlier we have discussed that at 32-cell stage embryo, the C3 and 
C4 blastomere contribute mostly towards mesodermal cells and that the D3 
and D4 blastomere contribute mostly towards endodermal cells. Thus if we 
coinjected GFP with the xHoxA13 mRNA into C3 and C4 blastomere and 
coinjected rhodamine-dextran with xHoxA13 mRNA into D3 and D4 cells 
then the mesodermal cells that have taken up the RNA should be labelled in 
green and the endodermal cells that have taken up the RNA should be 
labelled in red. This would allow us to study how the mesodermal and 
endodermal cells interact in the xHoxA13 embryos. We decided to use GFP 
on the C3 and C4 as GFP is more sensitive than rhodamine-dextran. There 
are fewer mesodermal cells compared to endodermal thus to allow for 




The GFP control was used as before, with 500pg coinjected with or 
without the xHoxA13 mRNA into the C3 and C4 blastomeres. With the 
rhodamine-dextran 4.6nl at 100|jg/ml was coinjected with or without 
xHoxA13 into the D3 and D4 blastomeres. We did a series of injections and 
coinjected xHoxA13 at C3 and C4 only, D3 and D4 only, and in all ventral 
vegetal blastomeres similar to the previous 32-cell injection. However unlike 
the previous 32-cell injections we started observing the phenotype in all of 
the injections, when previously only when all of C3, C4, D3 and D4 xHoxA13 
injections lead to a phenotype.
The reason for this difference becomes clear when we cryosectioned 
the embryos to identify where the labels have gone. Figure 7.12 shows 
photographs of an injection with GFP and rhodamine-dextran labels only 
without xHoxA13 mRNA. Looking at the transverse sections we can clearly 
see that the green from the GFP and the red from rhodamine-dextran show 
significant overlap, especially in the endoderm. If we assume that the 
overlap was due to the signals diffusing out and then mixing then it is also 
possible that the xHoxA13 may have also diffused similarly. This would then 
mean that the affected cells in a C3 and C4 or D3 and D4 injections might 
now mimic the affected cells seen in C3, C4, D3 and D4 injection leading to 
the apparently random appearance of the xHoxA13 phenotype in this round 
of injections.
We believe that this overlap might be due to the molecules moving 
across the blastomere boundary during injection. The time needed to inject 
with two labels instead of one is greater. To account for this extra time 
needed, we had to start our injections earlier, just as the blastomeres of the 
32-cell stage embryos are forming. By doing this, we might have injected 
the labels/mRNA into blastomeres that did not have a fully formed cell 
boundary yet. This in turn might have lead to the labels/mRNA diffusing 
between the two blastomeres leading to the overlap we see between the 
GFP and rhodamine-dextran.
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AC tier - GFP D tier - Rhodamine
D tier - Rhodamine
Figure 7.12 32-cell stage injections with 2 fluorescent labels.
Injections were done on 32-cell stage embryos on the C & D tiers. Injections at C- 
tier was marked with GFP and injections at D-tier was marked with Rhodamine- 
dextran. A) Shows whole embryo photos of the location of the markers. B) shows 




Our overexpression experiments shows that of the two most 
posterior Hox tested xHoxA13 is most likely to be involved in gut 
development as xHoxD13 overexpression did not have any visible effects on 
the gut development. In the xHoxA13 injections, the embryos developed a 
bubble (oedema) around the gut. However when we performed in situ with 
these guts for Xlhbox8 and Xcad2 we found that the normal expression 
pattern of specification markers Xlhbox8 and Xcad2 was maintained. This 
persistence of the endoderm patterning was unexpected in view of the 
degree to which the gut has altered in shape. However, we need to 
remember that some of the endoderm was not affected as we did not inject 
the dorsal vegetal side. According to fate maps this blastomere might 
contribute to some of the Xlhbox8 expressing region (Chalmers and Slack, 
2000; Dale and Slack, 1987), and as such a lack of the Hox mRNA in this 
region could mask a posterior respecification as Xlhbox8 would not be 
downregulated.
It might not be possible to investigate this possibility using RNA 
injection as injections to the dorsal vegetal side at the 8-cell stage might 
also induce some of the defects seen with the dorsal injections at the 4-cell 
stage, thus complicating the phenotype. Instead, to ensure expression in 
the entire endoderm without disrupting head structure it might be necessary 
to use a combination of transgenics and grafting. In this method, the Hox 
genes would be expressed throughout the whole embryo transgenically 
under the control of CMV promoter. Then around the gastrula stage , the 
endoderm and mesoderm from this transgenics embryo would be cut out 
and grafted to a donor embryo. Thus the recombinant embryo would just 
express the Hox genes in the whole endoderm and mesoderm, including the 
Xlhbox8 expressing region, allowing for detection of posterior 
respecification.
Since there was no change in specification of the endoderm in the 
ventral vegetal injections we decided to focus on the visible morphological
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changes in the gut. Observing the whole embryo there was an oedema that 
was formed around the gut. The gut itself contained a large cavity, lacked 
coiling and seemed to attach itself to the dorsal side of the embryo. We are 
currently unsure as to the role the oedema might play in the formation of the 
gut phenotype. There is a possibility that the formation of the oedema might 
have lead to the formation of the deformed gut. The water that is taken up 
inside the oedema might act as an obstacle to the endoderm, preventing its 
normal morphogenetic movements thus leading to the deformed gut 
observed. Thus far we have not been able to exclude this possibility as all 
the deformed gut observed thus far were always accompanied by the 
oedema. Hence at this point we can only conclude that the malformation of 
the gut and formation of oedema is somehow linked.
Looking at transverse sections of the xHoxA13 injected embryos 
shows that the gut of the affected embryos to be distinctly different from the 
uninjected ones. We were able to confirm whole mount observations that 
the xHoxA13 embryo guts did not show coiling. We were also able to 
discover that the guts of the xHoxA13 embryos were not a solid mass of 
cells towards the posterior of the embryo. A cavity has formed in the middle 
of the endoderm in this part of the embryo. Also the layers of cells seem 
much thinner in the xHoxA13 embryos, especially towards the dorsal side 
where the cells appear to be only 1-2 layers thick. We suggest that this may 
be due to disruption of the morphogenetic movements of the gut. Perhaps 
the xHoxA13 has promoted some cell-cell intercalation that would lead to 
the thinner layer of cells as well as the cavity in the middle of the endoderm.
We also traced the location of the coinjected GFP labels on 
cryosectioned embryos and found that in the abnormal xHoxA13 embryos, 
most of the mRNA was in the endoderm and not mesoderm. Initially we had 
thought that the xHoxA13 was eliciting its effects in the endoderm, however 
subsequent experiments confining the xHoxA13 to the endoderm only failed 
to generate the same phenotype. Injections of xHoxA13 into D3 and D4 
blastomeres of 32-cell stage embryo only resulted in normal embryos. It
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was only when all the C3, C4, D3 and D4 blastomeres were injected that the 
xHoxA13 phenotype was generated. This then indicated that the expression 
of xHoxA13 in the mesoderm as well as the endoderm is necessary to 
generate thexHoxAl3 phenotype.
At the moment we believe that the key to understanding this 
phenotype is an ability to visualise and understand the relative movements 
of the mesoderm and endoderm in the xHoxA13 embryos. We attempted to 
do this by injecting two different fluorescent dyes, GFP and rhodamine- 
dextran to the mesoderm and endoderm respectively. However we 
encountered a technical hurdle with this approach. Due to the extra time 
needed to inject both labels to the appropriate blastomeres, the injection 
had to be done earlier just as the blastomeres of the 32-cell stage embryo 
formed. This extra time would not be needed if we only had to inject a small 
number of embryos, but because of the incomplete penetrance of the 
xHoxAl3 phenotype it is important to inject at least 15 embryos per 
experiment to get a significant number of abnormal embryos. This, 
combined with the difficulty of obtaining regularly cleaving embryos makes 
it difficult to get a reasonable result with this method. To solve this problem 
we would need to develop a faster way of injecting the two labels into their 
respective blastomeres. Perhaps with 2 people doing the injections in 
tandem we might be able to do the injections later and still achieve a 
statistically significant number with the phenotype.
We still believe that this method is an appropriate approach to 
investigate the mechanism and causes of the xHoxAl3 phenotype. It is the 
most straightforward and simple way to deliver two separate labels to two 
separate groups of cells. We could in principle use transgenics to achieve 
this but this would mean that we need to make two separate constructs 
with two separate promoters, one for the endoderm and another for the 
mesoderm. This would take a much longer time than simply optimising the 
RNA injection method. Transgenics would probably be more useful at a later
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stage in the investigation, once the mechanism is known to help with the 
more specific and delicate experiments.
In conclusion we found that xHoxA13 is able to disrupt endoderm 
development on overexpression. It appears to perturb the morphogenesis of 
the gut but not the specification of the endoderm. The expression pattern of 
Xlhbox8 and Xcad2 seems to be more stable than previously expected, 
although this might be due to incomplete delivery of Hox RNA to the 
Xlhbox8 region. Thus far we have been able to show that the malformations 
of the gut only appears when xHoxAl3 was expressed in both the 
mesoderm and endoderm. However we need to remember that an 
overexpression experiment such as this does not prove involvement of 
xHoxAl3 in the normal development of the endoderm. To do this we would 
need to perform a loss of function experiment of some sort. Perhaps by 




VIII.1. Endoderm specification -  current model
Regional specification of the endoderm is defined as the commitment 
of each tissue region, which is manifested on culture in a neutral medium 
but may still be reversible by grafting to a new position (Slack, 1983). Like 
other embryological concepts, this one dates from the pre-molecular era. 
Nowadays, in Xenopus , we consider it is possible to observe specification 
by the expression of transcription factors such as Xlhbox8 and Xcad2 that 
would later drive the expression of tissue specific genes in fore and mid­
hind gut respectively (van den Akker et al., 2002; Wright et al., 1988). There 
may also be advanced activation of some differentiation products such as 
IFABP during this stage of development (Shi and Hayes, 1994). Throughout 
the years there have been two conflicting models for the specification of the 
endoderm in Xenopus. The early model based on vegetal explants (Gamer 
and Wright, 1995; Wright et al., 1988; Zorn et al., 1999) and the late model 
based on stage 20-23 endoderm explants (Horb and Slack, 2001).
The early model proposed that the specification of the endoderm 
occurs early in development (prior to gastrulation), cell-autonomously and in 
the absence of mesoderm. Certain regions of vegetal explants from blastula 
stage embryos, was shown to express Xlhbox8 and IFABP (Gamer and 
Wright, 1995; Wright et al., 1988). Anterior endoderm in particular was 
thought to be specified by the early blastula stage as marked by the 
expression of Xhex and Cerberus (Zorn et al., 1999). However recently this 
apparent cell-autonomous specification was shown probably to be due to 
previously undetected presence of mesoderm (Horb and Slack, 2001).
Indeed it was shown by these authors that endoderm-only explants 
made from a later stage embryo (stage 20-23), where the endoderm and 
mesoderm can easily be separated, does not express Xlhbox8 or Xcad2, 
indicating lack of specification. The presence of mesoderm is essential for
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the initial and continued expression of both Xlhbox8 and Xcad2. 
Heterologous recombinations done by Horb and Slack, also indicated that 
the signals sent by the mesoderm is acting in an instructive manner. 
Anterior endoderm took on a posterior specification when recombined with 
posterior mesoderm. Similarly posterior endoderm takes on an anterior 
specification when recombined with anterior mesoderm. This then lead to 
the second model of endoderm specification where its specification took 
place later in development (neurula stages) and was dependant on 
instructive signals from the mesoderm (Horb and Slack, 2001).
In our study, we have made findings that both agree and disagree 
with the Horb and Slack model. Similar to Horb and Slack (2001) we found 
that mesoderm was indeed essential for the specification of the endoderm 
as isolated endoderm failed to express both Xlhbox8 and Xcad2. This also 
confirms that the endoderm specification occurs late in development and is 
not cell-autnonomously. However unlike the earlier Horb and Slack study 
(2001) we found that the mesoderm was not capable of instructing the 
mesodermal fate. In our recombinations the endoderm maintained its 
original fate regardless of whether or not it was recombined with anterior or 
posterior mesoderm. We have considered several reasons for why we 
observed a permissive instead of an instructive one.
Out of the different possibilities (see Chapter 5 Discussion, p100) we 
believe that the discrepancy in results is probably due to the variable nature 
of the explants. The cuts done to create the explants are somewhat arbitrary 
and as such the results themselves can be variable if one is not careful. 
Thus, it was possible that Horb and Slack in their study did not perform 
enough repetitions to see this variability. Also, no in situ data was obtained 
alongside their PCR to confirm that the mesoderm was instructive. 
Considering that we obtained at least three consistent and repeatable with 
with our recombinations with both in situ and PCR, we believe that our 
result is the correct one and that the mesoderm is permissive not instructive 
at stage 20.
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This discovery meant that the endoderm must have been patterned 
earlier, and that up to the mid 20s stages continued association with 
mesoderm is necessary to maintain it. It is currently unclear as to how or 
when it receives its patterning as our attempts to make endoderm-only 
explants from early embryos (stage 10.5 and 13)) were unsucccessful: the 
explants always contained some mesoderm. However previous studies 
have found that Xlhbox8 is expressed as early as stage 12.5 (Wright et al., 
1988). Thus, it is conceivable that the endoderm is also patterned around 
this stage. This pattern is then maintained by the mesoderm, becoming 
stable after stage 25, presumably when the endoderm and mesoderm stop 
their relative movements and become finally aligned with each other 
(Chalmers and Slack, 2000). According to the traditional definition the 
period of mesoderm-dependent commitment is not specification since it is 
not maintained in a neutral medium. However it is specification if endoderm 
and mesoderm are considered together as a unit.
The fact that the mesoderm is permissive rather than instructive also 
had implications for our screens. Initially we wanted to screen various 
growth factors and inhibitors on endoderm-only and endo+meso explants in 
an attempt to identify the mesodermal signals. Any of these screens should 
be able to respond to an instructive signal, so long as the competence of 
the endoderm to respond is still maintained at the stage of testing. However 
if the mesoderm is permissive, then the growth factor screen on endo+meso 
explants becomes redundant. The endoderm in these explants already 
shows the normal anterior expression of Xlhbox8 and posterior expression 
of Xcad2. This normal expression would not change in the presence of any 
growth factors that are mimicking a permissive mesodermal signal.
The growth factors on endoderm-only explant, however, would still 
be relevant. In this screen the endoderm-only has no expression of Xlhbox8 
or Xcac/2, thus a growth factor mimicking a permissive signal should show 
recovery of the anterior expression of Xlhbox8 and posterior expression of 
Xcad2. Similarly the inhibitor screen on endo+meso explants would still be
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relevant as molecules that inhibit specification would result in a 
downregulation of the normal expression domain of Xlhbox8 and Xcad2.
Thus based on this we can still confirm that neither Activin A, BMP4, 
FGF4, FGF8, FGF10, EGF, or RA was able to induce specification in stage 
20 endoderm-only explants. We also excluded a possible role for Wnt as 
LiCI treatment of explants, which mimics Wnt activation by inhibiting GSK- 
3(3, did not yield any change to expression pattern of Xlhbox8 and Xcad2. 
This was consistent with the inhibitor screen as inhibitors of these pathways 
were shown to not affect the expression domains of Xlhbox8 and Xcad2.
VIII.2. Future work on endoderm specification
From our results we believe there are two main areas of interest that 
would need addressing to better understand the specification of endoderm 
in Xenopus. The first would be the mesodermal signals at stage 20. We have 
shown that even though they ae not capable of respecifying the endoderm 
they are still essential for the maintenance of expression of Xlhbox8 and 
Xcad2. It would be interesting to see how this is done, we have tested 
several growth factors and have excluded them from having a role in 
endoderm specification, at least as single agents.
However this list of growth factors was not exhaustive as it is limited 
by commercial availability. We have discussed previously testing for newly 
available commercial growth factors as well as possible new and novel 
growth factors that came out of the screen of anterior endoderm carried out 
by Aaron Zorn (see chapter 4 discussion, p84). Also we need to test for the 
possibility that the growth factors are acting collaboratively and not as a 
single inductive signal. We can directly test collaborative signals as well as 
newly available commercial factors using the endoderm explant method.
With commercially unavailable as well as novel factors we could 
perhaps use an oocyte based system to express them. Manually 
defolliculated oocytes when injected with mRNA coding for the protein of 
interest continually produce and secrete that protein when cultured in oocyte
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culture medium (OCM). This method has been used previously with animal 
caps to successfully reconstitute inductive signaling (Lustig and Kirschner, 
1995). This test could then be adapted to study endoderm respecification 
by putting the endoderm or endo+meso explants on the injected oocytes 
and thus allowing the expressed protein to affect the explants.
The other area of interest would be the earlier endoderm patterning 
event. We showed that stage 20 mesoderm is only maintaining a previously 
existing pattern. Our attempts to study this possible earlier patterning event 
using stage 10.5 and 13 embryos were unsuccessful. We found that, similar 
to vegetal explants made from stage 9 embryos, endoderm explants made 
from stage 10.5 and 13 showed a significant amount of xFOG and FoxF1 
indicating the presence of mesoderm. Expression of these two markers was 
noticeably missing from stage 20 endoderm-only explant. This meant that 
we could not perform a growth factor screen using earlier endoderm 
explants.
Thus to study the earlier patterning event we need to consider new 
methods that do not require generation of endoderm-only explants. 
Recently there was introduced a new method that allows for selective 
ablation of cells. This uses a modified viral protein known as M2(H37A), 
which is a small integral membrane protein isolated from a variant of the 
influenza virus. Normally this protein functions as a proton selective channel 
of the trans Golgi compartment during influenza infection. However if the 
protein is modified to have a His-Ala subtitution at the 37th residue the 
protein acquires a much broader specificity for all cations (Chizhmakov et 
al., 1996; Ogden et al., 1999; Tang et al., 2002). This in turn makes the 
protein much more toxic and it has been shown to be capable of killing 
transfected mammalian cells unless they are cultured with the anti 
antiinfluenza drug rimantadine (Smith et al., 2002). This is because 
rimantadine binds to the channel protein, preventing its function and 
consequently its toxicity.
153
In Xenopus it was demonstrated that microinjection of M2(H37A) 
RNA into selected blastomeres of early stage embryos results in death of 
their progeny by late blastula stages (Smith and Mohun, 2004). This meant 
that the protein is toxic as well in Xenopus. However if these injected 
Xenopus were cultured in medium containing the drug rimantadine, then 
they developed normally. This then means that the method enables 
temporal control as to when the cells are killed. This is important in our 
study of endoderm specification as this would allow us to ablate the 
mesodermal cells just before regional specification occurs and not disturb 
the earlier development events.
To ablate mesodermal cells specifically we would also need spatial 
control for the expression of the M2(H37A) protein. A recent paper 
describes the isolation of the 5’ promoter region for FoxF1, a gene 
expressed almost exclusively in the mesoderm around the endoderm (Tseng 
et al., 2004). This promoter has been shown to successfully drive expression 
of GFP and LacZ specifically in the lateral plate mesoderm. Hence it follows 
that if we put the gene M2(H37A) protein under the control of the FoxF1 
promoter we would be able to isolate the expression of the channel proteins 
to the mesoderm.
Thus the complete method for ablating the mesoderm around the 
endoderm would involve transgenically expressing the M2(H37A) protein 
under the control of the FoxF1 promoter. The transgenic embryo is then 
grown in medium containing rimantadine until it reaches stage 20 where the 
drug is removed, activating the channel protein and selectively killing the 
mesodermal cells. Various different growth factors attached to heparin- 
acrylic beads could then be implanted in these mesoderm free embryos, 
which should now be suitable for detecting permissive growth factors 
allowing for further study into the role of mesoderm at this particular stage 
of development.
We need to note however that this method is still just an idea and 
would require a good deal of optimization. Also we need to note that we
154
were ourselves unable to obtain a working transgenic with the FoxF1 
promoter. Discussions with members of Aaron Zorn’s lab revealed that 
other labs are having problems with this particular promoter as well. Despite 
all of these drawbacks, it might be worth pursuing this method as it could 
create an elegant in vivo system to study regional specification in Xenopus.
4 5
Figure 8.1 Stage 20 quarter explants.
Diagram above shows how the stage 20 embryo is divided in to four quarters from 
anterior to posterior: extreme anterior (EA), anterior (A), posterior (P) and extreme 
posterior (EP).
Other than these two major areas, we would also like to follow up a 
particularly intriguing result we observed during quarter explant 
heterologous recombination. The downregulation of Xcad2 when the 
extreme anterior endoderm were recombined with extreme posterior 
mesoderm. This downregulation of the posterior marker of development by 
posterior mesoderm was puzzling. We were not able to come up with a 
satisfactory model to explain this with our current ideas. Initially we thought 
that this could indicate that Xcad2 expression at the extreme anterior 
endoderm is very labile or that the Xcad2 inducing signal is coming from the 
middle of the embryo. However both these model does not explain why the 
Xcad2 expression is maintained with extreme anterior mesoderm 
recombination. At the moment more data is needed, more heterologous
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recombinations needs to be done with the other two regions in the middle of 
the embryo (A and P in Figure 8.1). This is to confirm whether this 
downregulation is specific to the extreme posterior mesoderm or occurs 
with any mesoderm except the extreme anterior mesoderm.
VIII.3. Hox Genes expression in Xenopus mesoderm
In our study we also attempted to investigate how the mesoderm 
obtained its positional identity so that it can subsequently pattern the 
endoderm. The Hox genes were our main focus for this investigation. In 
chick the Hox genes have been found to be expressed in a nested, 
overlapping patterns in the developing gut mesoderm (Roberts et al., 1995; 
Sakiyama et al., 2000; Sakiyama et al., 2001; Yokouchi et al., 1995). 
Interestingly the boundaries of expression pattern of some of these 
mesodermal Hox genes align with the morphological borders of the different 
gut regions (Grapin-Botton, 2005).
Similar nested expression pattern have been seen with the 
Abdominal B-type Hox in Xenopus (Lombardo and Slack, 2001). In this 
study xHoxA9, xHoxD9, xHoxDIO, xHoxC12 and xHoxA73 were shown to 
be regionally expressed in the mesoderm. These genes were also found to 
be expressed in isolated gut of stage 42 embryos with xHoxAl3 thought to 
be expressed in both mesoderm and endoderm. Our study builds on this 
and tested for the expression of these Hox genes as well as xHoxD13 in 
endoderm-only and endo+meso explants. Through in situ hybridisation we 
have shown that xHoxD9, xHoxDIO and xHoxC12 are expressed in the 
endo+meso explants. Since endo+meso explants contains the minimum 
amount of tissue for the correct specification of the endoderm, this then is 
consistent with a possible role for Hox genes in endoderm specification.
xHoxAl3 and xHoxD13 was found to be expressed in a modified 
endo+meso explant that included more posterior regions. Because of this 
modification we were not able to use similar arguments to support their 
possible role in endoderm specification. Their posterior expression indicates
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that they might be expressed at the proctodeal level, a different territory 
from the future intestine (Chalmers and Slack, 2000). However, it is still 
possible that xHoxAl3 and xHoxD13 might still be involved in endoderm 
development. It is conceivable that xHoxA13 and xHoxD13 can induce the 
formation of a posterior gradient from the proctodeal region which in turn 
will pattern the endoderm.
We did not obtain any clear staining with xHoxA9 in endoderm-only, 
endo+meso explants or isolated stage 42 gut. However the in situ on stage 
35 whole embryos showed the expected expression pattern for xHoxA9. We 
believe that the lack of staining with the xHoxA9 probe on the explants and 
gut represents a downregulation in the expression of xHoxA9 by stage 42.
We were also able to resolve the germ layers at which these 
Abdominal B-type Hox is expressed, the endoderm and mesoderm. By 
sectioning gut following wholemount in situ we found that xHoxD9, 
xHoxDIO, xHoxC12 and xHoxD73 are expressed in the mesoderm. xHoxAl3 
was also expressed in the mesoderm with a possible gradient expression 
towards the endoderm. We have discussed several possible reasons for the 
graduated expression of xHoxAl3, including an FGF8 like RNA gradient 
(Delfini et al., 2005; Dubrulle and Pourquie, 2004) or it might represent a 
different threshold of xHoxAl3 activation in endoderm compared to 
mesoderm. To determine which might be correct we believe that it is 
necessary to investigate activation of the downstream molecules of 
xHoxAl3 as well as its normal function in Xenopus. This would probably 
best done using either differential RNA analysis or microarrays.
VIII.4. Hox overexpression and endoderm
We also investigated the possible functions of Hox genes in 
endoderm specification by overexpressing the two most posterior Hox 
xHoxAl3 and D13 through RNA injections. Previously in chick it was 
demonstrated that loss of expression of Hoxa-13 and Hoxd-13 results in the
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alteration of muscle layers of the sphincter, which is consistent with a partial 
anterior transformation of this region (Kondo et al., 1996; Warot et al., 1997).
In our study we found no abnormal phenotype with xHoxD13 
injections. The expression domains of Xlhbox8 and Xcad2 was similar to 
control uninjected embryos. However we did see an altered phenotype with 
the xHoxAl3 RNA overexpression. We found that an injection to the vegetal 
ventral side of 8-cell stage embryo induced the formation of an oedema and 
affected the morphogenesis of the gut.
We were surprised to find that the normal expression domains of 
Xlhbox8 and Xcad2 were maintained in these deformed guts. However we 
later discovered that this lack of respecification could be due to a 
technicality. At the time of the experiment we decided to deliver the RNA to 
most of the gut by injecting to the ventral vegetal blastomeres of 8-cell 
stage embryo. We avoided injecting to the dorsal vegetal blastomeres 
because there was a possibility of inducing a head/anterior suppression 
which would complicate the analysis of the results. However in doing this 
we might have inadvertently not delivered fully the Hox RNA to the Xlhbox8 
expressing region in the embryo. According to the fate map dorsal vegetal 
blastomere can contribute to some of the anterior dorsal and ventral regions 
that form the Xlhbox8 domain (Chalmers and Slack, 2000; Dale and Slack, 
1987). As such the incomplete delivery of the Hox RNA to the Xlhbox8 
expressing region might have prevented its dowregulation, making it 
impossible to detect posterior respecification of the endoderm.
We also attempted to further characterise the obvious deformities 
seen in the gut of xHoxAl3 injected embryos. Sections revealed a cavity 
developing in the gut endoderm. We believe that this cavity is due to 
abnormal cell-cell intercalation movements rather than cell death as we did 
not observe any necrotic cells in the gut. We also found that the abnormal 
phenotype became visible around stage 39 and 41. However because we 
did not control the temporal expression of the xHoxAl3 RNA we cannot rule
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out the possibility that the xHoxAl3 might be affecting earlier development 
and that the effect only manifests itself by stage 39.
By observing the localisation of coinjected GFP we were able to 
identify that with the abnormal phenotype, the xHoxAl3 RNA was mainly in 
the endoderm. However we believe that this is not due to more endodermal 
precursors taking up the RNA during the injections. Our injections to the D3 
and D4 blastomeres at 32-cell stage, which would have affected mostly 
endodermal cells, could not induce the phenotype. Instead we found that 
injections to the C3 and C4 blastomeres, which contributes to mostly 
mesodermal cells, alongside injections to D3 and D4, was necessary to 
induce the phenotype. This then indicates that uptake of the xHoxAl3 RNA 
by the mesodermal cells is necessary to induce the phenotype. Thus the 
earlier observation of GFP in endoderm only could be due to either the 
mesodermal cells that took up the RNA moving towards the endoderm and 
disrupting the morphogenesis or that the mesodermal cells themselves were 
dying off and as a consequence causing disruption to the morphogenesis of 
the gut.
VI11.5. Future work on Hox genes in Xenopus
With the Hox experiments there are several things that need to be 
addressed. The first is to correct the overexpression of the Hox genes to 
overexpress them fully in the Xlhbox8 region to allow for detection of 
posterior respecification. We feel that for this purpose RNA injections would 
probably not be the best approach as the dorsal-vegetal injection necessary 
to do this would also induce head/anterior structure suppression 
complicating the analysis. Instead we should consider using a combination 
of transgenics and grafting. First the Hox genes would be expressed 
throughout the whole embryo under the control of a global promoter such 
as CMV. Then around gastrula, the endoderm and mesoderm from the 
transgenic embryo would be grafted to a host embryo. Thus the 
recombinant embryo would just express the Hox genes in the whole of 
endoderm and mesoderm, including the Xlhbox8 expressing region.
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We also still need to investigate why xHoxA13 expression was only 
found in the endoderm in the abnormal phenotype when it needs to be 
overexpessed in both mesoderm and endoderm. We believe that the best 
way to study this is still by using two fluorescent markers. This would help 
visualise how the endoderm and mesoderm move with respect to each 
other and give insight into how their interaction causes the abnormal 
phenotype. At the moment the biggest problem with this method is speed, 
we could not do it quickly enough to avoid the problem of RNA leaking from 
one blastomere to another. However this can be easily avoided by either 
involving two people to do the injections and cut the time in half or by 
somehow optimising the injection method to make it faster.
There are also other Hox genes, xHoxD9, xHoxDIO or xHoxC12, that 
have been shown to be expressed in the mesoderm but have not yet been 
tested for possible involvement in endoderm specification. The transgenic 
and grafting method described above should be suitable for overexpressing 
these Hox genes to see if they would disturb the specification of the 
endoderm.
Finally we must also remember that thus far we have only considered 
overexpressing the Hox genes. Overexpression itself is not enough to 
conclusively say that a particular Hox is involved in the normal development 
mechanism. For this purpose it is essential that we do a complementary 
knockout study alongside the overexpression. This would probably be done 
using morpholinos to knock down the RNA levels of the Hox in the embryos 
and observing if it could disturb the specification of the endoderm.
VIII.6. Conclusion
Our results supports, in part, the Horb and Slack model of endoderm 
specification. We also found that the endoderm does not become specified 
until after stage 25 and that the presence of mesoderm is essential for 
specification of the endoderm. However, contrary to Horb and Slack (2001), 
we believe the mesoderm between stage 20-25 is not capable of directing
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endoderm specification, instead it is only maintaining a previously existing 
pattern. We have also shown that the mesodermal signals maintaining 
expression of Xlhbox8 and Xcad2 between stage 20-25 is not Activin A, 
BMP4, FGF4, FGF8, FGF10, EGF or RA. We are also confident that the 
mesodermal signals do not belong to the WNT signalling pathway.
Obviously this model of endoderm specifcation in Xenopus is still 
incomplete. We still have not discovered the identity of the permissive 
mesodermal signals at stage 20. There are new novel factors, recently 
isolated from a microarray on anterior endoderm (Aaron Zorn, unpublished 
data), that need to be tested for possible involvement in endoderm 
specification. We are also still unsure when the initial patterning event takes 
place, although looking at the temporal expression of Xlhbox8 it might be as 
early as stage 12.5 (Wright et al., 1988).
Thus far based on our results we are still unable to either prove or 
disprove possible roles of Hox genes in endoderm specification. We have 
shown that they are expressed in the correct germ layer to provide 
positional information to the mesoderm which would in turn allow it to 
pattern the endoderm. However because of a technical limitations, RNA 
overexpression of xHoxAl3 and xHoxD13 might not have affected the 
Xlhbox8 region, thus masking the possible posterior respecification of the 
endoderm. Although we did obtain an interesting gut deformation 
phenotype that is induced by overexpression of xHoxAl3, showing that it 
disrupts the morphogenesis of the gut. We have not completed our 
characterisation of this phenotype but initial analysis indicates that 
overexpression needs to be in both mesoderm and endoderm and that the 
phenotype might be due to disruption of cell-cell movement.
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